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 ABSTRACT 
Immune system is made of a variety of cells, molecules and biological processes that interacts to 
prevent microbial invasions, recognize foreign molecules and eliminate existing sources of cellular 
injuries to restore tissues to their normal functions once problem has been solved. Innate immunity 
is the primary defense line against pathogens invasions. Its functioning typically undergoes severe 
alterations during transition period (TP) of dairy cows. An impairment of polymorphonuclear cells 
(PMN) functions related to reactive oxygen metabolites (ROM) production, myeloperoxidase 
(MPO) activity, chemotaxis and phagocytosis has been reported in this phase. Bovine PMN have an 
altered abundance in mRNA transcripts encoding for such functions between -1 and 2 weeks from 
calving, in comparison to the level found at 4 weeks after calving for the same genes. The exact 
cause of immune dysfunctions occurring in peripartum has never been clearly identified. Reduced 
immune competence could arise from the interaction of different factors affected from the typical 
peripartum trends (i.e. changes in endocrine asset, limitations of maternal immune responses against 
the allogeneic conceptus, alterations in energy balance and oxidative stress status). Nevertheless, its 
duration could be modified when peripartal changes exceed the control of homeorhetic and 
homeostatic mechanisms, leading to the physiological imbalance (PI) condition. Such a condition 
could also trigger the inflammatory-like status. It consists in a prepartal raise of pro-inflammatory 
cytokines (PICs) levels, that is linked to a raise in body temperature at calving, and that typically 
affects liver metabolism, implying severe losses in hepatic functions and a shift of anabolic priority 
of the organ in early lactation. The liver produces more α-globulins, known as positive acute phase 
proteins (APP), i.e. haptoglobin, ceruloplasmin and serum amyloid alpha (SAA). Conversely, it 
reduces the synthesis of albumin, retinol binding protein, paraoxonase (PON) and lipoproteins, 
known as negative APP and sequesters minerals, as zinc and iron, from blood flow. Inflammation 
lead to the activation of PMN, while the reduced immune competence commonly reported in TP has 
been associated to an opposite effect on leukocytes. Thus, these should be considered as two 
distinct phenomena, but they could arise from a common cause with a different magnitude and 
duration. Nutritional strategies to optimize dairy cow’s immunity during TP should be focused on 
reducing the PI degree related to calving, as this condition could be referred as a common 
denominator between immune dysfunction and diseases causes. Among such nutritional strategies, 
the correct management of energy sources to fit with altered requirements should be considered. 
Furthermore, fatty acids profile of lipid sources administered could also modify immune functions. 
Finally, the administration of supplementary products exerting antioxidant or anti-inflammatory 
activities, as well as methyl donors species, could be beneficial for dairy cows immunity in TP. In a 
wider perspective, although feed additives and nutritional strategy could be effective in mitigate 
immune alterations, we can conclude that adoption of proper management practices aimed to avoid 
PI condition in peripartal period of dairy cows could be the most effective strategy to prevent 
dysfunctions.  
Three experiments have been designed to elucidate the linkage between sudden changes 
occurring in peripartum and immune alterations in dairy cows. Throughout such experiments 
Holstein dairy cows were housed in tied stalls and monitored regularly for body condition score 
(BCS), body weight (BW), dry matter intake (DMI), milk yield (MY) and rumination time. Blood 
samples were collected regularly to assess a wide hematochemical profile and to test white blood 
cell functions through ex-vivo challenges. Furthermore, PMN diapedesis has been tested in-vivo 
through a carrageenan-skin test and rumen samples were collected at 30 days from calving (DFC). 
The first experiment was aimed in investigate the main causes of metabolic changes occurring at 
dry-off and the contribution of MY in such alterations. In fact, dry-off is related to deep changes in 
feeding behavior, gastro intestinal adaptations, metabolism and immune parameters in high-yielding 
cow’s career. Indeed, the release of cortisol, signals of systemic inflammation and altered redox 
balance have been reported immediately after milking interruption, and high MY have a role in 
aggravating such conditions. In our study, a group of 13 Holstein dairy cows were dried off at 55 
days from expected calving day, and regularly monitored from -7 to 34 days from dry-off (DFD). 
Animals were retrospectively divided in two groups according to their average MY in the last week 
of lactation, assuming a cut-off of 15 kg*d-1: low MY (6 cows) and high MY (7 cows). Data were 
submitted to ANOVA using a mixed model for repeated measures including MY at dry-off, time 
and their interaction as fixed effects. Increased fiber amounts of dry ration reduced DMI and 
increased rumination time. Leukocytes migration into mammary gland to contribute in the 
involution phase decreased their abundance in blood at dry-off, and their activity. Such activation of 
leukocytes at mammary site increased the abundance of nitrogen species in plasma and triggered a 
systemic inflammation in all the animals, as reflected from increased concentrations of positive and 
reduced concentrations of negative APPs. Such inflammation impaired liver functions, as suggested 
from the increased gamma-glutamyl transferase (GGT), bilirubin and alkaline phosphatase (ALP) 
concentrations. Both the production of nitrogen species and the systemic inflammatory status 
contributed in the depletion of antioxidant system in blood (thiol groups -SHp-, tocopherol, β-
carotene, ferric reducing antioxidant power -FRAP- and oxygen reactive antioxidant capacity -
ORAC-). Animals with higher MY at dry-off showed the worst condition, likely for the deeper 
metabolic changes they faced at milking interruption, and to the greater amount of mammary 
parenchyma to be reabsorbed. This study highlights the dry-off as a thorny point to manage dairy 
cows’ health and depose for a relationship between dry-off and immune alteration that typically 
occurs at calving. 
The second experiment was aimed in investigate changes occurring in the immune system prior 
to ketosis onset to elucidate their role in disease occurrence. Thus, a group of 13 Holstein dairy 
cows were monitored from -48 to 35 DFC and retrospectively divided into 2 groups basing on their 
plasma BHB levels: lower (CTR; 7 cows) or higher than 1.4 mMol/L (KET; 6 cows). Data were 
submitted to ANOVA using a mixed model for repeated measures including health status, time and 
their interaction as fixed effects. KET cows had a greater activation of the immune system prior to 
calving (higher plasma concentrations of PICs, myeloperoxidase and oxidant species, and greater 
interferon gamma responses to Mycobacterium avium) impaired liver functions (higher blood 
concentration of GGT) and lower plasma minerals. High plasma NEFA, BHB and glucose levels in 
KET cows suggest an insulin resistance status and a marked mobilization of body fat occurring 
during dry period. They were also associated to reduced DMI around calving and worse negative 
energy balance in early lactation. This caused in turn reduced MY and increased fat mobilization in 
early lactation. Impairment of liver function and activation of leukocytes during the dry period 
accentuated the acute phase response in KET cows after calving (greater concentrations of positive 
APPs and lower concentration of retinol binding protein), further impairing liver function (higher 
blood concentrations of glutamate-oxaloacetate transaminase -AST-GOT- and bilirubin). 
Leukocytes of KET cows had reduced inflammatory functions after an ex vivo stimulation assay 
(lower production of PICs and greater production of lactate). These alterations on WBC could be 
driven by the combined action of metabolites related to the mobilization of lipids and of anti-
inflammatory actions aimed to prevent over exuberant inflammation. This suggests that prepartal 
trends of immune parameters be highly related with the likelihood of developing diseases in early 
lactation. 
The third experiment consisted in the administration of Omnigen-AF (OAF), an immune 
stimulant that is effective in increasing leukocytes functions in immunosuppressed animals and in 
reducing incidence of infectious diseases in early lactating dairy cows. Its mode of action has never 
been elucidated, and a wider perspective of its metabolic effect could highlight its effectiveness in 
facing metabolic disorders of transition period also. Thus, a group of 10 Holstein dairy cows were 
divided into 2 groups: treated group (TRT; 5 cows) received 32.5 g of Omnigen-AF® (Phibro 
Animal Health Corporation) twice a day (65 g d-1) as top-dress on the morning and afternoon feeds, 
while control group (CTR; 5 cows) did not receive any supplementation. From -62 to 42 DFC 
animals were monitored regularly. Data were submitted to ANOVA using a mixed model for 
repeated measures including treatment, time and their interaction as fixed effects. Administration of 
OAF at dry-off did not affect BW, BCS, milk yield, milk and rumen fluid composition, and neither 
affected blood neutrophils concentrations. Nevertheless, it increased rumination time and improved 
the energy metabolism after calving (lower NEFA and BHB concentrations). TRT cows had an 
increased lymphocytes abundance at blood level, and their leukocytes had greater efficiency in 
facing biological stressors during the peripartum (lower lactate production and lower glucose 
consumption after a challenge with bacterial lipopolysaccharides). Despite these positive effects on 
immune cells, OAF did not affect the positive APPs concentrations after calving. A reduced 
abundance of albumin, PON and antioxidants also occurred with OAF after calving, suggesting 
some impairment of hepatic functions to occur. Nevertheless, the lack of any effect on main 
biomarkers related to liver function (bilirubin) and liver damage (GGT, AST-GOT, ALP) dismisses 
a real impairment of liver activities to occur with OAF. Positive effects in favoring the recovery of 
rumen functions, reducing mobilization of body fats after calving suggest OAF to be an effective 
strategy in preventing metabolic disorders of transition period. 
Key words: Immune dysfunctions, peripartum, dairy cows, innate immunity, dry-off, 
inflammation, metabolic stress, immune response, lipid metabolism, liver function, immune 
stimulant, metabolic disorders, transition period  
TABLE OF CONTENTS 
CHAPTER I - IMMUNE DYSFUNCTIONS AND PARTURITION ...................................................... 1 
The immune system of dairy cows: an in-depth analysis on alterations occurring from dry-off to 
early lactation .................................................................................................................................... 1 
ABSTRACT ............................................................................................................................................................ 1 
IMMUNE SYSTEM OVERVIEW .............................................................................................................................. 5 
Innate immunity ............................................................................................................................................. 5 
Adaptive immunity ....................................................................................................................................... 11 
PERIPARTURIENT PERIOD AND IMMUNE DYSFUNCTIONS ................................................................................ 14 
Peripartum alteration of metabolic functions .............................................................................................. 14 
The physiological imbalance conditions ....................................................................................................... 16 
Reduced immune competence ..................................................................................................................... 17 
The inflammatory-like status ........................................................................................................................ 19 
IMMUNE DYSFUNCTION: CAUSES AND EFFECTS ............................................................................................... 21 
Endocrine asset ............................................................................................................................................. 21 
Limitations of maternal immune responses against the allogeneic conceptus ............................................ 23 
Alterations in energy balance ....................................................................................................................... 23 
Oxidative stress status .................................................................................................................................. 26 
Immune dysfunction and diseases in transition period ................................................................................ 27 
NUTRITIONAL STRATEGIES TO FACE IMMUNE DYSFUNCTION IN TRANSITION PERIOD ................................... 30 
Variation of energy requirements and sources during peripartum .............................................................. 30 
Lipid sources supplementation ..................................................................................................................... 31 
Antioxidant elements supplementation ....................................................................................................... 33 
Methyl donors supplementation .................................................................................................................. 34 
Anti-inflammatory products supplementation ............................................................................................. 35 
CONCLUSIONS ................................................................................................................................................... 37 
TABLES ............................................................................................................................................................... 39 
CHAPTER II - DRY-OFF AND IMMUNE FUNCTIONS ................................................................. 65 
Innate immune response and metabolic changes at dry-off in high yield dairy cows ...................... 65 
ABSTRACT .......................................................................................................................................................... 65 
INTRODUCTION ................................................................................................................................................. 69 
MATERIALS AND METHODS ............................................................................................................................... 71 
Experimental design and animal management ............................................................................................ 71 
Body weight, body condition score, dry matter intake and rumination time .............................................. 72 
Health status ................................................................................................................................................. 72 
Blood samples collection .............................................................................................................................. 72 
Carrageenan skin test ................................................................................................................................... 75 
Statistical analysis ......................................................................................................................................... 75 
RESULTS ............................................................................................................................................................. 77 
Body weight, body condition score, dry matter intake, rumination time and health status ....................... 77 
Metabolic profile .......................................................................................................................................... 77 
White blood cells profile ............................................................................................................................... 79 
Whole blood stimulation assay ..................................................................................................................... 79 
Interferon gamma release assay and carrageenan skin test ........................................................................ 80 
DISCUSSION ....................................................................................................................................................... 81 
Dry-off dramatically affects metabolism and immune system of dairy cows............................................... 81 
High milk yield at dry-off is related to greater stress in dry period .............................................................. 86 
CONCLUSIONS ................................................................................................................................................... 89 
TABLES AND FIGURES ........................................................................................................................................ 91 
SUPPLEMENTARY FILES ................................................................................................................................... 102 
CHAPTER III - IMMUNE ALTERATIONS BOOST KETOSIS ........................................................ 107 
Altered immune functions in the dry period boost ketosis onset in early lactation ...................... 107 
ABSTRACT ........................................................................................................................................................ 109 
INTRODUCTION ............................................................................................................................................... 111 
MATERIALS AND METHODS ............................................................................................................................. 113 
Experimental design and animal management .......................................................................................... 113 
Body weight, body condition score, dry matter intake, rumination time and milk yield ........................... 113 
Health status ............................................................................................................................................... 114 
Blood samples collection ............................................................................................................................ 114 
Milk samples collection and analysis .......................................................................................................... 117 
Carrageenan skin test ................................................................................................................................. 117 
Rumen fluid parameters ............................................................................................................................. 117 
Retrospective analyses and animal grouping ............................................................................................. 118 
Statistical analysis ....................................................................................................................................... 118 
RESULTS ........................................................................................................................................................... 120 
Health status ............................................................................................................................................... 120 
Body weight, body condition score, dry matter intake, rumination time and milk yield ........................... 120 
Milk quality parameters .............................................................................................................................. 120 
Rumen fluid parameters ............................................................................................................................. 120 
Metabolic profile ........................................................................................................................................ 121 
White blood cells profile ............................................................................................................................. 122 
Whole blood stimulation assay ................................................................................................................... 123 
Interferon gamma release assay and carrageenan skin test ...................................................................... 123 
DISCUSSION ..................................................................................................................................................... 124 
Alterations of blood parameters in prepartum in post-partum ketotic cows resemble preeclampsia 
conditions ......................................................................................................................................................... 124 
Cows with ketosis have impaired feed behavior ........................................................................................ 128 
Ketosis is associated with inflammatory-like conditions post-partum ....................................................... 129 
Attenuated response of white blood cells to LPS and possible immunosuppression in post-partum ketotic 
cows .................................................................................................................................................................. 130 
CONCLUSION ................................................................................................................................................... 133 
TABLES AND FIGURES ...................................................................................................................................... 135 
SUPPLEMENTARY FILE ..................................................................................................................................... 148 
CHAPTER IV - METABOLIC EFFECTS OF AN IMMUNE STIMULANT IN TRANSITION COWS ...... 151 
Administration of an immune stimulant during the transition period improved energy metabolism 
and rumination without affecting inflammatory conditions............................................................. 151 
ABSTRACT ........................................................................................................................................................ 151 
INTRODUCTION ............................................................................................................................................... 155 
MATERIALS AND METHODS ............................................................................................................................. 157 
Experimental design and animal management .......................................................................................... 157 
Body weight, body condition score, dry matter intake, rumination time and milk yield ........................... 158 
Health status ............................................................................................................................................... 158 
Blood samples collection ............................................................................................................................ 159 
Milk samples collection and analysis .......................................................................................................... 161 
Carrageenan skin test ................................................................................................................................. 162 
Rumen fluid parameters ............................................................................................................................. 162 
Statistical analysis ....................................................................................................................................... 162 
RESULTS ........................................................................................................................................................... 165 
Body weight, body condition score, dry matter intake, rumination time and milk yield ........................... 165 
Health status ............................................................................................................................................... 165 
Milk quality and rumen fluid parameters ................................................................................................... 165 
Metabolic profile ........................................................................................................................................ 165 
White blood cells profile ............................................................................................................................. 167 
Whole blood stimulation assay, interferon gamma release assay and carrageenan skin test ................... 167 
DISCUSSION ..................................................................................................................................................... 168 
CONCLUSIONS ................................................................................................................................................. 173 
TABLES AND FIGURES ...................................................................................................................................... 174 
SUPPLEMENTARY FILE ..................................................................................................................................... 186 
CHAPTER V - FINAL REMARKS ............................................................................................. 191 
General considerations on altered immune functions during peripartum of dairy cows ............... 191 
INTRODUCTION ............................................................................................................................................... 191 
THE ROLE OF DRY-OFF ON IMMUNE DYSFUNCTIONS ..................................................................................... 193 
IMMUNE FUNCTIONS AND KETOSIS ................................................................................................................ 194 
OMNIGEN-AF AS A STRATEGY TO COPE WITH IMMUNE DYSFUNCTIONS ....................................................... 196 
GENERAL CONCLUSION ................................................................................................................................... 197 
REFERENCES ...................................................................................................................... 199 
APPENDIX .......................................................................................................................... 225 
 
CHAPTER I - IMMUNE DYSFUNCTIONS AND PARTURITION 
The immune system of dairy cows: an in-depth analysis on alterations occurring from 
dry-off to early lactation 
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ABSTRACT 
Immune system is made of a variety of cells, molecules and biological processes that 
interacts to prevent microbial invasions, recognize foreign molecules and eliminate existing 
sources of cellular injuries in order to restore tissues to their normal functions once problem 
has been solved. Innate immunity is the primary defense line against pathogens invasions. Its 
functioning typically undergoes severe alterations during transition period (TP) of dairy cows. 
An impairment of polymorphonuclear cells (PMN) functions related to reactive oxygen 
metabolites (ROM) production, myeloperoxidase (MPO) activity, chemotaxis and 
phagocytosis has been reported in this phase. Bovine PMN have an altered abundance in 
mRNA transcripts encoding for such functions between -1 and 2 weeks from calving, in 
comparison to the level found at 4 weeks after calving for the same genes. The exact cause of 
immune dysfunctions occurring in peripartum has never been clearly identified. Reduced 
immune competence could arise from the interaction of different factors affected from the 
typical peripartum trends (i.e. changes in endocrine asset, limitations of maternal immune 
responses against the allogeneic conceptus, alterations in energy balance and oxidative stress 
status). Nevertheless, its duration could be modified when peripartal changes exceed the 
control of homeorhetic and homeostatic mechanisms, leading to the physiological imbalance 
(PI) condition. Such a condition could also trigger the inflammatory-like status. It consists in 
a prepartal raise of pro-inflammatory cytokines (PICs) levels, that is linked to a raise in body 
temperature at calving, and that typically affects liver metabolism, implying severe losses in 
hepatic functions and a shift of anabolic priority of the organ in early lactation. The liver 
produces more α-globulins, known as positive acute phase proteins (APP), i.e. haptoglobin, 
ceruloplasmin and serum amyloid alpha (SAA). Conversely, it reduces the synthesis of 
albumin, retinol binding protein, paraoxonase (PON) and lipoproteins, known as negative 
APP and sequesters minerals, as zinc and iron, from blood flow. Inflammation lead to the 
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activation of PMN, while the reduced immune competence commonly reported in TP has 
been associated to an opposite effect on leukocytes. Thus, these should be considered as two 
distinct phenomena, but they could arise from a common cause with a different magnitude 
and duration. Nutritional strategies to optimize dairy cow’s immunity during TP should be 
focused on reducing the PI degree related to calving, as this condition could be referred as a 
common denominator between immune dysfunction and diseases causes. Among such 
nutritional strategies, the correct management of energy sources to fit with altered 
requirements should be considered. Furthermore, fatty acids profile of lipid sources 
administered could also modify immune functions. Finally, the administration of 
supplementary products exerting antioxidant or anti-inflammatory activities, as well as methyl 
donors species, could be beneficial for dairy cows immunity in TP. In a wider perspective, 
although feed additives and nutritional strategy could be effective in mitigate immune 
alterations, we can conclude that adoption of proper management practices aimed to avoid PI 
condition in peripartal period of dairy cows could be the most effective strategy to prevent 
dysfunctions. 
Key words: Immune dysfunctions, peripartum, dairy cows, innate immunity 
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IMMUNE SYSTEM OVERVIEW 
Immune system is made of a variety of cells, molecules and biological processes that 
interacts to prevent microbial invasions, recognize foreign molecules and eliminate existing 
sources of cellular injuries in order to restore tissues to their normal functions once problem 
has been solved (Sordillo, 2016). Two main defense lines could be distinguished according to 
the specificity of their mode of action and on the time course of their activation during a 
defensive process. 
Innate immunity 
Innate immunity is the primary line, which provides an immediate and nonspecific defense 
against any tissue injury and a variety of potential invading pathogens. It acts within seconds 
from the initial damage, as its components are already present or are activated quickly at the 
site of pathogen exposure. Its activation results in the inflammatory response, that induces 
alteration of vascular endothelium, leading to characteristic symptoms in affected tissues. 
Redness, heat and pain results from increased blood flow caused by enlarged vascular 
diameter. Swelling or edema results from the exit of fluid and proteins from the blood and 
their accumulation in tissues, consequently to the separation of tightly joined endothelial cells 
of blood vessels walls (Ryman et al., 2015). Innate immunity consists in a wide range of 
physical barriers, receptors, soluble and cellular components (phagocytes).  
Physical barriers. Physical barriers as skin, tears and mucus exert a mechanical action 
against infectious agents and are essential to avoid the pathogens entering the body.  
Recognition pathways. Once physical barriers have been compromised, the recognition of 
damaging agents is required to activate body defenses. Recognition is driven by factors 
known as pathogen-associated molecular patters (PAMPs) that are expressed on the surface, 
secreted or expressed intracellularly in invading bacteria, and damages associated molecular 
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patterns (DAMPs) that are expressed in hosts cells undergoing a tissue damage or apoptosis 
condition (Jungi et al., 2011; Kumar et al., 2011; Sordillo, 2016; Trevisi et al., 2016). 
Examples of PAMPs include lipopeptides of Gram-positive bacteria and lipopolysaccharides 
(LPS) of Gram-negative bacteria, while DAMPs include uric acid and extracellular ATP. 
Recognition occurs through a complex of proteins acting synergistically to identify the cause 
of damage: patterns of recognition receptors (PRRs) and cluster of differentiations (CDs). 
Once recognition occurred, these proteins trigger an intracellular signaling cascade that 
directly facilitate antimicrobial activity or activate cellular and soluble components of innate 
immunity. 
PRRs are proteins located on both non-immune and immune cells (ascribed to both innate 
and adaptive immunity). Main PRRs are summarized in Table 1. Toll-like receptors (TLRs) 
are single membrane spanning proteins that are the most studied PRRs in mammals. Ten 
different TLRs have been identified in the bovine (McGuire et al., 2006). Family of TLRs 
includes TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TLR10, TLR11, 
TLR12, and TLR13. C-type lectin receptors (CLRs) are membrane proteins involved in the 
recognition of carbohydrates (i.e. beta-glucans and mannose) through a calcium domain. 
Nucleotide binding oligomerization domain-like receptors (or Nod-like receptors - NLRs) are 
plasmatic proteins which act as intracellular sensors of PAMPs that enter the cell via 
phagocytosis or pores (as bacterial peptidoglycans), and DAMPs associated with cell stress. 
They include class II major histocompatibility complex transactivator (CIITA - that is 
involved in the activation of major histocompatibility complex of class II), IPAF and inhibitor 
of apoptosis domain-containing protein 1 (BIRC1). Retinoic acid-inducible gene (RIG)-like 
receptors (RLRs) are helicases involved in the release of pro inflammatory cytokines and 
type I interferons against RNA and DNA viruses. They include RIG-I (that binds short 5’-
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phosphate-double strained RNA), melanoma differentiation-associated protein 5 (MDA5 - 
that binds long double strained RNA) and LGP2 (Takeuchi and Akira, 2010). 
CDs are cell-surface molecules (receptors or ligands) that could be used to distinguish 
between leukocytes classes (immunophenotyping). Main CDs utilized with this aim include 
CD4 (helper T-cells), CD8 (cytotoxic T-cells) and CD14. They are involved in cell signaling 
or adhesion of innate immune cells and act synergistically with PRRs in the recognition 
pathway. As an example, LPS binding to TLR4 in complex with CD14 and LPS-binding 
protein induce inflammatory pathways as the signaling cascades related to mitogen-activated 
protein kinase and nuclear factor-κB (NF-κB). 
Soluble components. Several endogenous defenses could act against invading pathogens 
once they have been recognized. Some of those are preexisting, while some others are directly 
induced from the activity of recognition pathways. 
Complement is contained in serum and body fluids and consists in a complex of proteins 
that are synthesized mainly from hepatocytes, but also from monocytes and tissue 
macrophages (Sordillo, 2016). After its activation through PRR, complement triggers a 
cascade within its effector molecules, as complement factors C3, C5a and C5b-9 complex, 
creating pore-forming complexes with a direct antimicrobial action against bacterial cells 
(Hajishengallis and Lambris, 2010). Complement also have a role in opsonizing bacteria, in 
the recruitment of phagocytes and in the activation of their phagocytosis and bacterial killing 
activities (Rainard, 2003).  
Cytokines are soluble proteins with a very short half-life that are produced by both immune 
and nonimmune cells. They could interact with each other synergistically, additively or 
antagonistically and high affinity receptors for each cytokine are expressed on host cells 
(Sordillo, 2016). Their effect is driven, other than the quantity and type of cytokine expressed, 
from the relative expression of receptors on their target cells (Sordillo and Streicher, 2002; 
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Bannerman, 2009). Cytokines could be divided in three main groups according to their effects 
on inflammatory processes (Table 2). Pro inflammatory cytokines (PIC) are rapidly secreted 
at the beginning of the infection and are aimed to enhance inflammatory response (Ryman et 
al., 2015). Their systemic effects include the increase in body temperature and hearth rate and 
the decrease in feed intake (Dantzer and Kelley, 2007). They include tumor necrosis factor, 
alpha (TNFA), interleukin-1, beta (IL-1B), interleukin-2 (IL-2), interleukin-8 (IL-8), 
interleukin-12 (IL-12), interleukin-17 (IL-17), interferon alpha (IFNA) and gamma (IFNG). 
Anti-inflammatory cytokines (AIC) are typically related to the final phase of infection and 
they are involved in solving the inflammatory process. They include interleukin-4 (IL-4) and 
interleukin-10 (IL-10). Third class of cytokines could exert both pro and anti-inflammatory 
actions, depending on the infection phase at which they are released (Droogmans et al., 1992). 
They include interleukin-6 (IL-6). Release of cytokines is mainly induced from the signaling 
cascade related to the activation of NF-κB (Takeuchi and Akira, 2010) that lead to the 
expression of different patterns of cytokines based on the ligand (PAMP or DAMP) that has 
been recognized. LPS (PAMP related to Gram negative bacteria) lead to a greater expression 
of PIC, while lipopeptides (PAMP related to Gram positive bacteria) express a slower 
cytokines response during the early stages of infection (Bannerman, 2009). 
Oxylipids are lipid mediators that are mainly synthesized from the oxidation of 
polyunsaturated fatty acids (PUFA) of cell membranes through processes that could be both 
non-enzymatic, and triggered by reactive oxygen metabolites (ROM), or enzymatic, and 
triggered by cyclooxygenases (COX), lipoxygenases (LOX) or cytochrome P-450. Two main 
classes of oxylipids were classically distinguished based on the type of PUFA they came 
from. Omega-6 derived oxylipids that originate mainly from arachidonic and linoleic acids 
and include prostaglandins (PG), thromboxane (TX), leukotrienes (LT) and lipoxins (LX). 
Omega-3 derived oxylipids that originate from eicosapentaenoic acid (EPA) and 
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docosahexaenoic acid (DHA) and include protectins and resolvins (Raphael and Sordillo, 
2013). These compounds regulate the onset, magnitude and duration of inflammatory 
response, exerting both a pro or anti-inflammatory action depending on the timing and 
magnitude of their expression. Historically it was thought that Omega-6 derived oxylipids 
were pro-inflammatory, while Omega-3 derived oxylipids were anti-inflammatory (Serhan 
and Chiang, 2009). Nowadays, a more complex relationship between oxylipids and 
inflammation is emerging, as biosynthetic profiles of oxylipids and their effects have been 
related to both the availability of diverse PUFA and the timing of their metabolism through 
various oxidizing pathways (Table 3; Sordillo, 2016).  
Phagocytes. Phagocytes are white blood cells (WBC) that exert a common anti-bacterial 
action via phagocytosis at the infection site (Paape et al., 2002). It consists in the engulfment 
of bacteria in a phagosome followed by killing and the elimination of wastes with exocytosis. 
Bacterial killing occurs with the production of hydrolytic enzymes or highly toxic products, 
such as ROM. These result from respiratory burst, a reaction triggered from a membranal 
nicotinamide adenine dinucleotide-phosphate (NADPH) oxidase, which reduce oxygen and 
produce superoxide anion and hydrogen peroxide. Other ROM sources includes the 
combination of hydrogen peroxide with chloride triggered from the enzyme myeloperoxidase 
(MPO) to obtain hypochlorite. Phagocytes includes three main cellular classes that could be 
present in the infection site or recruited from blood flow. 
Macrophage are mononucleate WBC located in peripheral tissues and aimed to detect, 
recognize and kill pathogens. Their activation via PRR induces the production of pro 
inflammatory oxylipids and cytokines as IL-1B, IL-6 and TNFA, that acts on vascular 
endothelium to reduce blood velocity and increase the expression of adhesion molecules on 
endothelial cells, in order to recruit polymorphonuclear cells (PMN) to the infection site 
(Ryman et al., 2015). Macrophages also provide a connection between innate immunity and 
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specific defenses, as they are involved in the antigen presentation to primary T-cells (Rainard 
and Riollet, 2006).  
Dendritic cells (DCs) act as messengers between innate and adaptive immune responses, 
migrating into lymph nodes from tissues that are in contact with external environment (i.e. 
skin, nose, lung, stomach and intestine) once activated. Similar to macrophages, they act as 
antigen presenting cells in lymph nodes, activating lymphocytes and adaptive immune 
response (Mackensen et al., 2000; Sordillo, 2016). They are involved in the production of 
cytokines as IL-12, IL-23 and IFNA (Table 2). 
PMN includes neutrophils and eosinophils. Those cells act as sentinels, monitoring blood 
flow through chemotaxis and searching for signals of bacterial invasion in peripheral tissues. 
This activity largely depends on L-selectin (SELL), a surface protein that allows PMN slow 
rolling along the interior vessel walls. Once PIC and oxylipids produced from activated 
macrophages are detected, they trigger the secretion of IL-8 by epithelial cells (Table 2). This 
PIC stimulate the production of adhesion molecules that stop PMN rolling along the vessel 
and allows their migration to peripheral tissues (Suriyasathaporn et al., 1999; Paape et al., 
2002). This process is named diapedesis and consists in the movement of PMN between 
endothelial cells and across the basement membrane of the vessel to infected sites (Maddox et 
al., 1999; Hodgkinson et al., 2007). Once inflammatory response starts, neutrophils became 
the main cell type into affected tissues within 30 to 60 minutes from the beginning of 
extravasation (Summers et al., 2010). Furthermore, IL-8 increase the production of ROM to 
enhance respiratory burst activity against bacteria (Paape et al., 2003; Forsberg, 2004). PMN 
use also neutrophil extracellular traps to kill bacteria, consisting in a net of fibers of chromatin 
and serine proteases that trap and kill bacteria, acting as a physical barrier to avoid their 
spread through tissues (Sordillo, 2016). 
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Adaptive immunity 
When innate immune system and inflammation are ineffective in solving infection, the 
presentation of antigens mediates the activation of adaptive immunity. Generation of adaptive 
immunity is time consuming (could take days for developing), and the efficiency of innate 
immunity became crucial to face infections in the meantime (Janeway et al., 2005). Innate 
immunity involves two types of cells: antigen presenting cells and lymphocytes (Sordillo, 
2016). The result of their interaction is a response that is specific and diverse for each antigen 
involved, that could distinguish between self and non-self-antigens and allow to develop a 
memory component against repeated exposition to the same antigen. 
Antigen presenting cells. Adaptive immunity can selectively react to foreign antigens 
only, without responding to host’s own antigens (Sordillo, 2016). This recognition is driven 
from membrane bound proteins named major histocompatibility complexes (MHCs). Those 
complexes could trigger an immune response only when combined with antigens on specific 
cells, in a process known as antigen presentation (Kazansky, 2008). MHC could be 
differentiated in two main classes. MHC of class I is expressed in all host cells, while MHC 
of class II is expressed on antigen presenting cells ascribed to innate immunity (as 
macrophages and DCs) and lymphocytes (as mature B cells). 
Lymphocytes. Adaptive immunity consists in mononuclear leucocytes named lymphocytes. 
Those recognize bacterial antigens through membrane receptors and provides a specific 
protection through the expression of antibodies (Shafer-Weaver and Sordillo, 1997). 
Lymphocytes could be divided in T and B-cells that differ in functions and protein products 
(Table 4). 
T-cells are a wide group of lymphocytes that could be further distinguished in two sub-
groups. αβ-T-cells includes two classes of lymphocytes, distinguished based on the expression 
of different CDs on their surface. T-helper cells (Th) are differentiated based on the 
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expression of CD4 (but not CD8) on their surface. They are involved in the production of 
cytokines, as IL-2 and IFNG (Table 2). These mediators regulates magnitude and duration of 
cell-mediated immune response, exerting a role in the activation of other lymphocytes, but 
also affects innate components, acting on macrophages, neutrophils and other cells that 
participate in immune response (Sordillo and Streicher, 2002). Th lymphocytes could be 
further differentiated in functional groups that includes Th1, Th2, Th17 and T-regulatory cells 
(Treg). The proportion of these can vary significantly depending on tissue localization 
(Sordillo, 2016).  
T-cytotoxic cells (Tc) are differentiated based on the expression of CD8 and negative 
expression of CD4 on their surface. They are aimed to the recognition and elimination of host 
cells infected with antigens, based on the alteration of MHC I. Furthermore, they are involved 
in apoptotic processes in old and damaged host cells, in order to decrease the susceptibility of 
the organism to infections. Their action could have a scavenger effect on secretory cells in 
mammary gland (Sordillo, 2016). They also produce cytokines involved in the regulation of 
the immune response (Aitken et al., 2011). γδ-T-cells has not been fully elucidated in their 
function, but their percentage is higher in bovine peripheral blood mononuclear cells 
compared with humans (Baldwin and Telfer, 2015). They are involved in the protection of 
epithelial surfaces against bacterial diseases and mediate cytotoxicity with variable 
involvement of MHCs. Their action is based on unique surface molecules (WC1) that are co-
receptors for recognition of microbial pathogens and signaling cell activation.  
B-cells are lymphocytes that proliferate and differentiate in two sub-groups once activated 
from antigens (Shafer-Weaver and Sordillo, 1997). The first sub-group, named plasma-cells is 
involved in the production of antibodies, known as immunoglobulins (Igs) that recognize and 
act against specific microbial virulence factors influencing host defenses against pathogens. 
Igs are differentiate into several functional isotypes and their abundance and composition 
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within tissues affect the likelihood of developing new infections. IgA are present at mucosal 
surfaces and are involved in agglutination, which impede certain pathogens (i.e. viruses) to 
spread through tissues. Furthermore, they are able to neutralize some bacterial toxins (Sordillo 
and Streicher, 2002; Aitken et al., 2011). IgG are highly concentrated in serum and have a 
role as opsonin, increasing phagocytosis in PMN. Two sub-isotypes could be further 
distinguished: IgG1 and IgG2. IgE are associated with allergic reactions and parasitic 
infections. IgM is the largest and first produced Ig and exert a role in opsonization, 
agglutination and complement fixation. IgD is a non-secreted regulatory molecule. The 
second sub-group, named memory cells, is involved in the heightened state of immune 
reactivity and clonal expansion of antigen-specific effector cells that occurs when host cells 
and tissues are re-exposed to the same antigen. This memory response is much faster, 
stronger, longer lasting and more effective in solving infection compared with primary 
responses (Sordillo, 2016). 
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PERIPARTURIENT PERIOD AND IMMUNE DYSFUNCTIONS 
In dairy cows, peripartum includes last two months of gestation and first month of 
lactation. Within peripartum, the three weeks prior to calving and the three weeks following 
parturition are named transition period (TP) and are known as the most challenging phase 
during life of all the mammals (Drackley, 1999). For dairy cows, such challenge arise from 
the transition between two phases of life that differ on endocrine and physiological assets and 
nutritional requirements: the dry period, that includes the time between halting of milk 
removal (milk stasis) and the subsequent calving, and the early lactation (Van Knegsel et al., 
2014).  
Peripartum alteration of metabolic functions 
Sudden changes in body homeostasis are to a certain extent physiological during the TP. 
Peripartum is known to be related to altered endocrine asset, as trend of different hormones 
changes during transition from lactation to dry period and, even more, at calving time. 
Steroids, as estradiol and progesterone, are known to fluctuate before calving, while protein 
homeorhetic hormones such as prolactin, growth hormone (GH), insulin-like growth factor-1 
(IGF-1) and insulin are known to fluctuate during the whole TP (Bauman and Bruce Currie, 
1980; Tucker, 1985). Such hormonal changes typically accompany drastic alteration in 
physiological assets and nutrient requirements. Cows entering dry period are in a positive 
energy balance (PEB) condition (Mäntysaari and Mäntysaari, 2015), that is further 
accentuated by the reduction in energy requirements  when milk production is halted. In late 
dry period, three weeks prior to calving, two-thirds of the development of fetus are completed 
and its nutrient requirements reach maximal levels, taking the priority in the redistribution of 
glucose and amino acids on the cow’s own needs for body maintenance (Bell, 1995; Dingwell 
et al., 2001). As soon as milk production starts, mammary gland changes metabolic asset to 
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achieve the maximum dairy cow’s potential for milk yield, milk proteins, fat and lactose, 
inducing a drastic increase in energy, protein and mineral requirements. Such an increase in 
requirements could not be satisfied from the increase in feed intake in early lactation, that is 
slowed down from the reduced rumen volume at the end of dry period. Furthermore, drastic 
changes in diet composition from a forage-based to a concentrate reach ration could lead to 
alteration in rumen microbiota and fermentations reducing feed intake. Those conditions 
makes requirements to exceed nutrients supplied with feed intake, leading to a physiological 
negative energy balance (NEB) that has been quantified in an average value of -12,2 Mcal/d 
in Holstein dairy cows (Rastani et al., 2001) and to a mineral deficiency, in particular for 
calcium and magnesium (Mulligan and Doherty, 2008).  
Main effect of NEB at the beginning of lactation is the consumption of blood glucose, 
leading to a sudden mobilization of reserves to face energy requirements with alternative 
sources. Lipomobilization consists in a reduced lipogenesis and an increased lipolysis ratio 
resulting in the brake down of triglycerides stored in the adipose tissue. Therefore, hematic 
levels of non-esterified fatty acids (NEFA) and glycerol increase. In normal conditions, these 
are completely oxidized in liver to acetyl coenzyme A, that enter the Krebs cycle to produce 
energy. Other than increased amounts of total circulating NEFA, lipomobilization that occurs 
in early lactation has been related to changes in fatty acids compositions both in blood 
circulating NEFA and in phospholipidic membranes of cells and circulating lipoproteins 
(Drackley, 1999). Saturated fatty acids (SFA) increases in comparison to mid lactation, and 
account for 35.7% of total plasmatic long chained-fatty acids after calving. In normal 
conditions, palmitic (C16:0) and stearic acids (C 18:0) are the main SFA in cell membranes of 
dairy cows (Contreras et al., 2010). Nevertheless, membranal amounts of C16:0 and C 18:0 
decreases during TP in comparison to mid-lactation, as several other SFA including lauric 
(C12:0) and myristic acids (C14:0) increase (Drackley, 1999). On the other hand, unsaturated 
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fatty acids (UFA) account for 64.3% on total plasmatic long chained-fatty acids at the 
beginning of lactation. In cell membranes, they mainly includes oleic and linoleic acids, while 
the amounts of eicosatrienoic acid (C20:3) and EPA (C20:5) are known to decrease in cell 
membranes in comparison to mid-lactation (Douglas et al., 2006). Contemporaneously to 
lipomobilization, also a massive amino acids mobilization from muscle tissues occurs to face 
growing requirements of mammary gland for the synthesis of milk and new parenchymatic 
tissue (Doepel et al., 2006).  
 The physiological imbalance conditions 
Changes occurring in peripartum could exceed the control of homeorhetic and homeostatic 
mechanisms, leading to a physiological imbalance condition (PI). During PI, physiological 
parameters could shift from their normal ranges, impairing body functions. PI could occur in 
cows with a milk yield higher than 25 kg/d at dry-off, as a consequence of the high WBC 
activity during the early involution phase (Putman et al., 2018). Results of a recent study 
(Bertulat et al., 2013) showed also a raise of fecal cortisol (measured as 11,17-
dioxoandrostane) to occur immediately after dry-off in these animals, as an effect of increased 
udder pressure at milking interruption. Another cause of PI could be the administration of 
acidogenic diets during close-up, that could affect the mineral equilibrium in TP, especially 
for calcium and magnesium (Nightingale et al., 2015). Furthermore, PI in TP could result 
from stress induced by pen movements, re-socialization, environment, weather, diet and 
simply parturition, as these phenomena are related to raises in glucocorticoids (cortisol) and 
catecholamines (epinephrine, norepinephrine, dopamine) concentrations (Higuchi et al., 1994; 
Do Nascimento et al., 2004; Cooke et al., 2012). Nevertheless, most of PI conditions are 
related to energy balance, feed intake and lipomobilization in early lactation. As an example, 
excessive lipid deposition that arise from a prolonged dry period, or severe NEB that arise 
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from high milk yields, could increase the magnitude and duration of mobilization at the 
beginning of lactation. Higher NEFA can decrease appetite, as NEFA exert anorexic effects, 
reducing dry matter intake (DMI) in early lactation and further reducing glycaemia 
(Ingvartsen and Andersen, 2000; Allen et al., 2009). Another cause of reduced DMI could be 
the occurrence of infectious diseases, as mastitis or uterus infections related to calving, that 
triggers the release of PIC with anorexic effects (Trevisi et al., 2011a; Jahan et al., 2015). As 
soon as lipomobilization became severe, the Krebs cycle gets overloaded by NEFA, leading 
to their partial oxidation and to the diversion of acetyl coenzyme A to the production of 
ketone bodies as beta-hydroxybutyrate (BHB), acetoacetic acid and acetone (Drackley et al., 
2006; Ingvartsen, 2006). Furthermore, a larger amount of amino acids is used for 
gluconeogenesis to provide energy, reducing their availability for other metabolic functions. 
Glutamine is one of the main amino acids that undergoes a deficiency in early lactation, as up 
to 74% of its stocks are completely oxidized for energy production (Newsholme et al., 1985, 
1999; Calder et al., 1990).  
Reduced immune competence 
Reduced immune competence typically affects innate immune cells during TP. An 
impairment of PMN functions related to ROM production, MPO activity, chemotaxis and 
phagocytosis has been reported in this phase (Cai et al., 1994; Kimura et al., 1999; Mehrzad et 
al., 2001). Most of these changes are reflected in altered expression of messengers-RNA 
(mRNA) transcripts, even though such alterations have not been fully elucidated. Previous 
studies found bovine PMN to have an altered abundance in several mRNA transcripts (see 
below) between -1 and 2 weeks from calving, in comparison to the level found at 4 weeks 
after calving for the same genes (O’Boyle et al., 2012; Crookenden et al., 2016, 2017).  
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A down regulation during the whole TP (Table 5) has been reported for genes related to 
normal cells functions, as for glucose transporters (solute carrier family-2 member 1), proteins 
involved in cell survival and differentiation (CD117, CD45, CD337, galectin S8 and annexin-
A3) and in the regulation of apoptosis (as protein kinase C beta, BCL2 apoptosis regulator 
and Fas-ligand). Nevertheless, most of mRNA to be down regulated encode genes related to 
immune functions, as adherence and migration (integrins family), antioxidant systems 
(superoxide dismutase 1), generation of oxidant species within the respiratory burst (MPO), 
for the main pro-inflammatory mediators (PIC as IFNG, IL-12, TNFA and IL-23 and 
enzymes related to the production of pro-inflammatory oxylipids) and regulator proteins for 
the antigen presentation (X-box binding protein 1). Same studies found this down regulation 
to be counterbalanced by a greater expression of other genes (Table 6). This occurs 
exclusively at calving time for genes related to antimicrobial activity (S100 calcium binding 
protein A9, beta defensins 1 and 10, integrin alpha-X, peroxisome proliferation activated 
receptor delta and retinoid-X-receptor alpha), anaerobic glycolysis (lactate dehydrogenase A) 
and pro inflammatory oxylipids production (phospholipase A2). On the other hand, an up 
regulation of genes related to anti-inflammatory functions (AIC as IL-10 and IL-6 and 
receptors that inhibits the activity of PIC, as IL-1B receptor type II) and immunomodulation 
(defensin beta 4A) has been reported during the whole TP, especially after calving. Finally, 
other genes were reported to have characteristic variations throughout the TP, being both up 
or down regulated in comparison to their levels at 4 weeks after calving (Table 7). Receptors 
involved in the production of PIC through NF-κB (receptor-interacting serine/threonine-
protein kinase 1 and TLR4), receptors for Igs (CD16a and Fc-fragment of IgE, high affinity I, 
receptor for gamma polypeptide), PIC inhibition (Interleukin 1 receptor antagonist) and PMN 
migration (SELL, interleukin-8 receptor beta), as well as proteins involved in the regulation 
of apoptosis and cell functions (MCL1 apoptosis regulator, BCL2 family member and ATP 
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binding cassette subfamily A member 1) were up regulated before calving and down-
regulated thereafter. For other genes related to cell-to-cell interactions, induction of apoptosis 
and inflammation (CD90) and involved in PMNs migration (Matrix metallopeptidase 9) an 
opposite pattern has been reported: they were down regulated before calving and up regulated 
thereafter.  
Despite the patterns of some genes appeared somehow contradictory, and a transient 
amelioration of some antibacterial functions could be hypothesized at calving time, the 
general trend of such variations suggests an impairment of viability, survival and sensitivity to 
pro-inflammatory mediators in PMNs throughout the TP. Furthermore, their anti-bacterial 
activities related to chemotaxis, phagocytosis and respiratory burst were also impaired, while 
their sensitivity to oxidative stress status increased due to a reduced efficiency in their 
antioxidant systems. Thus, a delayed migration of functionally adequate neutrophils and other 
innate immune factors could trigger a hypo-responsive state that decrease the capacity of 
innate immune system to face insults (Sordillo, 2016), and such a condition increase the 
likelihood to develop diseases in TP (Minuti et al., 2015). 
The inflammatory-like status 
In dairy cows, an inflammatory-like status commonly occurs during peripartum. It consists 
in a prepartal raise of PIC levels (Jahan et al., 2015), that is linked to a raise in body 
temperature at calving, and that typically affects liver metabolism, implying severe losses in 
hepatic functions and a shift of anabolic priority of the organ in early lactation (Cappa et al., 
1989; Trevisi et al., 2005; Loor et al., 2007; Bertoni et al., 2008). In particular, the liver 
produces more α-globulins, known as positive acute phase proteins (APP), i.e. haptoglobin, 
ceruloplasmin and serum amyloid alpha (SAA) (Ceciliani et al., 2012). Conversely, it reduces 
the synthesis of albumin, retinol binding protein, paraoxonase (PON) and lipoproteins, known 
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as negative APP (Bertoni et al., 2008) and sequesters minerals, as zinc and iron, from blood 
flow (Bertoni and Trevisi, 2013). Plasmatic trends of those parameters are proportional to the 
severity of inflammation (Castell et al., 1989), but they have different sensitivity to acute 
phase, as they are released in different time intervals from the onset of the inflammation. 
Haptoglobin in particular, have a long half-life relative to other APP (i.e. SAA) and reflects 
instantaneously an inflammatory condition and thus, it has been widely used as a biomarker 
of such a condition in dairy cows (Huzzey et al., 2011). Effects of inflammation on WBC 
functions has been investigated by Nightingale et al. (2015), who grouped 240 Holstein 
transition dairy cows in three classes according to their postpartal haptoglobin level: low (0 to 
8.4 µg/mL), moderate (8.5 to 458 µg/mL) and high (459 to 1757 µg/mL). They found animals 
with highest haptoglobin levels after calving to have the most severe neutropenia in blood that 
was driven from the recruitment of their PMN in inflamed peripheral tissues. Furthermore, 
their PMN showed the greatest activated status, as they showed the greatest production of PIC 
(TNFA), the highest expression of extravasation-related receptors (SELL) and the greatest 
respiratory burst activity. Nevertheless, T-lymphocytes and adaptive immunity appeared to be 
impaired in these animals, as suggested from their lower expression of IFNG in comparison 
with cows that showed low haptoglobin levels after calving (Nightingale et al., 2015). Thus, 
an inflammation in peripartum seem to activate innate-immune cells impairing functions of 
adaptive components and thus, impairing the immune system capacity to restore normal 
functions in tissues. Investigations on the main causes triggering a haptoglobin peak in 
peripartum suggests the occurrence of a PI condition as the real driving element of 
inflammatory-like status (Table 8). The worsening of the inflammatory-like status could 
affect productive performances of dairy cows in early lactation (Trevisi et al., 2012, 2016).  
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IMMUNE DYSFUNCTION: CAUSES AND EFFECTS 
The exact cause of immune dysfunctions occurring in peripartum has never been clearly 
identified. Reduced immune competence could arise from the interaction of different factors 
affected from the typical peripartum trends (Trevisi et al., 2011a). Nevertheless, its duration 
could be modified from the occurrence of the PI, that could also trigger the inflammatory-like 
status. Inflammation lead to the activation of PMN, while the reduced immune competence 
commonly reported in TP has been associated to an opposite effect on WBC (Trevisi and 
Minuti, 2018). Thus, these should be considered as two distinct phenomena, but they could 
arise from a common cause with a different magnitude and duration. 
Endocrine asset  
A direct relationship with immune functions has been well documented for most of 
hormones that are known to fluctuate during peripartum (Table 9). Cortisol is known to 
reduce PMN functions through specific receptor-ligand interactions that are linked to the NF-
κB functioning. Same mode of action on the activation of cyclic adenosine monophosphate 
response element binding protein has been reported for catecholamines (Burton et al., 1995). 
Also fluctuations of estrogens and protein hormones affects both innate and adaptive immune 
systems, impairing functions of PMN and lymphocytes (Davis, 1998; Kelley et al., 2007; 
Sordillo, 2016). Trends of those hormones could partially account for reduced immune 
competence occurring in TP, even though their alterations do not overlap with the entire 
duration of the phenomenon.  
Studies on mastectomized pregnant cows showed those animals to face a shorter and less 
marked immune suppression status at calving in comparison with animals with mammary 
gland, without any alteration on circulating WBC (Nonnecke et al., 1993; Kimura et al., 1999, 
2002). These results suggest a marginal direct contribution of endocrine asset in reducing 
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immune competence around calving, while the largest effect could result from the 
contribution of endocrine asset in affecting the NEB triggered from the lactation 
requirements. Such an interaction has been reported to deeply affect immune functions, 
contributing both in reduced immune competence and inflammatory-like status (Sordillo, 
2016). Reduced leptin levels are known to trigger an insulin resistance status before calving 
that, together with fluctuation in steroids hormones, reduces prepartal DMI, increasing the 
NEB at the beginning of lactation (Esposito et al., 2014). NEB conditions are known to 
reduce the expression of liver GH receptors, leading to an increased GH and reduced IGF-1 
blood concentration in early lactation, and such an endocrine asset increases lipolysis and 
gluconeogenesis (Lucy, 2001). Furthermore, catecholamines provide a direct stimulus for 
lipomobilization process, and cortisol further increases this phenomenon activating 
peroxisome proliferation activated receptor, alpha (PPARA), that is involved in the regulation 
of lipid metabolism (Drackley, 1999). Thus, an indirect effect on immune functions (which is 
discussed in detail in the section related to NEB) should be considered for these hormones 
(Table 9). Furthermore, the occurrence of an inflammatory-like status could modify the effect 
of some of these hormones on immune cells. For instance, cortisol levels depend on the 
synthesis of a specific carrier at liver level, named corticosteroid binding globulin. When an 
inflammation occurs, and liver syntheses are impaired, reduced production of corticosteroid 
binding globulin triggers an initial increase in free cortisol, that means more bioactivity. Then, 
the negative feed-back prevails, and the hypophysis-pituary-adrenal axis secretes less cortisol, 
decreasing also the depressive effect of this hormone on immune cells (Trevisi et al., 2013a). 
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Limitations of maternal immune responses against the allogeneic conceptus  
Reduced immune competence reported in TP could partially arise from the physiological 
limitation of maternal immune responses against the allogeneic conceptus during the late 
gestation period (Esposito et al., 2014). Other than fluctuation in steroids hormones, such a 
regulation is triggered from the differentiation of regulatory immune cells (i.e. M2 
macrophages, γδ T-cells and Treg cells) that can inhibit inflammation and T cells response 
(Majewski and Hansen, 2002; Padua et al., 2005; Esposito et al., 2014). In particular, M2 
macrophages are involved in inhibition of inflammatory conditions, and could increase the 
risk in developing uterine infections (Esposito et al., 2014). 
Alterations in energy balance 
Effects of NEB at the beginning of lactation on immune functions are disparate, and could 
depend on the degree of NEB, on the intensity of lipomobilization and on NEFA profile 
during this phase. After an inframammary infection with Streptococcus uberis, a repression of 
genes related to inflammatory response and chemotaxis has been reported in PMN of cows 
under NEB condition (Moyes et al., 2010). In fact, IL-8 signaling pathway, IL-1B receptor-
associated kinase-1, mitogen-activated protein kinase-9 and TNF-associated receptor factor-6 
were down regulated, while MHC-I was up-regulated. At the same time, a greater expression 
of mRNA for anti-inflammatory genes, as glucocorticoids receptors, and nuclear factor 
(erythroid-derived 2)-like 2 -mediated oxidative stress occurred, indicating an impaired 
capacity of the animal in solving infection, and a greater likelihood in developing further 
infectious diseases. Nevertheless, the real contribution of energy balance on immune 
dysfunctions during TP is difficult to assess, as variations in energy balance partially overlaps 
with other factors, as endocrine changes and health status, during this phase (Table 9). Two 
main mode of action of NEB in affecting immune functions could be recognized. 
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Firstly, NEB decreases the availability of essential nutrients for immune cells functions 
triggering the shift to alternative sources to supply the deficiency. Glucose is the main energy 
source for immune cells, while glutamine, NEFA and ketones could be used as alternative 
sources (Calder, 2013). Other than the lower glycaemia, such an effect could be driven from 
the lower glucose uptake of resting immune cells during TP, that has been related to the lower 
expression of a family of glucose transporters on their surface (Solute carrier family-2 - Table 
5; O’Boyle et al., 2012). Glutamine is a precursor of purines and pyrimidines that is involved 
in cell division, DNA and RNA synthesis in WBC. Furthermore, it is related to the production 
of NADPH, that is essential in respiratory burst reaction. The lower efficiency in the 
utilization of alternative energy sources, the direct toxic effect of certain metabolites at high 
concentration and the deficiency of essential nutrients could partially explain the reduced 
immune competence reported with NEB conditions at the beginning of lactation (Table 10), 
as the impairment of normal functions of phagocytosis, chemotaxis and diapedesis of blood 
PMN (Stevens et al., 2011). Studies conducted on fed restricted animals in mid-lactation, 
inducing an early lactation-like NEB condition without the endocrine alteration related to 
calving (Moyes et al., 2010; Crookenden et al., 2017) revealed an altered expression of 
transcripts in their PMN that was consistent with a reduced immune competence to occur 
(Table 11). In fact, most mRNA encoding for defensins, cytokines and eicosanoids were 
down-regulated, as well as genes related to antigen presentation (MHC-I and human 
leukocytes antigen - HLA), respiratory burst (superoxide dismutase 1) and inflammatory 
response (TNFA). Most of these genes were further impaired when lipomobilization was 
increased from a PI condition. In fact, most of genes altered in an underfeeding condition 
(defensins, IL-10 and eicosanoids) were further altered when NEB occurred in 
overconditioned cows (BCS > 3.5 out of 5) prior to the NEB condition, suggesting a major 
role of lipid metabolites in such an alteration (Bernabucci et al., 2005; Crookenden et al., 
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2017 - Table 12). Thus, energy balance contributes to immune dysfunctions during 
peripartum, although transient nutritional deficiencies could not fully explain the degree and 
duration of alterations. In fact, none of previous experiments that induced an early lactation-
like-NEB condition have been able to mimic the extensive immunological changes that 
normally occurs in TP. A NEB of -6,2 Mcal d-1 induced in mid lactating cows (80% of 
requirements for maintenance) did not affected serum TNFA, WBC count or milk IgG 
concentrations, and no effect appeared on clinical symptoms following an endotoxin-induced 
mastitis in comparison to ad-libitum fed animals (Perkins et al., 2002). Furthermore, 
experimentally induced NEB alone did not affected adhesion or antigen presentation in 
leukocytes (Perkins et al., 2001). A reduced phagocytosis of PMN appeared with a more 
marked feed restriction (60% of requirements for maintenance for 7 days), even though 
relatively minimal alteration of other immune functions appeared after a mastitis challenge 
(Moyes et al., 2009).  
Secondly, changes in NEFA composition that occurs during NEB could directly affect 
immune functions, with different mechanisms. Altered NEFA profile affects the membranes 
fluidity in WBC (Drackley, 1999), affecting the formation of glycolypoproteins composing 
lipid raft, that are involved in lymphocytes activation, antibodies production and 
inflammation (Sordillo, 2016). Changed NEFA profiles in cell membranes could also have a 
role in altering the production of immune mediators as oxylipids (Table 3; Raphael and 
Sordillo, 2013) with both pro or anti-inflammatory effects depending on the kind of NEFA. 
Thus, a possible explanation for different effects sorted on immune functions by NEB induced 
in early post-partum rather than in mid-lactation could be the different NEFA profile found 
both in blood and cells membrane during the two different phases. Down regulation of IL-10 
and TNFA found in bovine PMN during NEB (Crookenden et al., 2017) is consistent with the 
effect exerted by PUFA on peroxisome proliferation activated receptor, gamma (PPARG) 
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and TLRs, that affects cytokines production through NF-κB. In human, α-linoleic acid is 
known to inhibit PPARG, while DHA inhibits both TLR2 and TLR4. However, in bovine 
PUFA do not appear to affect PPARG activity (Bionaz et al., 2013). Furthermore PUFA are 
known to impair antigen presentation reducing mRNA expression for HLA in bovine PMN 
(Gorjão et al., 2006). On the other hand, the inflammatory-like status and the increased 
production of PIC detected as consequence of NEB (Esposito et al., 2014), could be driven 
from the increased expression of mRNA encoding for TLR2 and TLR4 sorted by SFA in 
circulating PMN (Lee et al., 2003, 2004b; Sordillo et al., 2009). 
Oxidative stress status 
The loss of reduction-oxidation (redox) homeostasis and tissue damaging resulting from 
the accumulation of excessive oxidants amounts (ROM and reactive nitrogen species) or 
depletion of antioxidant defenses is referred to as oxidative stress (Sordillo, 2016). This 
condition has been commonly reported during TP of dairy cows (Bionaz et al., 2007; Celi, 
2011; Celi and Gabai, 2015) and its causes could be identified in different metabolic 
processes that occurs during this phase (Table 13). Most of these processes are directly related 
to the inflammatory-like status, to the impairment of liver functions and from dietary changes 
that occurs around calving.  
Low to moderate ROM amounts serves as messengers in a wide range of redox regulated 
signaling pathways, as those related to NF-κB and mitogen activated protein kinase, that are 
involved in the production of cytokines, oxylipids and immunoregulatory factors (Finkel, 
2011; Brown and Griendling, 2015). Nevertheless, oxidative stress status that occurs in TP 
could cause damages to DNA, proteins and lipids and could contribute to dysfunctional 
immune responses in this phase (Sordillo et al., 2009). In fact, abnormal ROM levels could 
trigger the lipid peroxide chain reaction in cell membranes and immune cells are highly 
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susceptible to this process, due to the high PUFA contents of their membrane. Lipid peroxide 
reaction consists in the acquisition of electrons from lipids by hydroxyl radicals, which 
generates lipid-peroxy radicals triggering an autolytic chain reaction within plasma 
membrane, removing further electrons from adjacent fatty acids. Damages includes altered 
cellular functions and signal transduction, which could exacerbate the inflammatory response 
and contribute in dysfunction of the vascular endothelium that occurs during TP (Lacetera et 
al., 2005; Sordillo et al., 2007, 2009). Furthermore, proteins are highly susceptible to the 
oxidative stress as they serve as catalysts mediators in cells, and thus the effect sorted by 
oxidation on one molecule is greater than stoichiometric (Dalle-Donne et al., 2005). Such 
effect includes alteration of protein functions as receptors, enzymes, transporters or structural 
elements, and could also directly contribute in provoking immune responses, as oxidized 
proteins can generate new antigens (Halliwell and Whiteman, 2004). The generation of 
oxidant species within the activity of immune cells is related to the production of 
characteristic oxidation products in proteins. In example, neutrophils releases hypochlorous 
acid through the MPO activity, and this metabolite is involved in the generation of di-tyrosil 
residues from serum albumin (Bordignon et al., 2014).  
Immune dysfunction and diseases in transition period 
The occurrence of diseases is known to raise during the TP, and their effect could be 
severe in impairing productive performances in the following lactation (Pinedo et al., 2010). 
In fact, TP diseases tend to occur in complexes with each other rather than as isolated events 
(Sordillo, 2016), and the occurrence of one of those diseases (named as primary) will increase 
significantly the risk ratio in developing others (named as secondary), up to the culling of the 
animal (Curtis et al., 1985; Ingvartsen, 2006). Relationship between diseases of TP and 
immune dysfunction is complex and has not been fully elucidated. A distinction between 
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metabolic and infective disorders is necessary. Examples of metabolic diseases related to TP 
are fatty liver, milk fever, retained placenta (RP), metritis, ketosis, left displacement of 
abomasum (LDA) and lameness (Kelton et al., 1998; Ingvartsen, 2006). Relationships 
between these disorders and the occurrence of an immune dysfunction in dairy cows is not 
clearly understood. As an example, fatty liver is known to contribute in immune dysfunctions 
impairing the ability of the liver to detoxify endotoxin, and thereby rending the cow 
extremely sensitive to endotoxic shock and death (Andersen et al., 1996). As most of 
metabolic diseases occurs at the beginning of lactation, while immune dysfunction seems to 
begin earlier, is possible to retain PI as the main cause of metabolic disorders. Nevertheless, 
most of the metabolic disorders are known to further impair PI conditions, triggering the 
production of PIC with anorexic power and the inflammatory-like status. Such a condition 
reduces DMI and increases the duration of NEB, increasing the risk ratio for secondary 
diseases, either metabolic or infectious (Table 14).  
Differently from metabolic disorder, increased incidence of infective disease at the 
beginning of lactation could be clearly interpreted as a direct effect of impaired immune 
competence at calving (Ingvartsen, 2006). In fact, previous studies found that cows that 
developed endometritis and metritis had a reduced prepartal phagocytosis in leukocytes (Kim 
et al., 2005), a reduced glycogen concentration in circulating neutrophils at calving (Galvão et 
al., 2010) and a reduced TNFA expression in monocytes after a stimulation with E. coli 
(Galvão et al., 2012). Furthermore, reduced chemotaxis, delayed migration, reduced 
antimicrobial activity and ROM production detected in PMNs during TP are other explaining 
factors for increased susceptibility to mastitis, endometritis and metritis in transition cows, 
and could also account for the escalated severity of such diseases registered in comparison to 
mid lactating animals (Hill, 1981; Cai et al., 1994; Shuster et al., 1996). Further impairment 
of immune functions has been reported after the development of an infectious disease in TP, 
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due to the incapacity of immune system to solve the problem, that triggers a reiterated 
inflammatory condition.  
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NUTRITIONAL STRATEGIES TO FACE IMMUNE DYSFUNCTION IN 
TRANSITION PERIOD 
Nutritional strategies to optimize dairy cow’s immunity during TP should be focused on 
reducing the PI degree related to calving, as this condition could be referred as a common 
denominator between immune dysfunction and diseases causes. The provision of a balanced 
and healthy diet should be considered as a focal point in this respect. In this regard, although 
optimal dietary concentrations of fermentable carbohydrates fiber, sugar and starch for 
transition cows are still under definition, NRC provided guidelines for diet formulation that 
fits most of nutritional requirements of this phase (NRC, 2001). 
Variation of energy requirements and sources during peripartum 
Dairy cows should enter the dry period with a BCS of 3 out of 5 (ADAS 2006), in order to 
minimize the amount of lipid stores which could determine an excessive mobilization of 
NEFA in early lactation, reducing DMI and increasing the duration of NEB condition 
(Contreras et al., 2004; Esposito et al., 2014). An energy content of 1.25 Mcal kg DM-1 has 
been considered the ideal net energy for lactation (NEL) value to be provided between dry-off 
and -21 DFC to minimize the BCS gain during dry period. Providing higher energy amounts 
in this phase has been related to detrimental carryover effects during early lactation. On the 
other hand, an energy content 1.54-1.62 Mcal kg DM-1 has been considered the ideal NEL 
value to be provided between -21 DFC and calving day in order to meet the growing 
requirements of fetus and ensure a cow BCS below the 3.5 out of 5 threshold at calving day.  
One week prior to expected calving, an increased amount of not-fiber carbohydrates 
(NFC) or highly digestible neutral detergent fiber (NDF) sources should be provided. Such a 
strategy increases propionate levels, improving gluconeogenesis and bacterial protein 
synthesis at rumen level. Furthermore, it improves the development of rumen papillae, 
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ameliorating the VFA absorption in early lactation and minimizing the likelihood to develop 
rumen acidosis (with subsequent PI conditions) (Rabelo et al., 2003). In early lactation, the 
limiting factor for feed intake is the chemical effect of metabolites related to the oxidation of 
fuels. Thus, limiting dietary starch fermentability in this phase should maximize DMI, due to 
the less rapid production and less marked absorption of propionate (Allen et al., 2009). 
Conversely, the rumen availability of starch, NFC and fermentable fiber (in rations with 
adequate physical effective NDF -peNDF- amounts) should be incremented since the 2nd-3rd 
month of lactation only, when the peak of lactation occurs and cows have overcome the NEB 
condition. In fact, feed intake is limited from gut fill in this phase, and increased propionate 
productions, driven from the increased fermentable substrate, increase insulin concentration, 
reducing lipomobilization without affecting DMI (Drackley, 1999). Thus the NEB degree, as 
well as NEFA and BHB concentrations are reduced. As a consequence, also the liver 
triglycerides content is decreased, with a positive effect on the incidence of metabolic 
disorders and reproductive parameters (Gong et al., 2002). Thus, the availability of energy 
and protein sources for WBC in early lactation raises and the amount of lipomobilization-
related metabolites decreases when a proper energy plan is adopted in peripartum diet, 
suggesting an optimal energy management as a strategy to improve immune competence.  
Lipid sources supplementation 
Lipid metabolism has been indicated to face important alteration during TP, and fat 
supplementation could have a main role in affecting immune functions during this phase. 
Different effects arise from feeding different dietary fat levels and the fatty acids composition 
used could sort different effects. Feeding a high-fat diet to dairy cows during the dry period 
has been reported to induce the peroxisomal beta-oxidation process (Drackley, 1999). In 
comparison to mitochondrial beta-oxidation, which normally occurs, peroxisomal beta-
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oxidation is catalyzed by an oxidase (Acyl-CoA-oxidase) that produce hydrogen peroxide 
rather than reduced NAD, releasing a larger amount of heat and less reduced cofactors 
(Drackley, 1999). Moreover, peroxisome do not contain any electron chain linked to the ATP 
production and thus, this process is not regulated from the energy demand of the cell. 
Consequently, induction of the peroxisomal beta-oxidation has been suggested as a strategy to 
provide an aid to the mitochondrial pathway during the NEB condition, when a NEFA 
overflow occurs (Drackley, 1999). Such a strategy has been indicated to reduce the hepatic 
accumulation of triglycerides at calving, reducing the likelihood to develop fatty liver 
syndrome and the occurrence of a PI. Furthermore, it could be effective in mitigating negative 
effects sorted by lipomobilization on immune cells.   
Furthermore, the fatty acids composition of lipid sources fed during the TP affect the lipid 
composition of cell membranes and the NEFA profile at blood level during the 
lipomobilization process that occurs in early lactation. State the well-known modulatory 
effect of fatty acids on immune functions (Table 10), an effective strategy to modulate the 
immune response in TP could be the administration of rumen protected PUFA aimed to shift 
the fatty acids composition of cell membranes (Table 15).  
Omega-3 PUFA, as EPA and DHA, are known to reduce the inflammatory-like status 
reducing the arachidonic acid amount in cell membranes, that is related to the production of 
pro-inflammatory oxylipids. Such an effect attenuates the production of PGF2A from 
endometrium (Lessard et al., 2004; Mattos et al., 2004; Contreras et al., 2012a) and of 
prostaglandin E2, that is known to reduce IFNG synthesis and lymphocytes proliferation 
(Trebble et al., 2003; Brassard et al., 2007). Thus, EPA and DHA improve the cell-mediated 
immune response in early lactation, reducing oxidative stress damages and increasing 
phagocytosis in PMN, sorting a positive effect on uterine and udder health (Contreras et al., 
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2012b; Dirandeh et al., 2013), but also have a positive effect on adaptive immunity (Bertoni et 
al., 2006; Trevisi et al., 2012).  
Omega-6 PUFA includes the conjugated linoleic acid (CLA) family, that consists in 28 
isomers, even though cis-9 trans-11 and trans-10 cis-12 are the most important. 
Administration of these PUFA is known to attenuate the inflammatory-like status in early 
lactation through the modulation of the NF-κB and the inhibition of the LPS-induced 
inflammatory activity in macrophages. Such an effect ameliorates the acute phase response, 
ensuring an augmented albumin and cholesterol concentration (both negative APP) in early 
lactation (Trevisi and Bertoni, 2008). Furthermore, an improvement of neutrophils functions 
has been reported consequently to the reduced oxidative stress status and to the reduced 
amount of NEFA and BHB in early lactation. In fact, CLA is known to protect PON, an 
important antioxidant enzyme, against the oxidative inactivation. It also increases the hepatic 
secretion of very low-density lipoproteins (VLDL) and apolipoprotein-B100 (Cheng et al., 
2004). Such proteins are involved in lipid redistribution through tissues, and their increase 
lead to a lower cellular accumulation of triglycerides containing palmitic acid, increasing 
DMI, reducing NEB and lipomobilization at the beginning of lactation (Cheng et al., 2004; 
Silvestre et al., 2011). 
Antioxidant elements supplementation 
Altered redox homeostasis that occurs in TP is triggered, other than the increased 
production of oxidant species during inflammation, from the consumption or lack of 
antioxidant system. An effective strategy to reduce negative effects of oxidative stress status 
on immunity could be the supplementation of minerals and vitamins involved in antioxidant 
systems activity during the late gestation and early lactation period (Table 15). Among 
vitamins, beta-carotene (vitamin A) is known to prevent fatty acid peroxidation chain 
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reaction, while ascorbic acid (vitamin C) and alpha-tocopherol (vitamin E) are known to 
mitigate oxidative stress acting as radical scavenger and disrupting fatty acid peroxidation 
chain reaction respectively (Sordillo, 2016). 
Trace minerals have critical roles in a variety of physiological process, particularly 
antioxidant defense, and a deficiency may depress immunity especially in peripartal or 
transition cows (Spears and Weiss, 2008). In fact, inflammatory-like status that commonly 
occurs after calving is known to reduce circulating minerals (i.e. zinc, iron and copper) 
sequestering them in liver (Osorio et al., 2016). Selenium is an active component of 
thioredoxin reductase and glutathione peroxidase enzymatic complexes, that controls redox 
signaling and reduce ROM production. Copper is an active component of ceruloplasmin, that 
exert oxidase activity as peroxyl radical scavenger. Zinc is an active component of 
metallothionein, which is a cysteine rich radical scavenger. Copper, zinc and manganese are 
also involved in superoxide dismutase functioning, that converts cytosol superoxide to H2O2, 
while iron allow the catalase action, that converts H2O2 to water (Sordillo, 2016). 
Methyl donors supplementation 
Methyl donors species are involved in lipid metabolism and lipoproteins synthesis. In dairy 
cows, their availability is limited from the extensive degradation in the rumen (Zhou et al., 
2016). At the beginning of lactation the availability of such compounds is suddenly reduced, 
as furthermore milk from dairy cows is high in methylated compounds, and the levels 
secreted into milk are maintained even at the cost of depleting liver tissue reserves (Pinotti et 
al., 2002; Zhou et al., 2016). Thus, their supplementation during late gestation and early 
lactation phases could ameliorate the utilization of lipid sources, mitigating negative effects of 
excessive lipomobilization on immune cells (Pinotti et al., 2003). Choline is a quasi-vitamin 
that is a structural component of phosphatidylcholine, which is contained in all the cell 
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membranes (Hartwell et al., 2000). Methionine and lysine are two essential amino acids that 
commonly undergoes a deficiency during NEB conditions. In lipid metabolism, all these 
compounds are required for the hepatic synthesis of VLDL (Bauchart et al., 1998). Greater 
VLDL levels ensure a faster redistribution of liver triglycerides, reducing hepatic infiltration 
of fats. Furthermore, methionine and lysine directly affect mitochondrial beta-oxidation of 
fatty acids in liver (Esposito et al., 2014). Thus, higher availability of these compounds could 
improve the lipid utilization during a marked lipomobilization. Furthermore, methyl donors 
are important sources of the intracellular antioxidants glutathione and taurine (Zhou et al., 
2016), and thus their administration in TP could mitigate oxidative stress, ameliorating 
leukocyte functions and reducing inflammation degree. 
Anti-inflammatory products supplementation 
Nutritional additives could be used in TP to transform the animal from a pro to an anti-
inflammatory phenotype in some extent (Bertoni et al., 2015). Vitamin D3 is known to act on 
Th cells, inhibiting Th1 sub-type in favor of Th2, and thus down regulating PICs and 
stimulating AICs production (Bertoni et al., 2015). Plant extract could further provide an aid 
in modulating over exuberant inflammations around calving. Acetylsalicylic acid is a 
common drug, formerly derived from plants, that has been successfully used in dairy cows to 
attenuate their systemic response to inflammations during TP (Bertoni et al., 2013). Its mode 
of action against inflammation consists in inhibiting COX enzymatic complex, thus reducing 
the synthesis of pro-inflammatory oxylipids. Providing 15 g/day of acetylsalicylic acid to 
dairy cows for three-four days after calving reduced the severity of inflammations and the 
incidence of clinical diseases in early lactation, thus exerting positive effects on their milk 
yields and fertility (Trevisi and Bertoni, 2008). Other plant extracts, as Hottuynia cordata 
supercritical extract, has been suggested as potential anti-inflammatory drugs. Although none 
36 
 
evaluated its effect on dairy cows in TP, experiments on murine models found an 
effectiveness in reducing TNFA production and inhibiting pro inflammatory oxylipids 
synthesis by COX enzymatic complex (Shin et al., 2010; Kim et al., 2012). Aloe arborescens 
Mill. has been successfully utilized in modulating inflammatory status of transition cows 
(Trevisi et al., 2013b). Administration of 150 g d-1 of Aloe extract during the 4 weeks around 
calving did not affect the production of positive APPs, but reduced mobilization of body fats, 
improving liver metabolism and mitigating the reduction of negative APPs after calving (i.e. 
albumin, PON, cholesterol, lipoproteins and retinol binding proteins). Finally, the treatment 
with cytokines during TP has been hypothesized as a potential strategy to reduce the severity 
of inflammatory phenomena. In an in-vitro model of swine alveolar macrophages, 0.5 UI/mL 
of IFNA reduced the expression of the TNFA gene (Amadori, 2007), suggesting it as a 
potential strategy to mitigate inflammatory status during TP of dairy cows. Nevertheless, 
daily oral administration of either 10 or 0.5 IU/kg BW of IFNA to dairy cows during TP 
increased the severity of inflammatory phenomena after calving (Trevisi et al., 2009). Such an 
effect could be driven by lymphocytes in the rumen liquor of dairy cows, that could have 
counteracted and inverted the antiphlogistic signal of IFNA. 
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CONCLUSIONS 
Mitigate immune dysfunctions occurring in TP of dairy cows is a pivotal goal to prevent 
the infectious and metabolic diseases in early lactation. Although wide literature background 
has been developed about this topic, immune dysfunctions in TP remain a challenging topic to 
investigate. Sudden changes occurring at different levels during this tricky phase of dairy 
cows life made challenging to identify the real driving mechanism of immune alterations. 
Nevertheless, a multifactorial contribution could be hypothesized for their appearance. Feed 
additives and nutritional strategy could be effective in mitigate immune alterations. In a wider 
perspective, we can conclude that adoption of proper management practices aimed to avoid PI 
condition in peripartal period of dairy cows could be the most effective strategy to prevent 
immune alterations. 
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TABLES 
Table 1. Main families of pattern of recognition receptors (PRRs), their classification 
according to the cell position, their main sites of location within the organism and their target 
ligands 
CATEGORY FAMILY DESCRIPTION LOCATION TARGET 
Membrane 
PRRs  
Toll-like 
receptors 
(TLRs) 
Single membrane 
spanning proteins 
Macrophages, 
dendritic cells 
PAMPs1 
C-type 
lectin 
receptors 
(CLRs) 
Proteins (lectins) that 
recognize 
carbohydrates with a 
calcium domain  
Macrophages, 
dendritic cells, 
lymphatic 
endothelial cells, 
carcinomas  
PAMPs1 
(carbohydrates) 
Cytoplasmic 
PRRs 
Nod-like 
receptors 
(NLRs) 
Proteins with a 
triphosphate 
nucleotides-binding 
domain 
Cytoplasm  PAMPs1 
(peptidoglycans) 
DAMPs2 (cell 
stress) 
RIG4-I-like 
receptors 
(RLRs) 
Helicases Cytoplasm  DAMPs2 (5’-
phosphate-RNA, 
dsDNA3) 
1Pathogen associated molecular patters. 
2Damage associated molecular patterns. 
3Double strained DNA. 
4Retinoic acid-inducible gene. 
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Table 2. Main cytokines, their site of production, their role on inflammation and their 
function on immune system 
CYTOKINE PRODUCTION  EFFECT ON INFLAMMATION 
AND FUNCTION1 
REFERENCE 
Interleukin-1, 
beta 
(IL-1B) 
Macrophages, mammary 
epithelial cells  
(+) 
Stimulate diapedesis in neutrophils 
Lopez-Castejon 
and Brough, 2011; 
Ryman et al., 2015 
Interleukin-2, 
(IL-2) 
T-helper cells (+) 
Activation of PMN4 and 
lymphocytes 
Sordillo and 
Streicher, 2002 
Interleukin-8 
(IL-8) 
Macrophages, monocytes, 
epithelial cells 
(+) 
Stimulate chemoattraction and 
activation (adhesion, diapedesis 
and ROM2 production) in PMN4 
and monocytes 
Suriyasathaporn et 
al., 1999; Paape et 
al., 2000 
Interleukin-12 
(IL-12) 
Dendritic cells (+) 
Stimulate activation of T-cells 
 
Interleukin-17 
(IL-17) 
T-helper 17 cells (+) 
Acting in concert with TNF and 
IL-1B, it activates signaling 
cascades that lead to the induction 
of chemokines. Acting as 
chemoattractant, chemokines 
recruit monocytes and neutrophils 
to the site of inflammation 
Sordillo, 2016 
Interleukin-
23, 
(IL-23) 
Dendritic cells (+) 
Upregulation of matrix 
metalloproteinase 9, increase of 
angiogenesis, reduction of CD8+3 
T-cell infiltration in tumors 
Crookenden et al., 
2016; Crookenden 
et al., 2017 
Interferon, 
alpha 
(IFNA) 
Dendritic cells (+) 
Stimulate phagocytosis in 
macrophage, anti-viral 
 
Interferon, 
gamma 
(IFNG) 
T-helper cells (+) 
Activation of PMN4 and 
lymphocytes, anti-viral 
Sordillo and 
Streicher, 2002 
Tumor 
necrosis 
factor, alpha 
(TNFA) 
Macrophages  (+) 
Stimulate diapedesis in PMN4 
(production of IL-8 in PMN4 and 
adhesion molecules on vascular 
endothelial cells), enhances acute 
phase of inflammation, stimulate 
the production of antimicrobial 
peptides 
Ryman et al., 2015 
Interleukin-4 
(IL-4) 
Basophils (-) 
Induces differentiation of naive 
helper T cells (Th0 cells) to Th2 
cells 
Sordillo, 2016 
Interleukin-10 Monocytes, type-2 T-
helper cells, mast cells, 
(-) 
Pleiotropic effects in 
Crookenden et al., 
2016; Crookenden 
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(IL-10) CD4+CD25+Foxp3+ 
regulatory T-cells and in a 
certain subset of activated 
T-cells and B-cells 
immunoregulation and 
inflammation. It downregulates the 
expression of Th1 cytokines, 
MHC class II antigens, and co-
stimulatory molecules on 
macrophages. It also enhances B 
cell survival, proliferation and 
antibody production. It can block 
NF-κB activity and is involved in 
the regulation of the JAK-STAT 
signaling pathway 
et al., 2017 
Interleukin-6, 
(IL-6) 
Macrophages (+/-) 
Immune mediator, stimulate the 
production of antimicrobial 
peptides, stimulate diapedesis in 
neutrophils 
Crookenden et al., 
2016; Crookenden 
et al., 2017 
1 (+) indicate a pro and (-) an anti-inflammatory effect. 
2Reactive oxygen metabolites. 
3Cluster of differentiation-8 positive T-cells. 
4Polymorphonuclear cells. 
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Table 3. Main oxylipids classes and species arise from the main polyunsaturated fatty acid 
(PUFA) through different oxidation pathways, and their effect on inflammatory response 
CLASS PRECURSORS PATHWAY OXYLIPID EFFECT ON 
INFLAMMATION1 
Protectin Omega-3 PUFA 
(EPA2 and 
DHA3) 
  (-) 
Anti-inflammatory 
Resolvins Omega-3 PUFA 
(EPA2 and 
DHA3) 
  (-) 
Anti-inflammatory 
Prostaglandin 
(PX) 
Omega-6 PUFA 
(Arachidonic 
acid) 
Cyclooxygenase 
(COX) 
Prostacyclin 
(PG-I2) 
(+) 
Vasodilatation, 
inhibition of platelet 
aggregation 
Cyclooxygenase 
(COX2) 
PG-E2 (+) 
Induction of pain and 
fever 
Cyclooxygenase 
(COX2) 
PG-D2 (-) 
Inhibition of leukocyte 
adhesion to endothelial 
cells, 
decrease of cytokine 
expression by blocking 
NF-κB5, 
enhancement of LOX 
activity 
Cyclooxygenase 
(COX2) 
15d-PG-J2 (-) 
Inhibition of leukocyte 
adhesion to endothelial 
cells, 
decrease of cytokine 
expression by blocking 
NF-κB 
Thromboxane 
(TX) 
Omega-6 PUFA 
(Arachidonic 
acid) 
Cyclooxygenase 
(COX) 
Thromboxane-
A2 (TX-A2) 
(+) 
Aggregation, 
vasoconstriction 
Lipoxin  
(LX) 
Omega-6 PUFA 
(Arachidonic 
acid) 
Lipoxygenase 
(15-LOX + 5-
LOX) 
Lipoxin-A4 
(LX-A4) 
(-) 
Anti-inflammatory 
proprieties 
Lipoxygenase 
(15-LOX + 5-
LOX) 
Lipoxin-B5 
(LX-B5) 
(-) 
Anti-inflammatory 
proprieties 
Leukotriene 
(LT) 
Omega-6 PUFA 
(Arachidonic 
acid) 
Lipoxygenase 
(5-LOX) 
Leukotriene-A4 
(LT-A4) 
(-) 
Can be converted by 15-
LOX in platelets for LX 
biosynthesis 
1(+) indicate a pro and (-) an anti-inflammatory effect. 
2Eicosapentaenoic acid. 
3Docosahexaenoic acid. 
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Table 4. Classification of lymphocytes and their main functions within organism 
TYPE GROUP SUB-GROUP MARKERS1 FUNCTION 
T-
cells 
αβ-T-
cells 
T-
helper 
cells 
(Th) 
FUNCTIONAL 
GROUP 
CD4+/CD8- Cytokines production (IL-22, IFNG3) 
Th1 
Th2 
Th17 
T-regulatory 
cells 
(Treg) 
T-cytotoxic cells  
(Tc) 
CD4-/CD8+ Elimination of host cells with altered 
MHC I4, apoptosis, cytokines 
production 
γδ-T-
cells 
- - Protection of epithelial surfaces 
against bacterial diseases; mediate 
cytotoxicity through WC1 
B-
cells 
Plasma-
cells 
- - Production of immunoglobulins (Igs) 
Ig LOCATION FUNCTION 
IgA Mucosal 
surfaces 
Agglutination, 
neutralization 
of bacterial 
toxins 
IgG 
(1 
and 
2) 
Serum  Increase 
phagocytosis 
in PMN 
(opsonin) 
IgE  Face parasitic 
infections 
IgM  Opsonization, 
agglutination 
and 
complement 
fixation 
IgD  Non-secreted 
regulatory 
molecule 
Memory-
cells 
- - Heightened state of immune 
reactivity and clonal expansion of 
antigen-specific effector cells that 
occurs when host cells and tissues are 
re-exposed to the same antigen 
1Immunophenothyping of leucocytes according to the expression of cluster of differentiations 
4 and 8 on their surface: (+) indicate positive and (–) indicate negative. 
2Interleukin-2. 
3Interferon, gamma. 
4Major histocompatibility complex of class I. 
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Table 5. Patterns of mRNA transcripts encoding for genes that are down regulated in bovine 
PMN during transition period in comparison to 4 weeks after parturition, and their functions 
(O’Boyle et al., 2012; Crookenden et al., 2016, 2017) 
CATEGORY GENE FUNCTION Weeks from calving1 
-1 0 1 2 4 
Lectins Galectin S8 
(LGALS8) 
Development, differentiation, 
cell-cell adhesion, cell-matrix 
interaction, growth regulation, 
apoptosis, RNA splicing 
D 
b 
D 
c 
D 
ab 
D 
ab 
a 
Receptors 
 
Talin 2 
(TLN2) 
Assembly of actin filaments a D 
b 
a a a 
Integrin subunit 
beta-2 
(ITGB2) 
Cell adhesion and signaling D 
b 
a D 
ab 
D 
ab 
a 
Integrin subunit 
alpha M 
(ITGAM) 
Neutrophil adherence and 
phagocytosis 
D 
b 
D 
b 
D 
b 
D 
b 
a 
Integrin subunit 
alpha 4 
(ITGA4) 
α4β1 lymphocyte homing 
receptor 
D 
b 
D 
c 
D 
b 
D 
b 
a 
Integrin subunit 
alpha L 
(ITGAL) 
Cell adhesion and signaling D 
b 
D 
b 
D 
ab 
D 
ab 
a 
Antioxidant  Superoxide 
dismutase 1 
(SOD1)  
Destruction of superoxide radicals 
in cytosol 
D 
b 
a a a a 
Enzymes Myeloperoxidase 
(MPO) 
Antimicrobial (hypochlorite 
production) 
D 
ab 
D 
bc 
D 
c 
D 
c 
a 
Protein kinase C 
beta 
(PRKCB) 
B cell activation, apoptosis, 
endothelial cell proliferation, 
intestinal sugar absorption 
D 
b 
D 
ab 
D 
ab 
D 
ab 
a 
Regulator 
proteins 
X-box binding 
protein 1 
(XBP1) 
 
Regulation of MHC II2, plasma 
cell and eosinophil 
differentiation, angiogenesis, viral 
replication, endoplasmic 
reticulum stress response 
D 
a 
D 
b 
ab ab ab 
Transporters  Solute carrier 
family 2 member 
1 
(SLC2A1) 
Glucose transporter D 
b 
D 
c 
D 
b 
D 
bc 
a 
Immune 
mediators 
Spleen associated 
tyrosine kinase 
(SYK) 
Transmit signals from the B-Cell 
receptor and T-Cell receptor. 
plays a similar role in transmitting 
signals from a variety of cell 
surface receptors (CD743, 
fragment crystallizable receptor 
and integrins) 
D 
b 
D 
ab 
D 
ab 
D 
ab 
a 
Cytokines 
 
Interferon, 
gamma 
(IFNG) 
Pro-inflammatory a D 
b 
a a a 
Interleukin 12A Pro-inflammatory D D D a a 
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(IL12A) ab b ab 
Tumor necrosis 
factor alpha 
(TNF) 
Pro-inflammatory D 
b 
D 
c 
a a a 
Interleukin 23 
subunit alpha 
(IL23A) 
Pro-inflammatory D 
b 
D 
c 
a D 
ab 
a 
Eicosanoids Arachidonate 5-
lipoxygenase 
activating protein 
(ALOX5AP) 
Leukotrienes synthesis: pro-
inflammatory 
b D 
a 
b b b 
Arachidonate 5-
lipoxygenase 
(ALOX5) 
Leukotrienes synthesis: pro-
inflammatory 
a D 
b 
a a a 
Caspase Caspase 8 
(CASP8) 
Toll like receptor pathway: 
stimulate apoptosis  
a D 
b 
D 
ab 
D 
ab 
a 
Cluster of 
differentiations 
CD117: KIT 
proto-oncogene 
receptor tyrosine 
kinase 
(KIT) 
Cell survival, proliferation and 
differentiation 
D 
b 
D 
c 
a a a 
CD45: protein 
tyrosine 
phosphatase, 
receptor type C 
(PTPRC) 
Cell growth, differentiation, 
mitotic cycle, oncogenic 
transformation 
D 
ab 
D 
ab 
D 
ab 
D 
b 
a 
CD337: natural 
cytotoxicity 
triggering 
receptor 3 
(NCR3) 
Apoptosis and natural cell death-
regulator  
D 
b 
D 
c 
D 
b 
D 
b 
a 
Receptors Annexin A3 
(ANXA3) 
Anti-coagulation, regulation of 
cellular growth and signal 
transduction pathways, inhibition 
of phospholipase A2 and cleavage 
of inositol 1,2-cyclic phosphate to 
inositol 1-phosphate  
a D 
b 
D 
ab 
D 
ab 
a 
Nuclear receptor 
corepressor 1 
(NCOR1) 
Inhibition of gene expression D 
ab 
D 
b 
D 
ab 
D 
ab 
a 
Regulator 
proteins 
BCL2 apoptosis 
regulator 
(BCL2) 
Regulation of apoptosis D 
b 
D 
c 
a D 
ab 
a 
Transmembrane 
protein 
Fas-ligand 
(FASLG) 
Apoptosis, regulation of immune 
system and progression of cancer 
D 
bc 
D 
c 
D 
b 
D 
b 
a 
1D indicates genes that are down-regulated during transition period in comparison to their 
levels at 4 weeks after parturition; a, b and c indicates the significance of comparisons. 
2Major histocompatibility complex II. 
3Cluster of differentiation 74. 
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Table 6. Patterns of mRNA transcripts encoding for genes that are up regulated in bovine 
PMN during transition period in comparison to 4 weeks after parturition, and their functions 
(O’Boyle et al., 2012; Crookenden et al., 2016, 2017) 
CATEGORY GENE FUNCTION Weeks from calving1 
-1 0 1 2 4 
Cytokines Interleukin 10 
(IL10) 
Anti-inflammatory b U 
a 
b b b 
Interleukin 6 
(IL 6) 
Pro- and anti-inflammatory U 
bc 
U 
a 
U 
ab 
U 
abc 
c 
Defensins  Beta-defensin 1 
(DEFB1) 
Antimicrobial (epithelial 
surfaces), 
immunomodulatory  
b U 
a 
b b b 
Beta-defensin 10 
(DEFB10) 
Antimicrobial, 
immunomodulatory  
b U 
a 
b b b 
S100 calcium 
binding protein A9 
(S100-A9) 
Respiratory burst (H2O2 
production) 
b U 
a 
b b b 
Defensin, beta 4A 
(BNBD4) 
Antimicrobial, 
immunomodulatory  
c U 
a 
U 
b 
U 
bc 
c 
Eicosanoids Phospholipase A2 
group IVA 
(PLA2G4A) 
Leukotriene pathway: 
release arachidonic acid 
from the membrane 
b U 
a 
b b b 
Enzymes Lactate 
dehydrogenase A 
(LDHA) 
Anaerobic glycolysis b U 
a 
b b b 
Matrix 
metalloproteinases 
Matrix 
metallopeptidase 8 
(MMP8) 
Polymorphonuclear cells 
migration 
b U 
a 
b U 
ab 
b 
Cluster of 
differentiations 
CD121B: 
Interleukin 1 
receptor, type 2  
(IL1R2)  
Interleukins-1 alpha and 
beta inhibitor 
a U 
b 
a a a 
CD14 molecule 
(CD14) 
Toll like receptor pathway: 
detection of bacterial LPS2 
U 
b 
U 
b 
U 
bc 
U 
c 
a 
CD44 molecule  
(CD44) 
 
Lymphocyte activation, 
recirculation and homing, 
hematopoiesis and tumor 
metastasis 
b U 
a 
b b b 
Peptides Lingual 
antimicrobial 
peptide 
(LAP) 
Antimicrobial U 
bc 
U 
a 
U 
ab 
U 
abc 
c 
Receptors 
 
Integrin subunit 
alpha X 
(ITGAX) 
Adhesion b U 
a 
b b b 
Interleukin 2 
receptor subunit 
alpha and beta 
(IL2RA and IL2RB) 
Allows interleukin-2 
functions 
U 
bc 
U 
a 
U 
b 
U 
bc 
c 
Chemokine (C-X-C 
motif) receptor 1 
Interleukin-8 membrane 
receptor: neutrophil 
U 
ab 
U 
a 
c U 
bc 
c 
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(CXCR1) chemotaxis and activation 
Toll-like receptor 2 
(TLR2) 
Membrane receptor 
involved in pathogen 
recognition and 
immunoregulation 
U 
b 
U 
a 
U 
bc 
U 
bc 
c 
Regulatory genes MYD88, innate 
immune signal 
transduction adaptor 
(MYD88) 
Signal transducer in 
interleukin-1 and toll-like 
receptor 4 pathways  
U 
b 
U 
a 
c c c 
Ribosomal 
proteins 
Ribosomal protein 
L23 
(RPL23) 
Protein synthesis U 
b 
U 
ab 
U 
b 
a a 
Transcription 
factor 
Peroxisome 
proliferation 
activated receptor 
delta 
(PPARD) 
Cell inflammatory 
responses 
b U 
a 
b b b 
Peroxisome 
proliferation 
activated receptor 
gamma 
(PPARG) 
Cell inflammatory 
responses 
U 
ab 
U 
a 
U 
ab 
b b 
Retinoid X receptor 
alpha 
(RXRA) 
Endothelial cell 
inflammatory responses: 
receptor for retinoic acid 
b U 
a 
b b b 
Signal transducer 
and activator of 
transcription 3 
(STAT3) 
Immune mediator: mediates 
cellular responses to 
interleukins and other 
growth factors 
U 
a 
U 
a 
U 
b 
ab ab 
1U indicates genes that are up-regulated during transition period in comparison to their levels 
at 4 weeks after parturition; a, b and c indicates the significance of comparisons. 
2Lipopolysaccharides. 
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Table 7. Patterns of mRNA transcripts encoding for genes that are both up and down-
regulated in bovine PMN during transition period in comparison to 4 weeks after parturition, 
and their functions (O’Boyle et al., 2012; Crookenden et al., 2016, 2017) 
CATEGORY GENE FUNCTION Weeks from calving1 
-1 0 1 2 4 
Enzymes Receptor interacting 
serine/threonine kinase 1 
(RIPK1) 
Apoptosis and 
necroptosis; 
participates in NF-
κB2, AKT3, and 
JNK4 functioning 
U 
a 
D 
ab 
D 
c 
D 
bc 
b 
Cluster of 
differentiations 
CD90: Thy-1 cell surface 
antigen 
(THY1) 
Cell-cell and cell-
matrix interactions: 
neurite outgrowth, 
nerve regeneration, 
apoptosis, metastasis, 
inflammation, and 
fibrosis 
D 
c 
U 
a 
U 
b 
bc bc 
CD16a: Fc fragment of 
IgG, low affinity IIIa, 
receptor 
(FCGR3A) 
Cluster of 
differentiations 
surface molecules 
U 
a 
D 
c 
D 
c 
ab ab 
Matrix 
metalloproteinases 
Matrix metallopeptidase 9 
(MMP9) 
Polymorphonuclear 
cells migration 
D 
c 
U 
a 
U 
b 
U 
b 
bc 
Receptors Interleukin 1 receptor 
antagonist 
(IL1RN) 
Interleukin-1, beta 
inhibitor 
U 
a 
ab D 
b 
D 
b 
ab 
Selectin L 
(SELL) 
Leukocytes 
migration 
U 
a 
U 
a 
D 
b 
D 
b 
ab 
Fc-fragment of IgE, high 
affinity I, receptor for 
gamma polypeptide 
(FCER1G) 
Immunoglobulin E 
receptor; involved in 
allergic reactions 
U 
ab 
U 
a 
D 
c 
D 
bc 
abc 
Chemokine (C-X-C motif) 
receptor 1 
(CXCR1) 
Interleukin-8 
membrane receptor: 
neutrophil 
chemotaxis and 
activation 
U 
ab 
U 
a 
c U 
bc 
c 
Chemokine (C-X-C motif) 
receptor 2 
(CXCR2) 
U 
ab 
U 
a 
D 
c 
bc bc 
Toll-like receptor 4 
(TLR4) 
Pathogen recognition 
and regulation of 
immune response 
U 
a 
ab D 
b 
ab ab 
Regulator proteins 
MCL1 apoptosis regulator, 
BCL2 family member 
(MCL1) 
Regulation of 
apoptosis: induced 
myeloid leukemia 
cell differentiation 
protein 
U 
ab 
U 
a 
D 
c 
D 
bc 
abc 
Transporters  ATP binding cassette 
subfamily A member 1 
(ABCA1) 
Cholesterol efflux: 
regulation of cellular 
cholesterol and 
phospholipid 
homeostasis 
a U 
b 
D 
c 
D 
ac 
a 
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1D indicates genes that are down-regulated and U those that are up-regulated during transition 
period in comparison to their levels at 4 weeks after parturition; a, b and c indicates the 
significance of comparisons. 
2Nuclear factor κB. 
3Protein kinase B. 
4c-Jun N-terminal kinase. 
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Table 8. Phenomena undergoing a physiological imbalance during peripartum, their possible 
causes and mechanisms through they are related with a raise in blood haptoglobin 
concentrations and to a greater inflammatory condition 
PHENOMENON CAUSE FACTOR STIMULATING 
HAPTOGLOBIN 
PRODUCTION 
REFERENCE 
Udder involution 
at dry-off 
Milk yields higher that 
25 kg d-1 at dry-off 
Leukocytes activities during 
udder involution 
Bertulat et al., 
2013 
Tissue homeostasis Infections (metritis, 
mastitis) and tissue 
damages related to 
calving (mechanical 
damages and altered 
permeability of rumen 
epithelia) 
Increased production of pro 
inflammatory cytokines 
Vels et al., 2009; 
Minuti et al., 2015 
Mineral 
equilibrium 
Acidogenic close-up 
diets 
Mineral deficiencies during dry 
period (i.e. Ca and Mg) 
Nightingale et al., 
2015 
Hypothalamus-
hypophysis- 
adrenal axe    
Stress related to 
parturition, pen 
movements, re-
socialization, 
environment, weather, 
diet 
Glucocorticoids production 
stimulates haptoglobin release 
from parenchymal liver cells 
Higuchi et al., 
1994; Do 
Nascimento et al., 
2004; Cooke et 
al., 2012 
Lipomobilization Marked negative 
energy balance 
condition arise from 
high milk yields; 
Excessive lipid 
deposition during dry-
off 
Excessive deposition of 
triglycerides in liver (fatty liver) 
reduces the production of 
haptoglobin by parenchymal 
cells (production is in direct 
response to lipids infiltration, 
which acts as harmful stimulus) 
Katoh et al., 2002 
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Table 9. Trends of main hormones during transition period and their effect on immune 
functions 
CLASS HORMONE TREND  EFFECT ON IMMUNE 
SYSTEM1 
REFERENCES 
Glucocorticoids Cortisol  Increase at 
dry-off and 
calving time 
Immune competence (D-): 
down regulation of selectin-
L and cluster of 
differentiation-18 adhesion 
molecules on PMN3, 
impairing their chemotaxis 
and diapedesis;  
altered cytokines 
production through 
impairment of NF-κB7 
functions  
Immune competence (I-): 
reduce feed intake favoring 
lipomobilization. Induce 
increased expression of 
PPARA2, which leads to 
coordinate induction of 
enzymes involved in 
plasma transport, 
intracellular trafficking and 
metabolism of fatty acids 
Burton et al., 
1995; Drackley, 
1999; Drackley et 
al., 2005; Bertulat 
et al., 2013 
Catecholamines Epinephrine, 
norepinephrine, 
dopamine 
Increase at 
dry-off and 
calving time 
Immune competence (D-): 
activation of genes 
encoding for a variety of 
cytokines through the 
cAMP-RBP6 activation  
Immune competence (I-): 
provide the primary 
stimulus for increased 
mobilization of NEFA4 
from adipose tissue  
Drackley, 1999; 
Padgett and 
Glaser, 2003 
Steroids Progesterone High levels 
during 
gestation 
and rapid 
fall at 
calving 
Immune competence (D-): 
decrease functional 
capabilities of lymphocytes 
and PMN3, reduce capacity 
to face bacterial infections 
Immune competence (I-): 
decrease feed intake 
favoring lipomobilization  
Roth et al., 1982; 
Drackley et al., 
2005; Lamote et 
al., 2006 
Estrogen  Increase in 
late 
pregnancy 
Protein 
hormones 
Insulin Increase in 
late 
pregnancy 
and fall in 
early 
lactation 
Immune competence (I-): 
increased insulin resistance 
of peripheral tissues 
reduces peripheral glucose 
increasing negative energy 
balance condition and 
lipomobilization  
Bell, 1995; Lucy, 
2001; Taylor et 
al., 2004 
Growth 
hormone (GH) 
Increase in 
early 
Immune competence (I-): 
down regulation of liver 
(Lucy, 2001) 
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lactation GH receptor during NEB5 
increase GH and decrease 
IGF-1 blood concentration, 
increasing lipolysis and 
gluconeogenesis  
Insulin like 
growth factor 
(IGF-1) 
Decrease in 
early 
lactation 
 Leptin Falls in late 
pregnancy 
and remain 
low 
postpartum 
Immune competence (I-):  
can influence feed intake 
and contribute to peripheral 
insulin resistance in 
peripartum, increasing 
NEB5 condition 
Esposito et al., 
2014 
1(I) and (D) indicate an indirect and direct mode of action respectively; (+) and (-) indicate a 
positive or negative effect on immune function respectively. 
2Peroxisome proliferation activated receptor, alpha. 
3Polymorphonuclear cells. 
4Not esterified fatty acids. 
5Negative energy balance. 
6Cyclic adenosine monophosphate response element binding protein. 
7Nuclear factor-κB. 
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Table 10. Main metabolites related to the negative energy balance status, their trend during 
transition period, their effects on immune cells and their mode of action 
METABOLITE, 
TREND1 
CELL EFFECT2 MECHANISM REFERENCE 
Glucose, 
(-) late gestation 
and after 
calving 
Macrophages, 
polymorphonuclear 
cells 
Immune 
competence (-) 
Decrease of 
proliferation, 
differentiation, 
viability, 
chemotaxis and 
phagocytosis 
Primary energy 
source for 
leukocytes. Low 
efficiency in 
alternative 
energy sources 
utilization  
Barghouthi, 
Everett, & 
Speert, 1995; 
Gamelli, Liu, 
He, & 
Hofmann, 1996; 
Pithon-Curi, De 
Melo, & Curi, 
2004 
Lymphocytes  Immune 
competence (-) 
Reduced mitogen-
induced activation 
Proliferation and 
secretory 
activities are 
glucose 
dependent 
Sordillo, 2016 
Not esterified 
fatty acids 
(NEFA), 
(+) after calving 
Polymorphonuclear 
cells 
Immune 
competence (-) 
Inhibition of 
phagocytosis and 
synthesis of DNA 
Impairment of 
cell viability 
Lacetera et al., 
2004 
Monocytes  Immune 
competence (-) 
Decreased 
diapedesis and 
secretion of IgM3, 
TNFA4 and IL-65 
Reduced 
expression of 
mRNA encoding 
for L-selectin, 
TNFA4 and IL-65 
Lacetera et al., 
2004 
Macrophages Inflammation (+) 
Increase respiratory 
burst and induce 
apoptosis and 
necrosis 
Increase of ROM 
production 
Scalia et al., 
2006 
Lymphocytes  Immune 
competence (-) 
Altered 
proliferation, 
decreased secretion 
of IgM3 and IFNG6 
 Lacetera et al., 
2004 
Saturated fatty 
acids (SFA), 
Palmitic 
(C16:0) and 
stearic acids 
(C18:0) 
decrease their 
abundance in 
cell membranes, 
while lauric 
(C12:0) and 
myristic (C14:0) 
increase after 
White blood cells Altered 
lymphocytes 
activation, 
antibodies 
production and 
inflammation 
driven from the 
inhibition of CD147 
and 
lipolysaccharides-
induced tumor 
necrosis factor 
(TNF) production 
SFA can 
covalently 
modify proteins 
trough fatty 
acylation, 
altering 
membrane 
fluidity, 
influencing how 
proteins anchor 
to plasma 
membrane and 
affecting lipid 
Raphael and 
Sordillo, 2013 
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calving raft formation 
Polymorphonuclear 
cells 
Inflammation (+) 
Activation of Toll-
like receptors 
(TLRs) 2 and 4, 
increased apoptosis 
and necrosis 
Pro-
inflammatory. 
C12:0, C14:0 
and C16:0 are 
PAMP9 that 
activate NF-κB10 
mediated gene 
expression, 
increasing 
inflammation 
and respiratory 
burst activity 
Lee et al., 2003; 
Lee et al., 2004; 
Scalia et al., 
2006 
Macrophages Immune 
competence (-) 
Decreased secretion 
of IgM3, IFNG6, 
TNFA and IL-65. 
Altered ROM8 
production 
Immune 
competence (-) 
Reduced 
phagocytosis, 
diapedesis, antigen 
presentation and 
synthesis of DNA 
Impaired cell 
viability for the 
low efficiency in 
utilization as 
energy source 
UFA, 
Oleic and 
linoleic acids 
increase, while 
eicosatrienoic 
acid (C20:3) 
and EPA 
(C20:5) 
decrease in cell 
membranes 
after calving 
Polymorphonuclear 
cells 
Inflammation (+) 
Increased ROM8 
production, 
increased 
phagocytosis 
α-linoleic acid 
interacts with 
PPARG11. EPA 
and DHA 
interacts with 
TLR2, TLR4, 
PPAR and sterol 
response element 
binding protein 
family of 
transcription 
factors. 
All these genes 
are involved in 
NF-κB10 
activation and 
UFA could act 
both as pro or 
anti-
inflammatory 
factors 
Lee et al., 2003; 
Lee et al., 2004; 
Gorjão et al., 
2006; Scalia et 
al., 2006; Lee et 
al., 2010 Inflammation (+) 
reduced expression 
of mRNA for IL-10 
and IL-8, stimulated 
expression of IL-1B 
and ICAM I, altered 
expression of 
cyclooxygenase 
(COX) 2 and TNFA 
Monocytes Immune 
competence (-) 
Reduced antigen 
presentation to 
lymphocytes  
EPA and DHA 
reduce MHC II12 
and ICAM113 
expression 
decreasing 
IFNG6 
production 
Lee et al., 2003; 
Lee et al., 2004; 
Gorjão et al., 
2006; Scalia et 
al., 2006 
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Macrophages Immune 
competence (-) 
Increased 
phagocytosis, 
inhibition of TLRs 
Anti-
inflammatory. 
EPA and DHA 
inhibits TLR2 
and TLR4 
reducing 
expression of 
NF-κB10 
Calder et al., 
1990; Lee et al., 
2003; Lee et al., 
2004 
Lymphocytes Inflammation (+) 
Increase the 
production of IL-
10, TNFA and 
IFNG6 
EPA and DHA 
inhibits the 
production of 
prostaglandin 
E2, that is known 
to reduce IFNG6 
synthesis and 
lymphocytes 
proliferation 
Gorjão et al., 
2006b; Hughes 
and Pinder, 
2000; Trebble et 
al., 2003; 
Brassard et al., 
2007 
Increase the 
production of IL-4 
in circulating T-
cells 
BHB, 
(+) early 
lactation 
Macrophage, 
polymorphonuclear 
cells 
Immune 
competence (-) 
Decreased 
chemotaxis, 
respiratory burst 
and superoxide 
anion production 
Decrease cell 
viability as are 
useless as 
alternative 
energy source  
Calder et al., 
1990; Hoeben et 
al., 1997; 
Sartorelli et al., 
1999; 
Suriyasathaporn 
et al., 1999 
Lymphocytes Immune 
competence (-) 
Decreased 
blastogenesis, 
mitogenic responses 
and IgM3 
production 
Decrease cell 
viability as are 
useless as 
alternative 
energy source 
Targowski and 
Klucinski, 
1983; Nonnecke 
et al., 1992; 
Takeuchi et al., 
2010 
Glutamine, 
(-) late gestation 
and early 
lactation 
Macrophage, 
polymorphonuclear 
cells 
Immune 
competence (-) 
Reduced production 
of IL-1B and IL-6, 
reduced 
phagocytosis  
Glutamine 
availability drive 
those functions 
(high oxidation 
efficiency) 
Wallace and 
Keast, 1992; 
Ogle et al., 
1994; Yassad et 
al., 1997 
Reduced production 
of nitric oxide 
(macrophages) and 
superoxide anion 
(polymorphonuclear 
cells) 
Glutamine drives 
the production of 
NADPH 
Lymphocytes Immune 
competence (-) 
Reduced cell 
division and 
synthesis of lactate 
Glutamine is 
precursor of 
purine and 
pyrimidine: 
essential in 
anabolic 
functions 
Newsholme et 
al., 1985; 
Newsholme et 
al., 1999; 
Pithon-Curi et 
al., 2004 
1Trend of main metabolites related to immune cells functions during transition period: (-) 
indicates metabolites that undergoes a reduction, (+) indicates metabolites that increase during 
transition period. 
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2Effect of main metabolites related to negative energy balance condition on immune 
functions: (-) indicate a depressive effect, (+) indicate a stimulating effect. 
3Immunoglobulins M. 
4Tumor necrosis factor, alpha. 
5Interleukin-6. 
6Interferon, gamma. 
7Cluster of differentiation 14. 
8Reactive oxygen metabolites. 
9Pathogen-associated molecular patterns. 
10Nuclear factor-κB. 
11Peroxisome proliferation activated receptor, gamma. 
12Major histocompatibility complex, II. 
13Intercellular adhesion molecule. 
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Table 11. Patterns and functions of mRNA transcripts encoding for genes that are up (U) or 
down-regulated (D) in bovine PMN with a negative (NEB) or positive (PEB) energy balance, 
induced feeding mid-lactating cows with 60% and 210% of their energy requirements for 
maintenance respectively (Crookenden et al., 2017) 
CATEGORY GENE FUNCTION NEB PEB 
Antigens Major histocompatibility complex, 
class I, A  
(HLAA) 
Human leukocytes antigen: 
antigen presentation 
D U 
Major histocompatibility complex, 
class II, DR alpha  
(HLA-DRA) 
Human leukocytes class II 
histocompatibility antigen, 
DR alpha chain: antigen 
presentation 
D U 
Antioxidant  Superoxide dismutase 1 
(SOD1) 
Destroy superoxide 
radicals in cytosol  
D U 
Cytokines Interleukin-10 
(IL10) 
Anti-inflammatory D U 
Interleukin-6 
(IL6) 
Pro- and anti-inflammatory U D 
Tumor necrosis factor, alpha 
(TNFA)  
Pro-inflammatory D U 
Defensins  Beta defensin-1 
(DEFB1) 
Resistance of epithelial 
surfaces to microbial 
colonization 
D U 
S100 calcium binding protein A9 
(S100A9) 
Respiratory burst (H2O2 
production) 
D U 
Eicosanoids Arachidonate 5-lipoxygenase activating 
protein  
(ALOX5AP) 
Leukotrienes pathway: 
leukotrienes synthesis 
D U 
Phospholipase A2 group IVA  
(PLA2G4A)  
Leukotriene pathway: 
release arachidonic acid 
from the membrane 
D U 
Clusters of 
differentiation 
CD121B: interleukin 1 receptor type 2 
(IL1R2)  
Interleukins 1, alpha and 
beta, inhibitor 
D U 
CD44 molecule  
(CD44) 
 
Lymphocyte activation, 
recirculation and homing, 
hematopoiesis and tumor 
metastasis 
U D 
Receptors Interleukin 1 receptor type 2  
(IL1R2) 
Cytokine receptor U D 
Toll-like receptor 2 
(TLR2) 
Membrane receptors for 
pathogen recognition and 
regulation of immune 
responses 
U D 
Toll-like receptor 4 
(TLR4) 
U D 
Ribosomal 
proteins 
Ribosomal protein-L23 
(RPL23) 
Protein synthesis U D 
Transcription 
factors 
Signal transducer and activator of 
transcription 3 
(STAT3)  
Immune mediator: 
mediates cellular responses 
to interleukins, and other 
growth factors 
U D 
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Table 12. Patterns of mRNA transcripts encoding for genes that are up (U) or down-regulated 
(D) after calving in cows that were over conditioned during dry period (BCS > 3.5), and their 
functions (Crookenden et al., 2017) 
CATEGORY GENE FUNCTION HIGH BCS 
Defensins  Beta-defensin 4A 
(DEFB4A) 
Antimicrobial, immunomodulatory D 
Beta-defensin 1 
(DEFB1) 
Antimicrobial (epithelial surfaces), 
immunomodulatory 
D (trend) 
Beta-defensin 10 
(DEFB10) 
Antimicrobial, immunomodulatory D 
S100 calcium binding 
protein A9 
(S100A9) 
Respiratory burst (H2O2 production) D 
Matrix 
metalloproteinases 
Matrix metallopeptidase 
8 
(MMP8) 
Neutrophil collagenase: 
polymorphonuclear cells migration 
D 
Matrix metallopeptidase 
9 
(MMP9) 
Neutrophil gelatinase: 
polymorphonuclear cells migration 
D 
Cytokines Interleukin 10 
(IL10) 
Anti-inflammatory D 
Interleukin 23, alpha 
(IL23A) 
Pro inflammatory U 
Eicosanoids Arachidonate 5-
lipoxygenase activating 
protein  
(ALOX5AP) 
Leukotrienes pathway: leukotrienes 
synthesis 
D 
Clusters of 
differentiation 
CD14 molecule 
(CD14) 
Toll like receptor pathway: detection 
of bacterial lipopolysaccharides 
D 
CD117: KIT proto-
oncogene receptor 
tyrosine kinase 
(KIT) 
Cell survival, proliferation and 
differentiation 
U 
Transporters  ATP-binding cassette 
subfamily A member 1 
(ABCA1) 
Transporter involved in cholesterol 
efflux: major regulator of cellular 
cholesterol and phospholipid 
homeostasis 
U 
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Table 13. Main biological process related to calving and involved in the development of the 
oxidative stress status in dairy cows: their site of occurrence, their biological function and the 
mechanism by which they contribute in altering redox status 
BIOLOGICAL 
PROCESS 
SITE FUNCTION MECHANISM REFERENCE 
Cellular 
respiration 
 
All tissues Conversion of 
nutrient to energy 
aimed to face 
requirements for 
milk synthesis and 
secretion  
ROM1 are formed in 
mitochondria as 
byproduct of electron 
transport chain 
Valko et al., 
2007 
Fatty acid 
metabolism 
Liver ROM1 are formed in 
peroxisome consequently 
to beta-oxidation  
Drackley, 
1999; Grum et 
al., 2002 
Respiratory burst Phagocytes Kill microbial 
pathogens during 
inflammation 
ROM1 are formed in 
phagocytes from 
NADPH2 oxidase system 
Babior, 1999 
Oxylipid 
biosynthesis 
Cellular 
membranes 
Regulation of 
inflammatory 
process and immune 
response 
Lipid peroxide and 
superoxide anion are 
byproduct of the oxidative 
reactions of PUFA3 
triggered by COX4, LOX4 
or cytochrome P450 
Raphael and 
Sordillo, 2013 
Reduced dietary 
intake 
Gut, tissue 
and blood 
Adaptation to 
physiological 
imbalance related to 
calving 
Reduced plasma 
concentrations of serum-
derived micronutrients as 
vitamins and minerals 
with antioxidant 
properties  
Spears and 
Weiss, 2008; 
Sordillo and 
Mavangira, 
2014 Increased 
utilization of 
antioxidant 
systems 
Blood and 
tissues 
Facing metabolic 
stress occurred in 
transition period 
Lipomobilization 
and triglycerides 
deposition 
Liver cells Supply to growing 
energy demand 
Liver damage and 
dysfunction reduce 
plasma cholesterol and 
high-density lipoproteins, 
which bound 
paraoxonase, an important 
antioxidant enzyme, to the 
blood 
Turk et al., 
2005 
Inflammatory 
status 
Face tissue damages 
and infections 
related to calving 
1Reactive oxygen metabolites. 
2Nicotinammide adenine dinucleotide phosphate. 
3polyunsaturated fatty acids. 
4Cyclooxygenase. 
5Lipoxigenase. 
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Table 14. Time course relationship between main transition period diseases, their effect on 
physiological imbalance conditions and possible secondary diseases triggered from it 
PRIMARY EFFECT ON PHYSIOLOGICAL 
IMBALANCE 
SECONDARY REFERENCE 
Retained 
placenta 
Raise of PIC1; depression of DMI2; 
increase of NEB3 and lipomobilization 
Mastitis  Emanuelson et al., 
1993 
Ketosis  Ketone bodies production; depression of 
DMI2; increase of NEB3; impairment of 
immune functions  
Mastitis, metritis, 
left displacement 
of abomasum 
Oltenacu and 
Ekesbo, 1994; 
Duffield, 2000 
Retained 
placenta 
Raise of PIC1; depression of DMI2; 
increase of NEB3 and lipomobilization 
Ketosis  Dohoo and Martin, 
1984 
Milk fever Depression of DMI2; increase of NEB3 
and lipomobilization; decreased smooth 
muscle function (essential for digestive 
tract); increased cortisol secretion 
Ketosis; left 
displacement of 
abomasum; 
retained placenta 
Dohoo and Martin, 
1984b; Loor et al., 
2013; Esposito et 
al., 2014 
Left 
displacement 
of abomasum 
Depression of DMI2; increase of NEB3 
and lipomobilization 
Ketosis  Dohoo and Martin, 
1984 
Fatty liver Increased haptoglobin production and 
inflammation; increased PIC1 
production; depression of DMI2; increase 
of NEB3 and lipomobilization 
Metritis, laminitis, 
displacement of 
abomasum, 
mastitis 
Van Winden and 
Kuiper, 2003; 
Ametaj et al., 2005 
Infectious 
diseases 
Decreased glutamine concentrations due 
to tissue and immune cells consumption; 
repression of genes related to 
inflammatory response and PMN4 
chemotaxis; greater expression of mRNA 
for anti-inflammatory genes and 
oxidative stress 
Metritis, mastitis, 
infectious diseases 
Holtenius et al., 
2004; Moyes et al., 
2009 
1Pro inflammatory cytokines. 
2 Dry matter intake. 
3Negative energy balance. 
4Polymorphonuclear cells. 
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Table 15. Main nutritional supplements aimed to modulate dairy cow’s immunity during 
transition period and their mode of action on immune cells 
SUPPLEMENT EFFECT MECHANISM REFERENCE 
Omega-3 PUFA 
(eicosapentaenoic 
acid - EPA - and 
docosahexahenoic 
acid - DHA) 
Inflammation (-) 
Mitigation of 
proinflammatory response 
(reduced TNF1 and IL-62 
production) of immune 
cells to high NEFA3 
concentrations (as those 
observed with high 
lipomobilization)  
EPA and DHA decrease the 
amount of arachidonic acid in 
cell membranes, shifting the 
oxylipid profile: increased 
production of resolvins, 
protectins and lipoxins 
(which attenuate the 
inflammatory process) and 
attenuated endometrial 
PGF2A8 production (pro-
inflammatory effect). 
Decreased expression of 
adhesion molecules involved 
in inflammatory interactions 
between leukocytes and 
endothelial cells; down 
regulation of Toll-like 
receptor 4 reduces the 
expression of transcription 
factors and PICs5 
Lessard et al., 
2004; Mattos et 
al., 2004; Trevisi 
et al., 2011b; 
Contreras et al., 
2012a; b; 
Dirandeh et al., 
2013; Minuti et 
al., 2015 
Immune competence (+) 
Improved lymphocytes 
and mononuclear cells 
function in transition 
period: improved cell-
mediated immune 
response; increased 
phagocytosis and 
decreased oxidative stress 
damages in PMN4, leading 
to improved uterine and 
udder health in early 
lactation; modified 
mononuclear cells/PMN4 
ratio 
Omega-6 PUFA 
(conjugated linoleic 
acid - CLA) 
Inflammation (-) 
Increased albumin and 
cholesterol concentrations 
in early lactation 
Modulation of the NF-κB9 
inhibiting the LPS10-induced 
inflammatory activity in 
macrophages 
Cheng et al., 
2004; Trevisi and 
Bertoni, 2008; 
Silvestre et al., 
2011 Immune competence (+) 
Enhanced neutrophils 
function in transition 
period 
Protection of paraoxonase 
against oxidative 
inactivation, reducing 
oxidative stress status;  
Increased secretion of 
VLDL11 and apolipoprotein 
B100, decreasing cellular 
accumulation of triglycerides 
from palmitic acid, 
increasing DMI12, reducing 
NEB13 and lipomobilization 
(lower NEFA3 and BHB14 
levels in blood) 
Vitamin A Prevention of oxidative 
stress status 
β-carotene prevents fatty acid 
peroxidation chain reaction 
Sordillo, 2016 
Vitamin C Mitigation of oxidative 
stress status 
Ascorbic acid act as a radical 
scavenger 
Sordillo, 2016 
Vitamin E Mitigation of oxidative 
stress status 
α-tocopherol disrupts fatty 
acid peroxidation chain 
reaction 
Trevisi et al., 
2011b; Sordillo, 
2016 
Vitamin D3 Inflammation (-) Inhibits Th1 sub-family of Bertoni et al., 
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Down-regulation of PICs5 
in favor of AICs6 
production 
lymphocytes in favor of Th 2 2015 
Selenium Mitigation and prevention 
of oxidative stress status 
Active component of 
thioredoxin reductase and 
glutathione peroxidase 
enzymatic complexes, that 
controls redox signaling and 
reduce ROM15 production 
Sordillo, 2016 
Copper Mitigation and prevention 
of oxidative stress status 
Active component of 
ceruloplasmin, that exert 
oxidase activity as peroxyl 
radical scavenger, and 
superoxide dismutase, that 
converts cytosol superoxide 
to H2O2 
Osorio et al., 
2016; Sordillo, 
2016 
Zinc Mitigation and prevention 
of oxidative stress status 
Active component of 
superoxide dismutase, that 
converts cytosol superoxide 
to H2O2, and metallothionein, 
which is a cysteine rich 
radical scavenger  
Sordillo, 2016 
Manganese  Mitigation of oxidative 
stress status 
Active component of 
superoxide dismutase that 
converts cytosol superoxide 
to H2O2 
Osorio et al., 
2016; Sordillo, 
2016 
Iron  Mitigation of oxidative 
stress status 
Active component of 
catalase, that converts H2O2 
to water 
Sordillo, 2016 
Choline Reduced hepatic 
triglycerides abundance; 
mitigation of oxidative 
stress status 
Component of 
phosphatidylcholine, that is 
required for the synthesis of 
VLDL11 by the liver; 
important sources of the 
intracellular antioxidants 
glutathione and taurine 
Esposito et al., 
2014; Zhou et al., 
2016 
Methionine and 
lysine  
Reduced hepatic 
triglycerides abundance; 
mitigation of oxidative 
stress status 
They affect mitochondrial 
beta oxidation of fatty acids 
in liver and export of 
triglycerides as VLDL11; 
important sources of the 
intracellular antioxidants 
glutathione and taurine 
Esposito et al., 
2014; Zhou et al., 
2016 
Acetylsalicylic acid Inflammation (-): 
Reduced positive APPs7 
abundance and improved 
liver synthesis 
Inhibition of cyclooxygenase 
enzymatic complex reducing 
the synthesis of pro 
inflammatory oxylipids  
Shin et al., 2010; 
Kim et al., 2012; 
Grossi et al., 2013 
Hottuynia cordata 
extract 
Inflammation (-): 
Reduced production of 
TNF1 and pro 
Shin et al., 2010; 
Kim et al., 2012 
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inflammatory oxylipids 
Aloe arborescens 
Mill. extract 
Inflammation (-): 
Increased negative APPs7 
concentration 
Reduced mobilization of 
body fats and improved liver 
synthesis 
Trevisi et al., 
2013b 
1Tumor necrosis factor. 
2Interleukin-6. 
3Not esterified fatty acids. 
4Polymorhonuclear cells. 
5Pro-inflammatory cytokines. 
6Anti-inflammatory cytokines. 
7Acute phase proteins. 
8Prostaglandin 2, alpha. 
9Nuclear factor κB. 
10Lypopolysaccharides. 
11Very low-density lipoproteins. 
12Dry matter intake. 
13Negative energy balance. 
14Beta-hydroxybutyrate. 
15Reactive oxygen metabolites. 
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CHAPTER II - DRY-OFF AND IMMUNE FUNCTIONS 
Innate immune response and metabolic changes at dry-off in high yield dairy cows 
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ABSTRACT 
Dry-off is related to deep changes in feeding behavior, gastro intestinal adaptations, 
metabolism and immune parameters in high-yielding cow’s career. Indeed, the release of 
cortisol, signals of systemic inflammation and altered redox balance have been reported 
immediately after milking interruption, and high milk yield (MY) have a role in aggravating 
such conditions. Our study was aimed in investigate the main causes of metabolic changes 
occurring at dry-off and the contribution of MY in such alterations. A group of 13 Holstein 
dairy cows were housed in tied stalls and dried off at 55 days from expected calving day. 
Animals were retrospectively divided in two groups according to their average MY in the last 
week of lactation, assuming a cut-off of 15 kg*d-1: low MY (6 cows) and high MY (7 cows). 
From -7 to 34 days from dry-off (DFD) BCS, BW, DMI and rumination time were measured. 
Blood samples were collected regularly to assess a wide hematochemical profile and to test 
white blood cell functions through ex vivo challenges. Data were submitted to ANOVA using 
a mixed model for repeated measures including MY at dry-off, time and their interaction as 
fixed effects. Increased fiber amounts of dry ration reduced DMI and increased rumination 
time. Leukocytes migration into mammary gland to contribute in the involution phase 
decreased their abundance in blood at dry-off, and their activity. Such activation of leukocytes 
at mammary site increased the abundance of nitrogen species in plasma and triggered a 
systemic inflammation in all the animals, as reflected from increased concentrations of 
positive and reduced concentrations of negative acute phase proteins. Such inflammation 
impaired liver functions, as suggested from the increased gamma-glutamyl transferase, 
bilirubin and alkaline phosphatase concentrations. Both the production of nitrogen species and 
the systemic inflammatory status contributed in the depletion of antioxidant system in blood 
(thiol groups, tocopherol, β-carotene, ferric reducing antioxidant power and oxygen reactive 
antioxidant capacity). Animals with higher MY at dry-off showed the worst condition, likely 
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for the deeper metabolic changes they faced at milking interruption, and to the greater amount 
of mammary parenchyma to be reabsorbed. This study highlights the dry-off as a thorny point 
to manage dairy cows’ health and depose for a relationship between dry-off and immune 
alteration that typically occurs at calving. 
Key Words. Dry-off, inflammation, immune dysfunction, metabolic stress 
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INTRODUCTION 
The proper dry period of dairy cows includes the time between halting of milk removal 
(milk stasis) and the subsequent calving. This phase allows the development of the mammary 
gland and the turnover of the secretory tissue (Oliver and Sordillo, 1988) and its essential to 
maximize milk yield in the following lactation. At dry-off, milk residuals in the mammary 
gland induce cellular distention and stimulate the release of autocrine mediators (i.e. feedback 
inhibitor of lactation protein) inhibiting milk synthesis (Wilde et al., 1998; Capuco and Akers, 
1999), while fragments arise from the hydrolysis of caseins acts as putative mediators of 
mammary gland involution (Shamay et al., 2003). 
A sudden dry-off has been widely practiced in all commercial dairy farms until increases in 
milk yields made challenging to stop milk production in order to achieve the 60 days goal for 
dry period (Dingwell et al., 2001). Some studies suggested a shortened dry period to face the 
problem (Van Knegsel et al., 2013), but such solution could not guarantee a fully involution 
of mammary gland tissues, reducing milk production in the following lactations (Klein and 
Woodward, 1943; Capuco and Akers, 1999). Thus, dairy farmers started to restrict feed 
supply and withdraw all grain several days before dry-off, in order to reduce drastically the 
milk production (Agenäs et al., 2003; Odensten et al., 2005), and to halt milking about 45 to 
50 days before expected date of parturition.  
At dry-off, the priority in redistribution of energy and protein sources shift from mammary 
gland to fetus, drowning the cow’s own needs for body maintenance (Dingwell et al., 2001). 
Adaptation to dry ration decreases the surface area of rumen papillae (Dieho et al., 2016), and 
leads fiber utilizing bacteria to prevail on amylolytic species in rumen fluid. Furthermore, 
halting of milk removal affects mammary gland both at gross and cellular levels, increasing 
the susceptibility to infections (Cousins et al., 1980). Finally, the hunger related to feed 
restriction and the modification of social structure after regrouping could induce 
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psychological stress in weaker animals (von Keyserlingk et al., 2008). Nevertheless, dry-off 
did not receive as much attention as other challenging periods, such as transition to calving, 
and only recent concerns about animal welfare promoted a deeper investigation of dry-off as a 
cause of metabolic stress (Odensten et al., 2005; Zobel et al., 2015). Consequently, high milk 
yield at dry-off has been identified as a negative factor for dairy cow’s health (Rajala-Schultz 
et al., 2005). In fact, increased udder pressure that follows milking interruption could induce 
severe pain and injuries with milk yield higher than 25 kg*d-1 at dry-off (Silanikove et al., 
2013) triggering a  raise of stress-related hormones immediately after dry-off (Bertulat et al., 
2013). Glucocorticoids and catecholamines interact with specific receptors on immune cells 
regulating different pathways (i.e. nuclear factor kappa-light-chain-enhancer of activated B-
cells and cyclic AMP response element binding protein). Such interactions modifies the 
transcription of genes encoding for a variety of cytokines. The resulting dysregulation of 
immune function could last up to early lactation, with a sufficient magnitude to have health 
implications (Padgett and Glaser, 2003), and suggesting stress occurring at dry-off to be 
related with severe immune dysfunction happening during the peripartal period of dairy cows 
(Trevisi et al., 2010).  
Based on above, our objective is to investigate the effect of abrupt dry-off on the 
metabolic, oxidative and immune status during the whole dry period of cows having high or 
low milk yield. Our hypothesis is that abrupt dry-off can negatively affect the immune 
response during the dry period, especially in cows with high milk yields at the end of 
lactation. 
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MATERIALS AND METHODS 
Experimental design and animal management 
The trial was carried out at Università Cattolica del Sacro Cuore research dairy barn 
(Experiment Station, San Bonico, Piacenza, Italy) in accordance with Italian laws on animal 
experimentation (DL n. 26, 04/03/2014) and ethics (Authorization of Italian Health Ministry 
N 1047/2015-PR). A group of 13 Italian Holsteins dairy cows were raised in individual tied 
stalls with controlled environmental conditions (room temperature of 20°C, relative humidity 
of 65%, 14 hours of light) and dried off at 55 days from expected calving day with a deep 
milking and a treatment with a mammary antibiotic (Mamyzin A; Haupt Pharma Latina S.r.l, 
Borgo San Michele – Latina, Italy). Before dry-off, cows were milked twice a day, at 4:00 am 
and pm, and milk yield was recorded. All the cows were individually fed with a component 
diet. Before dry period, animals received 1 kg of concentrate every 3 kg of produced milk. 
Since -7 days from dry-off (DFD) the concentrate was gradually reduced till the complete 
elimination at dry-off (Phase 1). After dry-off, animals received only hay till 10 DFD. 
Subsequently, animals received a hay-based ration with soybean meal and corn silage till the 
end of the experimental period (Phase 2). Same batches of hays and corn silage were used 
during the trial. Feeds were collected fortnightly and, after dry matter determination, samples 
were pooled for subsequent analyses. Feeds and diet composition are shown in table 1. 
From -7 to 34 DFD periodical checks were performed and blood samples were collected 
regularly, according to the time schedule shown in Figure 1 and described in the following 
sections. In addition, the health status of cows was monitored recording all clinical diseases 
appeared from -7 DFD till 30 days from subsequent calving. To investigate the effect of milk 
yield, after dry-off animals were retrospectively divided in two groups according to their 
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average milk yield in the last week of lactation, assuming a cut-off of 15 kg*d-1: low milk 
yield (LM; 6 cows) and high milk yield (HM;7 cows).  
Body weight, body condition score, dry matter intake and rumination time  
The body weight was measured with a single walking-in scale. The body condition score 
(BCS) was determined from the same operator with a 1 to 5 scale (Agricultural Development 
and Advisory Service, 1986) and its variation (∆BCS) was calculated as the difference 
between data at -7 and 34 DFD. The daily dry matter intake was measured weighting the 
amounts of feed administered and residuals for each cow. Rumination time was registered 
using the Ruminact system (SCR Europe, Podenzano, PC, Italy) and expressed on a daily 
base (Figure 1).  
Health status 
The body temperature was measured daily with a rumen bolus (DVM System 
TempTrackTM, HerdStrong, LLC, Greeley, CO). Mastitis were diagnosed by visual evaluation 
of abnormal milk from each quarter and SCC analysis on suspicious cases, retained placenta 
when the fetal membranes were not expelled within 24 h after calving, endometritis and 
metritis according to Sheldon et al. (2006), milk fever, displacement of abomasum and 
pneumonia by a veterinary diagnosis. Diarrhea was diagnose on visual evaluation of feces 
consistency and color through the fecal score method (Ireland-Perry and Stallings, 1993), 
assuming diarrheic feces those have a fecal score ≤ 2. 
Blood samples collection  
Blood samples were harvested trough jugular venipunction in evacuated collection tubes 
(BD Vacutainer; BD and Co., Franklin Lakes, NJ) before the morning feeding. Samples were 
used to perform different assays (Figure 1). 
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Metabolic profile assessment. For metabolic profile assessment (Figure 1), samples were 
collected into heparinized tubes and processed as described by Calamari et al. (2016). After 
collection, samples were centrifuged and packed cells volume (PCV) was determined. A 
clinical auto-analyzer (ILAB-650, Instrumentation Laboratory, Lexington MA, USA) was 
used to determine the concentration of glucose, not-esterified fatty acids (NEFA), beta-
hydroxybutyrate (BHB), urea, creatinine, Ca, P, Mg, Na, K, Cl, Zn, aspartate amino 
transferase-glutamate oxaloacetate transaminase (AST-GOT), gamma glutamyl transferase 
(GGT), alkaline phosphatase (ALP), total protein, haptoglobin, ceruloplasmin, albumin, total 
bilirubin, cholesterol and globulin in accordance with Calamari et al. (2016). Furthermore, 
reactive oxygen metabolites (ROMt), ferric reducing antioxidant power (FRAP), nitrate 
(NO3), nitrite (NO2) and nitric oxides (NOx) were determined according to Jacometo et al. 
(2015), paraoxonase (PON) according to Bionaz et al. (2007), thiol groups (SHp) according 
to Minuti et al. (2014), myeloperoxidase according to Bradley, Priebat, Christensen, & 
Rothstein (1982) and advanced oxidation protein products (AOPP) according to Hanasand et 
al. (2012). Finally, L-lactic acid (LLA) and D-lactic acid (DLA) were determined with a 
commercial kit (K-DLATE, Megazyme Co., Wicklow, Ireland). A multi-detection microplate 
reader (BioTek Synergy 2, Winooski, VT, USA) and commercial kits for ELISA method were 
used to determine the concentration of interleukin 1-beta (IL-1B; ESS0029; Thermo 
Scientific, Frederick, MD, USA) and interleukin 6 (IL-6; ESS0027; Thermo Scientific, 
Frederick, MD, USA) according to Jahan et al. (2015) and those of serum amyloid alpha 
(SAA; TP-802, Tridelta D.L., Ireland). Furthermore oxygen reactive antioxidant capacity 
(ORAC) were determined with a fluorometric method according to Jacometo et al. (2015). 
Retinol, tocopherol and β-carotene were analyzed by reverse-phase HPLC (LC-4000, Jasco 
Europe, Carpi MO, Italy), as described by Jahan et al. (2015).   
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White blood cells profile. For the white blood cells (WBC) profile (Figure 1), samples 
were collected with K-EDTA tubes and analyzed with Cell-DYN 3700 (Abbott Diagnostic 
Division, Santa Clara, CA). A laser optic assay was used to determine the amounts of total 
WBC, neutrophils, lymphocytes, monocytes, eosinophils and basophils. The neutrophils to 
lymphocytes ratio was calculated. The amount of red blood cells, hematocrit, mean cell 
volume, red cell distribution width, number of platelets and mean platelet volume were 
determined via electrical impedance assay. The amount of hemoglobin, mean cell hemoglobin 
and mean cell hemoglobin concentration where determined using spectrophotometry assay. 
Whole blood stimulation assay. For whole blood stimulation assay (WBA, Figure 1), 
blood samples were collected with heparinized serum tubes and stimulated with 0 (baseline), 
0.01 (low dose; L) and 5 µg/mL (high dose; H) of bacterial lipopolysaccharides (LPS, 
Escherichia coli O111:B4; Sigma–Aldrich Company Ltd., UK, Cat. No. L3012), according to 
Jahan et al. (2015).  After WBA, plasma samples were stored at −80ºC for the measurement 
of glucose, DLA, LLA, IL-1B, IL-6, NOx, NO2 and NO3. Variation of plasma parameters 
after WBA with L and H doses of LPS were expressed as fold change relative to the baseline. 
Interferon gamma release assay. For the interferon gamma (IFNG) release assay, whole 
blood samples were also collected into heparinized tubes (Figure 1). After collection, the 
tubes were stored in vertical position in a warm bath at a temperature of 38 ºC and transported 
to the laboratory within 20 min for the stimulation procedure. Whole blood was used in an 
IFNG release assay for Mycobacterium avium (internal method IZSLER, MP 13/011). 
Briefly, two 1-ml aliquots of each blood sample were distributed in a 24-well plate. One well 
was supplemented with 100 µl of a 1:10 dilution of Mycobacterium avium purified protein 
derivative (PPD, IZS Umbria e Marche, Perugia, Italy) to PBS, and 1 well with 100 µl of 
sterile PBS as control. The plate was positioned in a heated incubator (Grant Boekel, HIR10 
M) set to a temperature of 38 ºC and with a relative humidity of 95% for 24 h.  After 
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incubation, the blood was centrifuged at 8500 × g for 16 min at 4 ºC and plasma was stored at 
-20 °C until use. Plasma was later thawed and analyzed in a sandwich ELISA assay for 
bovine IFNG with a couple of monoclonal antibodies, as previously described (Trevisi et al., 
2014). Results were evaluated in terms of optical density difference (∆OD) between avian 
PPD-stimulated and control wells. 
Carrageenan skin test 
The carrageenan skin test (CST) was performed as specified by Jahan et al. (2015) to 
evaluate peripheral immune responses (Figure 1). The skin thickness was measured using a 
skinfold caliper (cat# 470119-588, VWR, USA) immediately before carrageenan injection (0 
days), then 2 and 9 days after the injection. The total response to each challenge was 
calculated as the area under the curve of the thickness, measured at day 2 and day 9, 
subtracting the thickness measured at day 0. 
Statistical analysis  
Data in the tables are presented as mean and standard error. Before analysis, the normality 
of distributions was verified for each parameter by reckoning skewness and kurtosis 
according to the Shapiro test of SAS. Non-normally distributed parameters were normalized 
through natural logarithms (among plasma parameters the IL-1B, IL-6, LLA, haptoglobin, 
SAA, NEFA, SHp, AOPP and β-carotene, among WBA the fold changes of DLA, IL-1B, IL-
6, NO2, NO3 and NOx and the total response to CST) and back transformed to plot them in 
the graphs and tables. Prevalence of health problems recorded during the study was evaluated 
by χ2 analysis (Freq procedure, SAS Inst. Inc., Cary, NC). Data of body weight, BCS, dry 
matter intake, rumination time, metabolic profile, WBC profile, WBA and CST were 
submitted to ANOVA using a mixed model for repeated measures (Mixed procedure, SAS 
Inst. Inc., Cary, NC) in accordance with Littell et al. (1998). The statistical model included 
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the fixed effect of milk yield at dry-off (MD), time (t) and their interaction (MD*t). For those 
parameters that were measured daily (dry matter intake and rumination time) time effect 
considered the average weekly value, while for other parameters (BW, BCS, metabolic 
profile, WBC profile, WBA and CST) it considered single DFD. The time was considered as 
a repeated measure within cow. For WBA, also the dose (D; L and H) and the full interaction 
effect (MD*t*D) were considered. The analysis was carried out using three covariance 
structures: autoregressive order, compound symmetry, and spatial power. These were ranked 
according to their Akaike information criterion, with the one having the lowest Akaike 
information criterion being eventually chosen (Littell et al., 1998). Pairwise comparisons were 
done using the least significant difference test. For t effect, pairwise comparisons were done 
between data collected before dry-off (-7 DFD for body weight, BCS, metabolic profile, 
WBC profile, WBA and CST; -2 weeks from dry-off for dry matter intake and rumination 
time) and subsequent observations. Data of ∆BCS and IFNG release assay were analyzed by a 
one-way ANOVA (GLM procedure, SAS Inst. Inc., Cary, NC), considering only the fixed 
effect of MD. Post-hoc comparisons were discussed when the P-value for main effect was ≤ 
0.05. Main effects at P ≤ 0.10 are discussed in the context of tendencies. Relevant trends not 
supported from statistical differences are discussed as numerical. 
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RESULTS 
Body weight, body condition score, dry matter intake, rumination time and health status 
Body weight (Supplemental file 1) increased after dry-off (t < 0.01), resulting higher at 34 
DFD in comparison to -7 DFD (P < 0.05), while BCS decreased after dry-off in HM cows 
only (MD*t = 0.04). Dry matter intake decreased (Figure 2.a) and rumination time increased 
(Figure 2.b) during the whole experiment and was not affected by dry-off. Dry matter intake 
was numerically higher in HM than LM cows (MD < 0.01) and rumination time was higher in 
HM than LM cows at -2 weeks from dry-off (MD*t = 0.03 and P < 0.01). 
No clinical diseases were recorded during the whole experimental period, and no MD 
effect was detected on the incidence of diseases in the first month of the following lactation 
(Supplementary file 2).  
Metabolic profile 
PCV (Figure 3.a) peaked one week after dry-off and decreased thereafter (t < 0.01; P < 
0.01 at 7 DFD). No MD nor MD*t effect appeared. 
Energy, protein and mineral metabolism biomarkers. Among energy metabolism 
biomarkers, glucose did not show any effect (Supplementary file 3.a). NEFA (Figure 3.b) 
increased immediately after dry-off and decreased thereafter, while BHB (Figure 3.c) 
decreased after dry-off, reached the nadir at 7 DFD and increased thereafter (t < 0.01 for both 
parameters). LLA (Figure 3.d) increased in the first week after dry-off (t < 0.01) and was 
higher in HM than LM cows at -7 DFD (MD*t = 0.02 and P < 0.01). DLA (Figure 3.e) 
decreased during the trial (t = 0.02) but was not affected by MD. 
Among protein metabolism parameters, creatinine (Figure 3.f) increased in the first week 
after dry-off, while urea decreased in the first week after dry-off and then gradually increased 
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(t < 0.01 in both parameters). Creatinine tended to be higher in HM than LM cows (MD = 
0.08). 
Among mineral metabolism parameters, Ca (Figure 3.h), P (Figure 4.a) and Zn (Figure 4.d) 
peaked at 2 DFD and then gradually decreased (t < 0.01). Ca resulted higher in HM than LM 
cows (MD = 0.03). Zn tended to be lower in HM than LM cows after dry-off (MD*t = 0.03; P 
< 0.1 at 2 and 7 DFD). Mg (Figure 3.i) and Cl (Figure 4.c) had the lowest values at 2 DFD 
and rose thereafter (t < 0.01). Mg and K (Figure 4.d) resulted higher in HM than LM cows 
(MD = 0.06 and < 0.01 respectively). Na concentration didn’t show any effect 
(Supplementary file 3.b). 
Liver function biomarkers. Among liver function biomarkers, AST-GOT didn’t show any 
effect (Supplementary file 3.c). GGT (Figure 4.e) and ALP (Figure 4.g) increased in the first 
week after dry-off and decreased thereafter (t < 0.01). Bilirubin (Figure 4.f) peaked at 2 DFD 
and then gradually decreased (t < 0.01) resulting numerically higher in HM than LM cows 
during the first week after dry-off (MD*t = 0.02).  
Inflammation biomarkers. Total protein (Figure 4.h) and globulin (Figure 4.i) peaked at 2 
DFD and then gradually decreased (t < 0.01 and = 0.02 respectively). No effect appeared on 
myeloperoxidase (Supplementary file 1.d). 
Among positive acute phase proteins (APP), haptoglobin (Figure 5.a) resulted higher in 
HM than LM cows (MD = 0.04). Ceruloplasmin (Figure 5.b) and SAA (Figure 5.c) peaked at 
2 DFD and decreased gradually (ceruloplasmin; t = 0.07) or slightly (SAA; t < 0.01) 
thereafter.  
Among negative APP, albumin (Figure 5.d) and cholesterol (Figure 5.g) gradually 
decreased after dry-off till the end of the experimental period (t < 0.01). Retinol (Figure 5.e) 
reached a nadir at 7 DFD and gradually increased thereafter (t < 0.01). PON (Figure 5.f) 
peaked at 7 DFD and slightly decreased thereafter (t < 0.01). 
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Among cytokines, IL-1B (Figure 5.h) resulted numerically higher in HM than LM cows 
from 7 DFD to the end of the experimental period (MD*t < 0.08). No effect appeared on IL-6 
concentration (Supplementary file 1.e).  
Oxidative stress biomarkers. Among oxidative stress biomarkers, thiol groups (Figure 5.i) 
and FRAP reached a nadir at 2 DFD, while tocopherol and β-carotene decreased during the 
whole experimental period. HM cows had higher concentrations of β-carotene (MD*t < 0.01; 
P < 0.1 at -7 and P < 0.05 at 27 DFD) and tendentially higher concentrations of ORAC 
(Figure 6.d; MD = 0.06) than LM cows. AOPP tended to decrease after dry-off (t = 0.09) and 
resulted numerically higher in HM than LM cows (MD*t = 0.09). No effect appeared on 
ROMt (Supplementary file 1.f). Nitrite (Figure 6.f), nitrate (Figure 6.g) and nitric oxides 
(Figure 6.h) increased after dry-off (t = 0.04 for NO2 and t < 0.01 for NO3 and NOx). Nitrite 
concentrations was higher in HM than LM cows (MD = 0.03). 
White blood cells profile 
Among WBC profile (Table 2), total WBC, neutrophils and monocytes decreased after 
dry-off and reached the nadir at 7 DFD (t = 0.03; < 0.01 and < 0.01 respectively). 
Eosinophils, red blood cells, hemoglobin and hematocrit peaked at 7 DFD (t = 0.04; = 0.02; < 
0.01 and = 0.02 respectively). Platelets resulted numerically higher in HM than LM cows at 
34 DFD (MD*t = 0.08). Mean platelet volume was lower in HM than LM cows (MD = 0.06). 
No effect appeared on other parameters (data not shown). 
Whole blood stimulation assay 
Fold changes of cytokines increased after WBA (Table 3), showing the greatest effect at 
the highest LPS dose (D < 0.01). Response to LPS increased after dry-off for the whole 
experimental period for IL-1B (t < 0.01; P < 0.01 at 7 and 34 DFD), while peaked at 7 DFD 
for IL-6 (t = 0.06; P < 0.1 at 7 DFD). 
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Fold change of DLA was not affected by LPS treatment while those of glucose tended to 
decrease and LLA increased by increased LPS dose (D = 0.06 and 0.03 respectively; Table 4). 
Response of LLA to LPS decreased after dry-off and reached the nadir at 7 DFD (t = 0.05).  
 Fold change of NO3 was not overall affected by WBA, while those of NOx tended to 
increase by increased LPS dose (D = 0.08) with a higher response in LM cows before dry-off 
(MD*t = 0.04; Table 5). Response of NO2 decreased after dry-off (t = 0.02) and reached the 
nadir at 7 DFD, independently from the LPS dose (Table 6). 
Interferon gamma release assay and carrageenan skin test 
Response to IFNG release assay (Supplementary file 4.a) and CST (Supplementary file 
4.b) did not show any effect. 
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DISCUSSION 
Dry-off dramatically affects metabolism and immune system of dairy cows  
Approaching to dry-off is related to physiological and nutritional changes that deeply 
affect nutrients requirements and feeding behavior in dairy cows (Dingwell et al., 2001). 
These changes could justify the likelihood to develop a metabolic stress condition, even 
though the magnitude and duration of variations induced from dry-off in biomarkers related to 
wellbeing has been poorly investigated. Our results suggest that adaptation to high fiber 
content of dry ration had reduce dry matter intake and increased rumination time at dry-off. In 
late dry period, two-thirds of the development of fetus are completed (Dingwell et al., 2001). 
This could explain the increase of body weight and the further reduction of dry matter intake 
observed, as fetal growth could be implied in the reduction of the rumen volume. A 
mobilization of lipid sources occurred at two DFD, as suggested by increase in NEFA levels. 
The light magnitude of such a phenomenon is suggested from the lack of any effect on 
glucose and BHB, indicating that glycaemia was not modified, and that liver has been able to 
fully oxidize the amount of NEFA received. Previous studies found similar patterns of energy 
metabolism biomarkers at dry-off paired with the decrease in insulin concentration (Odensten 
et al., 2005; Putman et al., 2018). It seems reasonable to assume that two processes could 
concur in such a mobilization of lipid sources. 1) Mobilization could be triggered by the 
release of adrenaline at dry-off, consequently to the stress induced by milk stasis in the 
mammary gland and changes in feeding routine. In fact, adrenaline is known to provide the 
primary stimulus for the mobilization of NEFA from adipose tissue during a stressing event 
(Drackley, 1999; Padgett and Glaser, 2003). 2) Mobilization could occur during the last week 
of lactation consequently to the hormonal response to the withdrawn of concentrates while 
milk production was still maintained. Our experimental design does not allow us to speculate 
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on the exact cause of lipid mobilization. In fact, samples were collected at -7 DFD and then at 
2 DFD, while an additional sample at time 0, just before dry-off, should be collected to 
distinguish between metabolic changes occurred due to the milking interruption from those 
occurred as a feed restriction effect. Whatever should be the driving mechanism of the 
mobilization process, the reduction of NEFA levels observed at 7 DFD suggests: 1) a 
mitigation of stressing conditions to occur after dry-off and 2) a reduction of energy 
requirements to occur with milking interruption, as also reflected from the decrease in dry 
matter intake observed during this phase.  
Changes in diet composition and feeding behavior could partially account for the increase 
of lactate and for the reduction of BHB and urea levels found in plasma after dry-off. In fact, 
fluctuations of rumen pH occurring during adaptation to dry ration inhibits bacterial 
utilization of lactate increasing its efflux to blood (Counotte and Prins, 1981). On the other 
hand, a half of hematic BHB is directly related to the ruminal production of butyric acid 
(Church, 1979), while plasmatic urea is paired with its concentration in rumen fluid (Marini 
and Van Amburgh, 2003; Odensten et al., 2005), and both parameters are known to decrease 
in rumen during dry period consequently to the higher fiber content of the ration and the 
lower feed intake of the animals in comparison to lactation. Furthermore, blood urea partially 
arise from amino acids deamination (Broderick and Clayton, 1997) and its lower level reflects 
also a lower utilization of amino acids in gluconeogenetic processes in order to face the 
energy deficit after dry-off. This interpretation, together with the increased creatinine level 
after dry-off, suggests the interruption of milk synthesis to have reduced protein requirements, 
increasing the amount of amino acids addressed to anabolic processes. Indeed, creatinine is 
the product of the metabolism of one of the main molecules for the storage of energy in the 
muscle (i.e., phosphocreatine), and it is thus a direct indicator of muscular body mass 
(Hayden et al., 1992).  
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Effects of dry-off on mineral metabolism are mainly related to the interrupted milking 
routine. The presence of higher levels of Ca immediately after dry-off is consistent with 
previous results (Putman et al., 2018). Such an increase could arise from the contribution of 
two main processes: 1) the sudden interruption of the mammary gland uptake from the 
hematic circulating pool of calcium and 2) the increased udder pressure arise from the stasis 
of milk residuals, that is known to weak the tight junctions between epithelial cells increasing 
paracellular transport of calcium in blood (Aslam and Tucker, 1998). Both processes had a 
transient effect during milk stasis phase only, as the decreased calcium concentration 
observed from two DFD up to the end of the experimental period suggests the exhaustion of 
milk residuals in the mammary gland and the recovery of homeostasis in its hematic pool. 
Lower concentrations of both Ca and Mg found in late dry period in comparison to late 
lactation where in agreement with their strong direct relationship with milk production. A 
similar relationship, even though indirect, has been reported for phosphorus. In fact, blood 
concentration of this mineral is directly regulated from calcium-regulating hormones, and thus 
depend on Ca concentrations more than milk yield (Cavestany et al., 2005).  
Early involution of mammary gland that occurs at the beginning of dry period implies an 
important contribution of leukocytes in the reabsorption of mammary tissues (Putman et al., 
2018). In our study, reduction of WBC, neutrophils and monocytes populations in blood 
observed after dry-off are consistent with results of Putman et al., (2018) and are related to the 
migration of those cells to the mammary gland during acute involution (Atabai et al., 2007). 
The increased concentration of eosinophils is also consistent with results of Putman et al., 
(2018), even though the interpretation is less certain. State that eosinophils are related to 
allergies and parasites (Gouon-Evans et al., 2000), it has been hypothesized that it may 
represent a subclinical hypersensitivity to the milk residuals in mammary gland after milking 
interruption (Putman et al., 2018). Such changes in WBC populations in blood is also paired 
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with their augmented sensitivity to biological stressors, as reflected from our results of WBA 
test with LPS. In fact, increased production of interleukins and NO2 after dry-off reflect a 
greater production of metabolites related to inflammation and of oxidant species. These 
results are consistent with an important leukocytes activity in the mammary gland at dry-off, 
that could be seeing as a main cause of the systemic inflammatory status observed in the same 
phase, and reflected from trends of plasma parameters (Castell et al., 1989). Metabolic 
inflammation typically affects liver metabolism, implying severe losses in hepatic functions 
and a shift of anabolic priority of the organ (Bertoni et al., 2008). In particular, the liver 
produces more α-globulins, known as positive APP, i.e. haptoglobin, ceruloplasmin and SAA 
(Ceciliani et al., 2012). Conversely, it reduces the synthesis of albumin, retinol binding 
protein, PON and lipoproteins, known as negative APP (Bertoni et al., 2008) and sequesters 
minerals, as zinc and iron, from blood flow (Bertoni and Trevisi, 2013). In our trial, increase 
in GGT, ALP and bilirubin concentrations found during the first week after dry-off reflects a 
reduced capacity of the liver to perform normal metabolic and clearance functions 
(Rodriguez-Jimenez et al., 2018). In fact, GGT and ALP are enzymes involved in AA 
metabolism and dephosphorilation of compounds respectively, that increase in blood mostly 
due to liver damages, while bilirubin results from degradation of red blood cells, and its 
clearance depends on liver enzymes functioning (van den Top et al., 1996). Furthermore, raise 
of globulins and total proteins observed during the first week after dry-off could be driven 
from the α-globulins fraction, as they are paired to the increase in ceruloplasmin and SAA 
(Crisman et al., 2008). These trends are consistent, together with the drop of retinol found at 
two DFD, with an acute inflammation occurred at dry-off, despite the lack of a time effect on 
haptoglobin concentrations and the decrease in albumin, PON and cholesterol at the end of 
the experimental period only. In fact, haptoglobin is known to peak instantaneously during 
acute phase, while negative APP could require a longer time to reflect inflammatory 
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conditions (Bertoni and Trevisi, 2013; Minuti et al., 2015), and their incapacity to detect the 
inflammation in our experiment could depend on the different sensitivity to acute phase of 
these APP. Inflammatory events are often linked to a body fat mobilization (Kushibiki et al., 
2003), that could partially explain the peak of NEFA observed after dry-off. Furthermore, 
increase in nitrate and nitrite concentrations found in blood after dry-off is consistent with 
results of Putman et al., (2018), who related it to the altered redox status during early 
involution of the mammary gland. On the other hand, the increase of nitric oxide could be 
related to WBC activities at mammary level, as it is mainly produced by activated 
macrophages as a cytotoxic agent (Coleman, 2001). Accumulation of such nitrogen species is 
known to trigger oxidative damages on macromolecules, as nitric oxide exerts a direct 
oxidative action, while nitrite is converted in nitrating agent for lipids and proteins by MPO 
during the neutrophils activation (Dedon and Tannenbaum, 2004). Body effort to contain such 
oxidative damages could account for the depletion of antioxidant systems after dry-off, 
explaining the decrease in hematic SHp, tocopherol and β-carotene levels. In fact, SHp (and 
specifically glutathione) allows the reduction of a wide spectrum of hydroperoxides 
participating in the glutathione peroxidase enzymatic complex functioning (Sordillo and 
Aitken, 2009), tocopherol is involved in the reduction of the chain propagation and 
amplification of lipid peroxidation process, while β-carotene indirectly participate in the 
protection against oxidative stress maintaining other antioxidant molecules in the reduced 
form (Ghiselli et al., 1995). Consumption of such antioxidant systems in containing oxidative 
damages, together with the dysregulation they normally undergoes during a systemic 
inflammations (Celi, 2011), could account also for a wider alteration in the redox status of the 
body, that is reflected from the decrease in the general indicators of antioxidant capacity after 
dry-off (i.e. FRAP and ORAC). In fact, FRAP represent a measurement of antioxidant power 
provided by bilirubin, uric-acid, vitamins C and E and proteins (Benzie and Strain, 1996), 
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while ORAC is a quantification of antioxidant power provided by water-soluble antioxidants, 
albumin and uric-acid against oxygen radicals (Cao and Prior, 1998) and concentrations of 
most of the compounds included in such complex indicators (i.e. albumin, proteins) decreased 
after dry-off due to the inflammatory status.     
The reduction in AOPP found at 27 and 34 DFD suggests a decreased activity of 
leukocytes in mammary gland during dry period. In fact, AOPP represent a synthetic marker 
of protein oxidation exerted by hypochlorous acid, that is produced by MPO during 
neutrophils activation (Celi and Gabai, 2015), and its reduction suggest the interruption of 
leukocytes contribution in mammary remodeling. Even though Zn levels raised immediately 
after dry-off, only the interruption of leukocytes activities in mammary gland allowed the 
organism to face the systemic inflammation occurred at milking interruption. In fact, the 
increased blood concentration of retinol and the decreased concentrations of positive APP and 
enzymatic efficiency indicators (ALP and bilirubin) indicate a fully recovery of homeostasis 
in liver metabolism to occur at 27 DFD only. On the other hand, the altered redox balance did 
not seem to ameliorate, as the production of nitrogen species and the consumption of 
antioxidant systems (SHp, FRAP, tocopherol, and β-carotene) continued up to 34 DFD. At 
least for β-carotene and tocopherol, a contribution of the increased vitamins requirements in 
growing fetus could be hypothesized in such a reduction.   
High milk yield at dry-off is related to greater stress in dry period 
The risk related to dry-off a cow with a milk yield higher than 25 kg*d-1 has been deeply 
investigated previously (Dingwell et al., 2001; Rajala-Schultz et al., 2005), and the 
relationship with the development of diseases such as mastitis is well known. In this respect, 
the adoption of an average milk yield of 15 kg*d-1 in our study demonstrate that “safety 
threshold” to dry-off a cow could be much lower, as hematic biomarkers allowed the 
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detection of important alteration in the body homeostasis to occur in animals having the 
highest milk yield at dry-off. The higher dry matter intake and the greater rumination time 
found in HM animals depose for a greater rumen volume and a more efficient utilization of 
feedstuff to face the higher milk production at dry-off. This is also in agreement with the 
higher creatinine concentration found in blood of HM cows, which suggests a greater muscle 
tissue abundance in those animals (Hayden et al., 1992). Furthermore, linkage of Ca and Mg 
with milk production (Dingwell et al., 2001) explains the higher concentration of these 
minerals found in HM cows. In fact, higher mineral requirements related to production in 
those animals could lead to higher circulating minerals concentrations as soon as cows were 
dried-off. Those differences demonstrate that HM cows faced deeper changes during the 
metabolic adaptation to dry-off, reflecting a greater risk to develop metabolic stress in those 
animals. HM cows showed greater lactate concentrations before dry-off and higher 
concentrations of haptoglobin and IL-1B after dry-off. This could indicate that inflammation 
appeared earlier and that acute phase had a longer duration in these animals (Bertoni et al., 
2008; Osorio et al., 2014). Furthermore, the latter raise of Zn and the greater concentrations of 
bilirubin (even though numerical) and NO2 found after dry-off suggest that these animals 
required a longer time to recover homeostasis (Bertoni and Trevisi, 2013). The greater degree 
of inflammation is consistent with a longer mammary tissue remodeling phase in high 
yielding cows, probably related to the greater amount of parenchymatic tissue to be 
reabsorbed (Arslan et al., 2013; Putman et al., 2018). In HM cows, higher blood 
concentrations of β-carotene and ORAC found both before and after dry-off suggested a 
greater antioxidant power. Furthermore, lower fold variation of NOx found at WBA before 
dry-off suggested a less marked oxidant production in their WBC. Nevertheless, negative 
consequences of the severe inflammation occurred at dry-off were reflected on the tendency 
for a greater AOPP level found at 27 and 34 DFD, indicating HM animals to develop a more 
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marked oxidative stress in late dry period. State the relationship between stress, inflammation 
and metabolic disorders (Biswas and Lopez-Collazo, 2009; Van Knegsel et al., 2014) high 
milk yield at dry-off could be a risk factor for the development of diseases, and a significant 
effect is well known for mastitis (Grummer et al., 2000). The investigation on this 
relationship was behind the aim of our study, as the low number of animals enrolled do not 
allow us to speculate about that. Thus, similar diseases incidence found in the first month of 
lactation among MD groups in our experiment requires care in the interpretation.  
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CONCLUSIONS 
Dry-off has been revealed as a challenging phase in high-yielding cow’s career, related to 
deep changes in feeding behavior, metabolism and immune parameters. An inflammation 
occurred at dry-off in all the animals, probably because of leukocytes contribution in the 
involution phase of mammary gland, impairing liver function and altering redox balance 
during the early dry period. Animals with higher milk yield at dry-off showed the worst 
condition, and this could probably be related to the deeper metabolic changes they faced at 
dry-off consequently to milking interruption, and to the greater amount of mammary 
parenchyma to be reabsorbed. This study highlights the dry-off as a thorny point to manage 
dairy cows’ health and could depose for a relationship between dry-off and immune alteration 
that typically occurs around calving time. In order to demonstrate this, a study where cows are 
followed during the subsequent lactation for all the parameters measured should be 
performed. 
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TABLES AND FIGURES 
Table 1. Composition and characteristics of the experimental diets fed during the 2 
experimental phases. Between dry-off day (-55 days from expected calving) and 10 days from 
dry-off (DFD) cows received only grass hay 
1Supplements were composited to provide 150000 UI of vitamin A, 10000 IU of vitamin D, 
200 mg of vitamin E, 100 mg of vitamin K, 100 mg of vitamin H1 50 mg of vitamin B1, 0.5 
mg of vitamin B12, 500 mg of vitamin PP, 4000 mg of choline, 350 mg of Mn, 800 mg of Zn, 
40 mg of Cu, 20 mg of I, 1 mg of Co, 1 mg Se. 
2Estimate using NRC 2001.
 Phase 1 Phase 2 
DFD -7; 0 10; 34 
Diet, % DM   
Item   
Corn silage 28.5 18.6 
Alfalfa hay 16.4 - 
Grass hay 23.4 71.4 
Concentrate (Dry period) - 10.0 
Concentrate (Lactation period) 31.7 - 
Concentrate composition, %DM   
Corn flour - 
Barley flour - 
Sorghum grain expanded - 
Soybean meal 90.5 
Soybean dry rolled - 
Sunflower meal - 
Corn gluten feed - 
Beet pulp - 
Wheat bran - 
Beet molasse slops - 
Potato protein - 
Hydrogenat palm oil - 
Limestone - 
Dicalcium phosphate - 
Sodium bicarbonate - 
Magnesium oxide 2.2 
Sodium Chloride 1.4 
Supplement3 5.9 
Chemical composition   
NEL, Mcal/kg of DM 1.59 
Crude protein, % DM 14.9 
Starch + sugar, % DM 23.7 
Ether extract, % DM 3.80 
NDF, % DM 39.4 
MP2, %CP 9.80 
RUP2, %CP 4.64 
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Table 2. White blood cells profile in dairy cows with an average milk production lower (LM) 
or higher (HM) than 15 L*d-1 in the week prior to dry-off 
Item, 
Unit 
MD1 
Days from dry-off 
SE2 
P-value 
-7 7 34 MD1 t3 MD*t4 
White blood cells, 
K*µL-1 
LM 6.84 6.52 6.54 0.73 0.99 0.03 0.21 
HM 6.91 6.11* 6.92 0.79    
Neutrophils, 
K*µL-1 
LM 3.45 3.00 3.32 0.30 0.65 <0.01 0.79 
HM 3.73 3.05** 3.50 0.33    
Monocytes, 
K*µL-1 
LM 0.55 0.41 0.55 0.04 0.88 <0.01 0.78 
HM 0.58 0.43** 0.53 0.04    
Eosinophils, 
K*µL-1 
LM 0.19 0.45 0.23 0.11 0.32 0.04 0.82 
HM 0.03 0.31* 0.15 0.12    
Red blood cells, LM 6.59 6.68 6.36 0.18 0.34 0.02 0.65 
K*µL-1 HM 6.26 6.59 6.10 0.20    
Hemoglobin, 
g*dL-1 
LM 10.7 11.2 10.7 0.38 0.39 <0.01 0.85 
HM 10.3 10.8** 10.1 0.41    
Hematocrit, 
% 
LM 31.3 32.1 31.1 1.23 0.57 0.02 0.38 
HM 30.2 32.2* 29.3 1.33    
Platelets, 
K*µL-1 
LM 325.7 318.4 279.1 48.6 0.71 0.17 0.08 
HM 334.0 285.8 348.5 52.5    
MPV5, 
K*µL-1 
LM 7.16 7.10 7.58 0.41 0.06 0.44 0.29 
HM 5.84 6.69 6.24 0.52    
1 Effect of milk yield at dry-off. 
2Standard error. 
3Time effect (comparisons are made with respect to -7 days from dry-off value: * is P < 0.05; 
** is P < 0.01). 
4Milk yield at dry-off x time interaction effect. 
5Mean platelet volume. 
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Table 3. Fold changes of cytokines after a whole blood stimulation assay with a low (L) or 
high (H) dose of bacterial lipopolysaccharides (LPS) in dairy cows with an average milk 
production lower (LM) or higher (HM) than 15 L*d-1 in the week prior to dry-off. Values are 
expressed with respect to baseline (unstimulated sample) 
Item D2 MD1 
Days from dry-off 
SE3 Effect P-Value 
-7 7 34 
IL-1B7 
L 
LM 3.74 7.79 8.59 6.54 MD1 0.61 
HM 4.54 9.20 10.84 7.06 t4 <0.01 
H 
LM 15.66 25.38 25.61 6.54 D2 <0.01 
HM 15.96 25.67 35.41 7.06 MD*t5 0.89 
Tot 
LM 9.70 16.58 17.10 5.45 MD*t*D6 0.77 
HM 10.25 17.44 
** 
23.13 
** 
5.89   
IL-6 
L 
LM 1.42 1.73 1.36 0.21 MD1 0.51 
HM 1.46 1.56 1.41 0.23 t4 0.06 
H 
LM 2.21 2.40 2.00 0.21 D2 <0.01 
HM 1.73 1.93 1.74 0.23 MD*t5 0.75 
Tot 
LM 1.81 2.07 1.68 0.18 MD*t*D6 0.75 
HM 1.60 1.74 
+ 
1.58 0.19  
 
1Milk yield at dry-off effect. 
2Dose effect: L is low dose (0.01 µg LPS /mL whole blood); H is high dose (5 µg LPS /mL 
whole blood); Tot is total effect of LPS stimulation. 
3Standard error. 
4Time effect (comparisons are made with respect to -7 days from dry-off value: + is P < 0.1; * 
is P < 0.05; ** is P < 0.01). 
5Milk yield at dry-off x time interaction effect. 
6Milk yield at dry-off x time x dose interaction effect. 
7Interleukin-1, beta.  
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Table 4. Fold changes of glucose and metabolites thereof after a whole blood stimulation 
assay with a low (L) or high (H) dose of bacterial lipopolysaccharides (LPS) in dairy cows 
with an average milk production lower (LM) or higher (HM) than 15 L*d-1 in the week prior 
to dry-off. Values are expressed with respect to baseline (unstimulated sample) 
Item D2 MD1 
Days from dry-off 
SE3 Effect P-Value 
-7 7 34 
Glucose 
L 
LM 0.95 0.97 0.96 0.022 MD1 0.17 
HM 0.98 0.95 0.99 0.023 t4 0.72 
H 
LM 0.92 0.93 0.91 0.022 D2 0.06 
HM 0.94 0.95 0.98 0.023 MD*t5 0.25 
Tot 
LM 0.94 0.95 0.94 0.016 MD*t*D6 0.85 
HM 0.96 0.95 0.98 0.017   
D-lactic acid 
L 
LM 1.00 1.04 1.05 0.032 MD1 0.57 
HM 1.04 1.02 1.03 0.034 t4 0.32 
H 
LM 1.01 1.02 1.08 0.032 D2 0.15 
HM 1.07 1.07 1.08 0.034 MD*t5 0.33 
Tot 
LM 1.01 1.03 1.07 0.025 MD*t*D6 0.79 
HM 1.06 1.04 1.06 0.027   
L-lactic acid 
L 
LM 1.03 1.01 1.04 0.015 MD1 0.62 
HM 1.03 1.03 1.04 0.017 t4 0.05 
H 
LM 1.05 1.02 1.07 0.015 D2 0.03 
HM 1.06 1.05 1.06 0.017 MD*t5 0.27 
Tot 
LM 1.04 1.02 1.06 0.012 MD*t*D6 0.97 
HM 1.05 1.04 1.05 0.013   
1Milk yield at dry-off effect. 
2Dose effect: L is low dose (0.01 µg LPS /mL whole blood); H is high dose (5 µg LPS /mL 
whole blood); Tot is total effect of LPS stimulation. 
3Standard error. 
4Time effect (comparisons are made with respect to -7 days from dry-off value: + is P < 0.1; * 
is P < 0.05; ** is P < 0.01). 
5Milk yield at dry-off x time interaction effect. 
6Milk yield at dry-off x time x dose interaction effect. 
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Table 5. Fold changes of nitrite, nitrate and nitric oxides after a whole blood stimulation 
assay with a low (L) or high (H) dose of bacterial lipopolysaccharides (LPS) in dairy cows 
with an average milk production lower (LM) or higher (HM) than 15 L*d-1 in the week prior 
to dry-off. Values are expressed with respect to baseline (unstimulated sample) 
Item D2 MD1 
Days from dry off SE3 Effect P-Value 
-7 7 34 
Nitric oxide 
L 
LM 1.00 1.00 1.00 0.075 MD1 0.51 
HM 0.88 1.03 1.02 0.081 t4 0.42 
H 
LM 1.16 1.16 1.04 0.075 D2 0.08 
HM 0.97 1.01 1.09 0.081 MD*t5 0.04 
Tot 
LM 1.08 
a 
1.08 1.02 0.061 MD*t*D6 0.51 
HM 0.93 
b 
1.02 1.06 0.066 
 
 
Nitrite 
L 
LM 0.98 0.98 1.03 0.069 MD1 0.60 
HM 0.96 0.88 1.19 0.074 t4 0.02 
H 
LM 1.00 1.02 1.13 0.069 D2 0.81 
HM 1.03 0.90 1.01 0.074 MD*t5 0.34 
Tot 
LM 0.99 1.00 1.08 0.053 MD*t*D6 0.60 
HM 0.99 0.89 1.10 
* 
0.057 
 
 
Nitrate 
L 
LM 1.00 1.00 1.00 0.126 MD1 0.48 
HM 0.87 1.08 0.96 0.136 t4 0.47 
H 
LM 1.23 1.30 1.07 0.126 D2 0.11 
HM 0.96 1.04 1.12 0.136 MD*t5 0.11 
Tot 
LM 1.11 1.15 1.03 0.098 MD*t*D6 0.48 
HM 0.91 1.06 1.04 0.105   
1Milk yield at dry-off effect. 
2Dose effect: L is low dose (0.01 µg LPS /mL whole blood); H is high dose (5 µg LPS /mL 
whole blood); Tot is total effect of LPS stimulation. 
3Standard error. 
4Time effect (comparisons are made with respect to -7 days from dry-off value: + is P < 0.1; * 
is P < 0.05; ** is P < 0.01). 
5Milk yield at dry-off x time interaction effect (a/b is P < 0.1). 
6Milk yield at dry-off x time x dose interaction effect.
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Figure 1. Scheduled time point, expressed as day from dry off (DFD), for hematic metabolic 
profile ( ), body weight and body condition score determination, white blood cells profiling, 
whole blood stimulation assay and carrageenan skin test performance ( ), interferon gamma 
release assay ( ), dry matter intake and rumination time measurement ( ). 
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Figure 2. Pattern of dry matter intake (a) and rumination time (b) in dairy cows with an 
average milk production lower (LM; solid line) or higher than 15 L*d-1 (HM; dotted line) in 
the week prior to dry off. MD is the effect of milk yield at dry off; t is time effect (** is P < 
0.01); MD*t is the interaction effect (A/B is P < 0.01); WFD is weeks from dry off; DRY is 
dry-off day (-55 days from expected calving). 
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Figure 2.Time course of packed cell volume (a) and plasma concentrations of NEFA (b), β-
hydroxybutyrate (c), L-lactic acid (d), D-lactic acid (e), creatinine (f), urea (g), calcium (h) 
and magnesium (i) in dairy cows with an average milk production lower (LM; solid line) or 
higher than 15 L*d-1 (HM; dotted line) in the week prior to dry-off. MD is the effect of milk 
yield at dry-off; t is time effect (** is P < 0.01; * is P < 0.05; † is P < 0.1); MD*t is the 
interaction effect (A/B is P < 0.01); DFD is days from dry-off; DRY is dry-off day (-55 days 
from expected calving). 
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Figure 3. Time course of plasma concentrations of phosphorus (a); potassium (b), chlorine 
(c), zinc (d), γ-glutamyl transferase (e), bilirubin (f), alkaline phosphatase (g), protein (h) and 
globulin (i) in dairy cows with an average milk production lower (LM; solid line) or higher 
than 15 L*d-1 (HM; dotted line) in the week prior to dry-off. MD is the effect of milk yield at 
dry-off; t is time effect (** is P < 0.01; * is P < 0.05; † is P < 0.1); MD*t is the interaction 
effect; DFD is days from dry-off; DRY is dry-off day (-55 days from expected calving). 
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Figure 5. Time course of plasma concentrations of haptoglobin (a); ceruloplasmin (b); serum 
amyloid-α (c), albumin (d), retinol (e), paraoxonase (f), cholesterol (g), interleukin-1 (h) and 
thiol groups (i) in dairy cows with an average milk production lower (LM; solid line) or 
higher than 15 L*d-1 (HM; dotted line) in the week prior to dry-off. MD is the effect of milk 
yield at dry-off; t is time effect (** is P < 0.01; * is P < 0.05; † is P < 0.1); MD*t is the 
interaction effect; DFD is days from dry-off; DRY is dry-off day (-55 days from expected 
calving). 
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Figure 6. Time course of plasma concentrations of ferric reducing antioxidant power (FRAP; 
a); tocopherol (b), β-carotene (c), oxygen reactive antioxidant power (ORAC; d), advanced 
oxidation protein product (AOPP; e), nitrite (f), nitrate (g) and nitric oxide (h) in dairy cows 
with an average milk production lower (LM; solid line) or higher than 15 L*d-1 (HM; dotted 
line) in the week prior to dry-off. MD is the effect of milk yield at dry-off; t is time effect (** 
is P < 0.01; * is P < 0.05; † is P < 0.1); MD*t is the interaction effect (a/b is P < 0.05; a/b is P 
< 0.1); DFD is days from dry-off; DRY is dry-off day (-55 days from expected calving). 
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SUPPLEMENTARY FILES 
Supplementary file 1. Trends of body weight (BW) and body condition score (BCS) in dairy 
cows with an average milk production lower (LM) or higher (HM) than 15 L*d-1 in the week 
prior to dry-off 
1Milk yield at dry-off (LM is low milk yield; HM is high milk yield). 
2Difference between BCS value at -7 and 34 DFD. 
3Time effect.  
4Milk yield at dry-off x time interaction effect. 
5Standard error. 
Item, 
Unit 
MD1 
Days from dry-off 
SE5 
P-Value 
-7 7 34 
MD1 t3 MD*t4 
BW,  
Kg 
LM 642.9 653.6 684.1 24.18 0.93 <0.01 0.87 
HM 645.3 653.7 690.5 
* 
26.11 
BCS 
LM 2.5 2.5 2.5 0.099 0.50 0.15 0.04 
HM 2.4 2.4 2.5 0.106 
∆BCS2 
LM   0.0 0.051 0.07   
HM   -0.1 0.055    
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Supplementary file 2. Incidence of diseases observed in the first month of lactation in dairy 
cows with an average milk production lower (LM) or higher (HM) than 15 L*d-1 in the week 
prior to dry-off 
1Milk yield at dry-off.  
2Cows that did not have any clinical diseases in the first month of lactation. 
3Retained placenta. 
4Endometritis or metritis. 
5Milk fever. 
6Displacement of abomasum. 
7Mastitis. 
8Pneumonia. 
9Diarrhea. 
10Sub clinical ketosis (blood BHB higher than 1.4 mmol*L-1). 
MD1 Healthy2 Problems occurrence, n 
RP3 ME/ED4  MF5 DA6 MA7  PN8  DH9  KET10 Total 
LM 
(7 cows) 3 
0 1 0 1 1 1 3 3 4 
HM 
(6 cows) 
3 1 0 1 0 1 0 1 3 4 
P 0.80 0.26 0.33 0.26 0.33 0.90 0.33 0.31 0.79 0.72 
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Supplementary file 3. Time course of plasma concentrations of glucose (a) sodium (b), 
aspartate amino transferase-glutamate oxaloacetate transaminase (AST-GOT; c), interleukin-6 
(d), myeloperoxidase (e) and total reactive oxygen metabolites (ROMt; f) in dairy cows with 
an average milk production lower (LM; solid line) or higher than 15 L*d-1 (HM; dotted line) 
in the week prior to dry-off. MD is the effect of milk yield at dry-off; t is time effect; MD*t is 
the interaction effect; DFD is days from dry-off; DRY is dry-off day (-55 days from expected 
calving). 
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Supplementary file 4. Optical density difference (∆OD) between avian PPD-stimulated and 
control wells in the interferon gamma (IFNG) release assay (a) and total peripheral response 
after the carrageenan skin test (CST; b) in dairy cows with an average milk production lower 
(LM; solid line) or higher than 15 L*d-1 (HM; dotted line) in the week prior to dry-off. MD is 
the effect of milk yield at dry-off; t is time effect; MD*t is the interaction effect; DFD is days 
from dry-off; DRY is dry-off day (-55 days from expected calving). 
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CHAPTER III - IMMUNE ALTERATIONS BOOST KETOSIS 
Altered immune functions in the dry period boost ketosis onset in early lactation 
 
108 
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ABSTRACT 
Ketosis impairs white blood cells (WBC) functions, thus increasing disease prevalence. 
Our study investigated changes occurring in the immune system prior to disease onset to 
elucidate their role in ketosis occurrence. A group of 13 Holstein dairy cows were housed in 
tied stalls and retrospectively divided into 2 groups based on their plasma beta-
hydroxybutyrate (BHB) levels: lower (CTR; 7 cows) or higher than 1.4 mMol/L (KET; 6 
cows). From -48 to 35 days from calving BCS, BW, DMI, rumination time and milk yield 
were measured, and blood samples were collected regularly to assess hematochemical profile 
and to test white blood cell functions by ex vivo challenge assays. Data were submitted to 
ANOVA using a mixed model for repeated measures including health status, time and their 
interaction as fixed effects.  
KET cows had a greater activation of the immune system prior to calving (higher plasma 
concentrations of pro inflammatory cytokines – PIC –, myeloperoxidase and oxidant species, 
and greater interferon gamma responses to M. avium), higher blood concentration of gamma 
glutamyl transferase and lower plasma minerals. Larger NEFAs, BHB, and glucose in KET 
vs. CTR was detected during the dry period. The latter may be cause by reduced insulin 
sensitivity in KET vs. CTR. The effect observed during the dry period was associated to 
reduced DMI and worse negative energy balance in early lactation and ensued reduced milk 
yield and increased fat mobilization. KET vs. CTR cows had accentuated acute phase 
response after calving (greater concentrations of positive acute phase proteins and lower 
concentration of retinol) impairing liver function (higher blood concentrations of glutamate-
oxaloacetate transaminase and bilirubin). WBC of KET vs. CTR cows had reduced response 
to an ex vivo stimulation assay with lower production of PIC and greater production of lactate. 
These alterations on WBC could be driven by the combined action of metabolites related to 
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the mobilization of lipids and by the occurrence of a transient unresponsive state against 
stimulation aimed to prevent over exuberant inflammation.  
Key Words. Immune response, dry period, inflammation, liver function 
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INTRODUCTION 
The transition period (TP) is the most critical phase for dairy cows due to the dramatic 
metabolic changes that implies (Drackley, 1999). In some cases the control of the 
homeorhetic and homeostatic mechanisms is not effective, leading to a physiological 
imbalance with a substantial increase in the risk of diseases (Ingvartsen and Moyes, 2012).  
Ketosis is the most prevalent metabolic disease postpartum and has a significant economic 
impact in the dairy industry (Duffield, 2000; Youssef and El-Ashker, 2017). It consists in 
abnormal high levels of circulating ketone bodies that are detectable in blood, milk, and urine. 
The hematic level of beta-hydroxybutyrate (BHB) is the golden standard to define sub clinical 
(>1400 µmol/L) and clinical (>3000 µmol/L) ketosis respectively (Gordon et al., 2013). The 
etiology of the disease is related to a prolonged negative energy balance (NEB) in early 
lactation (Herdt, 2000), along with a marked mobilization of non-esterified fatty acids 
(NEFA) from the adipose tissue. Under normal conditions, NEFA are completely oxidized in 
the liver to produce energy. When mobilization is excessive oxidation is not completed in the 
liver leading to ketone bodies production and their release into the blood (Ingvartsen, 2006). 
Classically, pathological levels of ketone bodies are reported during the third and fourth week 
post calving (Duffield, 2000). Advances in genetics and feeding management have anticipate 
metabolic challenges closer to calving with higher frequency of pathological peaks of BHB 
during the first 2 weeks post calving (Herdt et al., 1981; Rodriguez-Jimenez et al., 2018).  
Ketosis induces a reduction of feed intake (Kaufman, LeBlanc, McBride, Duffield, & 
DeVries, 2016) and rumination time (Abuajamieh et al., 2016), reducing milk yields 
(Duffield, 2000). Blood levels of NEFA, glucose, lactate, positive acute phase proteins (APP) 
and pro inflammatory cytokines (PIC) increase during ketosis (Chapinal et al., 2011; Zhang 
et al., 2016), while negative APP decrease (Rodriguez-Jimenez et al., 2018). Ketosis has also 
been associated with an impairment of liver functions and oxidative stress conditions 
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(Rodriguez-Jimenez et al., 2018). Furthermore, ketosis increases the expression of mRNA for 
anti-inflammatory genes in liver (Akbar et al., 2015) and metabolic changes related to the 
disease negatively affect white blood cells (WBC) functions (Sordillo, 2016). Thus, ketosis 
onset could impair immune functions and increase the risk of infectious diseases such as 
metritis and mastitis at the beginning of lactation (Duffield, 2000; Sordillo, 2016).  
Prior work detected an association between post-partum ketosis and certain prepartum 
conditions. Lower DMI and lower standing behavior prepartum was detected in cows with 
sub-clinical ketosis post-partum compared to a control group (Rodriguez-Jimenez et al., 
2018). High blood levels of NEFA (Chapinal et al., 2011) or higher lactate and interleukin-6 
(IL-6; Zhang et al., 2016) during prepartum was associated with higher risk of ketosis post-
partum. All the above conditions are negatively associated with the function of the immune 
system, including high NEFA (Lacetera et al., 2004); thus, it is possible that a dysfunctional 
immune system is causative of a higher risk of ketosis post-partum. Therefore, our hypothesis 
is that cows with clinical ketosis post-partum are characterized by a dysfunctional immune 
system during the dry period. Owing to the above, our study consisted in a retrospective 
analysis of blood BHB to detect ketosis in post-partum dairy cows aimed to test the 
relationship between ketosis onset in early lactation and trends of metabolic and 
immunological parameters during the dry period, to identify possible alterations reflecting a 
risky situation for disease occurrence. 
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MATERIALS AND METHODS 
Experimental design and animal management 
The trial was carried out at Università Cattolica del Sacro Cuore research dairy barn 
(Experiment Station, San Bonico, Piacenza, Italy) in accordance with Italian laws on animal 
experimentation (DL n. 26, 04/03/2014) and ethics (Authorization of Italian Health Ministry 
N 1047/2015-PR). A group of 13 Italian Holstein dairy cows were housed in individual tied 
stalls under controlled environmental conditions (room temperature of 20 °C, relative 
humidity of 65%, 14 hours of light) from -48 to 35 days from calving (DFC). All the cows 
were milked twice a day at the stand, at 4:00 am and pm. Animals were individually fed a 
component diet offered with two equal meals of forages at 12 h intervals and 2-8 meals of 
concentrates supplied by computer feeder. From -48 DFC till -7 DFC animals received a hay-
based ration with soybean meal and corn silage (Phase 1). Seven days before calving, 1 kg of 
lactation concentrate was added to the diet (Phase 2). After calving, 3 kg of alfalfa-dehydrated 
hay and 2 kg wk-1 of corn silage (till a maximum of 20 kg d-1) were added to the diet. Grass 
hay was gradually reduced to 2-2.5 kg d-1 and concentrate was increased by 0.5 kg d-1 to 
satisfy the requirement of 1 kg per 3 kg of produced milk (Phases 3 and 4). The same batches 
of hay and corn silage were used during the trial. Feeds were collected fortnightly and, after 
dry matter determination, samples were pooled for subsequent analyses. Feeds and diet 
composition are shown in Table 1. Periodical checks were performed, and blood samples 
were collected regularly during the trial, according to the time schedule shown in Figure 1 and 
described in the following sections. 
Body weight, body condition score, dry matter intake, rumination time and milk yield 
The body weight (BW) was measured with a single walking-in scale. The body condition 
score (BCS) was determined from the same operator with a 1 to 4 scale (Agricultural 
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Development and Advisory Service, 1986) and his variation (∆BCS) was calculated as the 
difference between data at calving day and 45 DFC. The individual DMI was measured by 
weighing the amounts of feed administered and residuals for each distribution. Rumination 
time was registered using the Ruminact system (SCR Europe, Podenzano, PC, Italy). Milk 
yield was weighed after each milking. Daily values of DMI, rumination time and milk yield 
were expressed as average weekly value. 
Health status 
Health conditions of cows were monitored daily and all veterinary interventions that 
occurred from -48 to 35 DFC were recorded. The body temperature was measured daily with 
a rumen bolus (DVM System TempTrackTM, HerdStrong, LLC, Greeley, CO). Mastitis was 
diagnosed by visual evaluation of abnormal milk from each quarter and SCC analysis on 
suspicious cases, retained placenta when the fetal membranes were not expelled within 24 h 
after calving, endometritis and metritis according to Sheldon et al. (2006), and milk fever, 
displacement of abomasum and pneumonia by inspection of a veterinary practitioner. 
Diarrhea was diagnosed by visual evaluation of feces consistency and color according to the 
fecal score method (Ireland-Perry and Stallings, 1993), assuming diarrheic feces those have a 
fecal score ≤ 2. 
Blood samples collection  
Blood samples were harvested trough jugular venipuncture in evacuated collection tubes 
(BD Vacutainer; BD and Co., Franklin Lakes, NJ) before the morning feeding. Samples were 
used to perform different assays (Figure 1). 
Metabolic profile assessment. For metabolic profile assessment (Figure 1), samples were 
collected into heparinized tubes and processed as described by Calamari et al. (2016). A 
clinical auto-analyzer (ILAB-650, Instrumentation Laboratory, Lexington MA, USA) was 
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used to determine the concentration of glucose, NEFA, BHB, urea, creatinine, Ca, P, Mg, Na, 
K, Cl, Zn, aspartate amino transferase-glutamate oxaloacetate transaminase (AST-GOT), 
gamma glutamyl transferase (GGT), alkaline phosphatase (ALP), total protein, haptoglobin, 
ceruloplasmin, albumin, total bilirubin, cholesterol and globulin in accordance with Calamari 
et al. (2016). Furthermore, reactive oxygen metabolites (ROMt), ferric reducing antioxidant 
power (FRAP), nitrate (NO3), nitrite (NO2) and nitric oxides (NOx) were determined 
according to Jacometo et al. (2015), paraoxonase (PON) according to Bionaz et al. (2007), 
thiol groups (SHp) according to Minuti et al., (2014), myeloperoxidase according to Bradley 
et al., (1982) and advanced oxidation protein products (AOPP) according to Hanasand et al. 
(2012). Finally, L-lactic acid (LLA) and D-lactic acid (DLA) were determined with a 
commercial kit (K-DLATE, Megazyme Co., Wicklow, Ireland). A multi-detection microplate 
reader (BioTek Synergy 2, Winooski, VT, USA) and commercial kits for ELISA method were 
used to determine the concentration of interleukin-1, beta (IL-1B; ESS0029; Thermo 
Scientific, Frederick, MD, USA) and IL-6 (ESS0027; Thermo Scientific, Frederick, MD, 
USA) according to Jahan et al. (2015) and those of serum amyloid alpha (SAA; TP-802, 
Tridelta D.L., Ireland). Furthermore oxygen reactive antioxidant capacity (ORAC) were 
determined with a fluorometric method according to Jacometo et al. (2015). Retinol, 
tocopherol and beta-carotene were analyzed by reverse-phase HPLC (LC-4000, Jasco Europe, 
Carpi MO, Italy), as described by Jahan et al. (2015).  
White blood cells profile. For the WBC profile (Figure 1), samples were collected with K-
EDTA tubes and processed with a clinical auto-analyzer (Cell-DYN 3700, Abbott Diagnostic 
Division, Santa Clara, CA). A laser optic assay was used to determine the amounts of total 
WBC, neutrophils, monocytes and basophils. The amount of mean cell volume and number of 
platelets were determined via electrical impedance assay. The amount of hemoglobin and 
mean cell hemoglobin where determined using spectrophotometry assay. 
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Whole blood stimulation assay. For whole blood stimulation assay (WBA, Figure 1), 
blood samples were collected with heparinized serum tubes and stimulated with 0 (baseline), 
0.01 (low dose; L) and 5 µg/mL (high dose; H) of bacterial lipopolysaccharides (LPS, 
Escherichia coli O111:B4; Sigma–Aldrich Company Ltd., UK, Cat. No. L3012), according to 
Jahan et al. (2015).  After WBA, plasma samples were stored at −80 ºC for the measurement 
of glucose, DLA, LLA, IL-1B, IL-6, NOx, NO2 and NO3. Variation of plasma parameters 
after WBA with L and H doses of LPS were expressed as fold change relative to the baseline. 
Interferon gamma release assay. For the interferon gamma (IFNG) release assay, whole 
blood samples were also collected into heparinized tubes (Figure 1). After collection, the 
tubes were stored in vertical position in a warm bath at a temperature of 38 ºC and transported 
to the laboratory within 20 min for the stimulation procedure. Whole blood was used in an 
IFNG release assay for Mycobacterium avium (internal method IZSLER, MP 13/011). 
Briefly, two 1-ml aliquots of each blood sample were distributed in a 24-well tissue culture 
microtiter plate. One well was supplemented with 100 µl of a 1:10 dilution of Mycobacterium 
avium purified protein derivative (PPD, IZS Umbria e Marche, Perugia, Italy, 0.5 mg/mL) in 
PBS while 1 well was supplemented with 100 µl of sterile PBS as control. The plate was 
positioned in a heated incubator (Grant Boekel, HIR10 M) set to a temperature of 38 ºC and 
with a relative humidity of 95% for 24 h.  After incubation, the blood was centrifuged at 8500 
× g for 16 min at 4 ºC and plasma was stored at -20 °C until use. Plasma was later thawed and 
analyzed with a couple of monoclonal antibodies according to the method described by 
(Trevisi et al., 2014), adapted to fit with a commercial ELISA kit for bovine IFNG 
(BOVIGAM, Prionics AG, 8952 Schlieren-Zurich, Switzerland). Results were evaluated in 
terms of optical density difference (∆OD) between avian PPD-stimulated and control wells. 
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Milk samples collection and analysis 
Milk samples were collected during the morning milking (Figure 1) into 100-ml 
polypropylene bottles. Butterfat, protein, lactose, casein contents, titratable acidity and 
coagulation properties [rennet clotting time (r) and curd firmness at 30 min (a30)] were 
measured by using infrared instrumentation (MilkoScan FT 120, Foss Electric, Hillerød, 
Denmark) according to Calamari et al. (2010) and Chessa et al. (2014). Furthermore, the 
outputs of fat and protein, and the fat to protein ratio were also calculated. Urea nitrogen was 
determined on skimmed milk by a spectrophotometric assay, using a urea nitrogen kit (cat# 
0018255440, Instrumentation laboratory, Milano, Italy) in association with a clinical auto-
analyzer (ILAB-650, Instrumentation Laboratory, Lexington MA, USA). Somatic cell count 
(SCC) were determined using an optical fluorimetric method with an automated cell counter 
(Fossomatic 180, Foss Electric). 
Carrageenan skin test 
The carrageenan skin test (CST) was performed as specified by Jahan et al. (2015) to 
evaluate  peripheral immune responses (Figure 1). The skin thickness was measured using a 
skinfold caliper (cat# 470119-588, VWR, USA) immediately before carrageenan injection (0 
days), then at 2 and 9 days after the injection. The total response of each challenge was 
calculated as the area under the curve of the thickness, measured at day 2 and day 9, 
subtracting the thickness measured at day 0. 
Rumen fluid parameters 
Rumen fluid samples were collected with an oro-gastric probe (Ruminator, Proofs 
Products, Guelph, Canada) before the morning feed administration. pH was immediately 
measured with a pH-meter (GLP 21, Crison Instrument SA, Alella, Barcellona, ESP). A 2-mL 
aliquot of the supernatant was transferred into tubes with 1 mL of 0.12 M oxalic acid and 
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immediately frozen at –20 °C for later analysis. Total volatile fatty acids (VFA) 
concentration, molar proportion of acetic, propionic, butyric, iso-butyric, valeric, iso-valeric, 
caproic, iso-caproic and enanthic acids were analyzed as previously described (Minuti et al. 
2014). Concentrations of single VFAs were expressed as relative amounts on total VFA 
concentration. A spectrophotometric clinical auto-analyzer (ILAB-650, Instrumentation 
Laboratory, Lexington MA, USA) and commercial kits for urea nitrogen (cat# 0018255440, 
Instrumentation laboratory, Milano, Italy) and lactate (K-DLATE, Megazyme Co., Wicklow, 
Ireland) were used to assess the concentration of ammonia and those of LLA, DLA and total 
lactic acid respectively. 
Retrospective analyses and animal grouping 
Animals were retrospectively divided in 2 groups based on their BHB levels measured in 
blood between 0 and 28 DFC (Figure 1), assuming a threshold of 1.4 mMol/L as a cut-off 
(Duffield, 2000). When blood BHB reached the sub clinical threshold animals were 
considered affected by ketosis (KET; 6 cows) and when remained below this threshold 
animals were defined as control (CTR; 7 cows). 
Statistical analysis  
Data in the tables are presented as mean and standard error. Before analysis, the normality 
of distributions was verified for each parameter by reckoning skewness and kurtosis 
according to the Shapiro test of SAS. Non-normally distributed parameters were normalized 
through natural logarithms (among plasma parameters IL-1B, IL-6, glucose, NEFA, DLA, 
LLA, Mg, AST-GOT, GGT, haptoglobin, bilirubin, cholesterol, AOPP, tocopherol, beta-
carotene, NOx, NO2 and NO3; among WBC profile the amounts of total WBC, neutrophils, 
neutrophils to lymphocytes ratio, monocytes, eosinophils and basophils; among milk 
parameters the butterfat, fat output and fat to protein ratio; among rumen fluid parameters the 
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ammonia; among WBA the fold changes of DLA, IL-1B, IL-6, NOx and NO3 and the total 
response to CST) or square root transformation (among the plasma parameters the Ca) and 
back transformed to plot them in  tables and graphs. 
Prevalence of health problems recorded during the study was evaluated by χ2 analysis 
(Freq procedure, SAS Inst. Inc., Cary, NC). Data of BW, BCS, DMI, rumination time, milk 
yield, metabolic and WBC profile, WBA, milk quality parameters, response to IFNG release 
assay and CST were submitted to ANOVA using a mixed model for repeated measures 
(Mixed procedure, SAS Inst. Inc., Cary, NC) in accordance with Littell et al. (1998). The 
statistical model included the fixed effect of health status (Hs; CTR and KET), time (t) and 
their interaction (Hs*t). For those parameters that were measured daily (DMI, rumination 
time and milk yield) time effect considered the average weekly value, while for other 
parameters (BW, BCS, metabolic and WBC profile, WBA, milk quality parameters, IFNG 
release assay and CST) time effect considered single DFC.  The time was considered as a 
repeated measure within cow. For WBA, also the dose (D; L and H) and the full interaction 
effect (Hs*t*D) were considered. The analysis was carried out using three covariance 
structures: autoregressive order, compound symmetry, and spatial power. These were ranked 
according to their Akaike information criterion, with the one having the lowest Akaike 
information criterion being eventually chosen (Littell et al., 1998). The pair-wise comparison 
was done using the least significant difference test. Data of rumen fluid parameters were 
analyzed by a one-way ANOVA (GLM procedure, SAS Inst. Inc., Cary, NC), considering 
only the fixed effect of Hs.  
Post-hoc comparisons were discussed when the P-value for main effect was  0.05. Main 
effects at P  0.10 are discussed in the context of tendencies. 
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RESULTS 
Health status 
The χ2 analysis on the occurrence of clinical diseases (Table 2) revealed no Hs effect for 
retained placenta, metritis and endometritis, milk fever, displacement of abomasum, 
pneumonia and diarrhea, and neither did we find any effect on cows affected by ketosis. The 
number of mastitis and total disease cases besides ketosis tended to be higher in KET than 
CTR cows (Hs = 0.09 and 0.06 respectively).  
Body weight, body condition score, dry matter intake, rumination time and milk yield 
BW, BCS and ∆BCS, resulted numerically higher in KET than CTR group during the 
whole experimental period, but no effect was detected (Supplementary file 1). DMI, 
rumination time and milk yield (Figure 2.a-c) resulted lower in KET than CTR cows after 
calving (Hs*t < 0.01). 
Milk quality parameters 
Among milk quality and rheological parameters (Table 3), both fat and protein outputs 
resulted lower in KET than CTR group at 28 DFC (Hs*t = 0.02 and 0.05 respectively). Urea 
nitrogen had a tendency for Hs*t effect, resulting lower in KET than CTR group at 7 DFC and 
numerically lower thereafter. No effect was detected on other parameters. 
Rumen fluid parameters 
Among rumen fluid parameters (Table 4), KET had a tendency for higher molar proportion 
of butyric and lower molar proportion of valeric acids (Hs = 0.08 and = 0.07 respectively) and 
had lower molar proportion of isovaleric acid (Hs = 0.05) compared to CTR group. No effect 
appeared on other parameters. 
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Metabolic profile 
Haematocrit and energy, protein and mineral metabolism biomarkers. Packed cell 
volume (Supplementary file 2.a) was not affected by health status. Among energy metabolism 
biomarkers, glucose concentration (Figure 3.a) was higher in KET than CTR group at -48 and 
-7 DFC, but KET had a more marked drop at 3 DFC and lower concentrations than CTR 
thereafter (Hs*t < 0.01). Concentration of NEFA and BHB (Figure 3.b-c) was higher in KET 
than CTR group during the whole experimental period (Hs = 0.01 and < 0.01 respectively), 
with larger differences observed after parturition (Hs*t = 0.02 for BHB). Concentration of 
LLA and DLA (Figure 3.d-e) was lower in KET than CTR group before calving, but both had 
a more pronounced peak at calving in KET group, resulting higher than in CTR thereafter 
(Hs*t = 0.01). Among protein metabolism biomarkers (Figure 3.f-g), urea concentration was 
lower in KET than CTR group at 14 DFC (Hs*t < 0.01), while creatinine concentration was 
overall higher during the examined period (Hs = 0.04). Among mineral metabolism 
biomarkers, concentration of P, Na, K, and Zn (Figure 3.h-l) was lower in KET than CTR 
group during the whole experimental period (Hs < 0.01 for P and K; Hs = 0.03 for Na and 
Zn). Concentration of Cl (Figure 3.k) was higher in KET than CTR group before calving (Hs 
= 0.02). Concentration of Ca and Mg was not different between the two groups 
(Supplementary file 2.b-c). 
Liver function biomarkers. AST-GOT and total bilirubin (Figure 4.a;.c) was higher in 
KET than CTR group after calving (Hs*t < 0.01 and = 0.05 respectively). GGT (Figure 4.b) 
tended to be higher in KET than CTR group both before and after calving (Hs = 0.06; Hs*t = 
0.09). ALP concentrations (Figure 4.d) had a tendency for Hs*t effect, resulting numerically 
higher in KET than CTR cows after calving. 
Inflammation biomarkers. Concentration of myeloperoxidase (Figure 4.e) was higher in 
KET compared to CTR group during the whole experimental period (Hs < 0.01). No effect 
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was detected for total protein and globulin (Supplementary file 2.d-e). Among positive APP, 
haptoglobin (Figure 4.f) was higher in KET vs. CTR group starting from the second week 
after calving (Hs*t = 0.01). Concentration of ceruloplasmin and SAA (Figure 4.g-h) was 
higher in KET compared to CTR group after calving (Hs = 0.09 and = 0.05 respectively; Hs*t 
= 0.01 and 0.03 respectively). Among negative APP, retinol (Figure 4.i) was lower in KET 
than CTR group after calving (Hs*t < 0.01), while PON was higher in KET compared to CTR 
cows before calving (Hs = 0.06) with differences disappearing after parturition (Figure 5.a). 
No difference between groups was detected for albumin and cholesterol (Supplementary file 
2.g-f). Concentration of IL-1B and IL-6 (Figure 5.b-c) was higher in KET vs. CTR group 
before calving (Hs*t = 0.03 and 0.05 respectively). 
Oxidative stress biomarkers. Concentration of ROMt, SHp, and AOPP (Figure 5.d-f) was 
higher in KET compared to CTR group (Hs < 0.01) and a tendency for a Hs*t effect appeared 
for ROMt. NOx and NO3 concentrations (Figure 5.g-h) resulted higher in KET than CTR 
group (Hs = 0.02 and = 0.01 respectively). Concentration of FRAP, ORAC, tocopherol, beta-
carotene and NO2 was not different between groups (Supplementary file 2.h-l).  
White blood cells profile 
Results of WBC profile are reported in Table 5. Amount of total WBC and neutrophils was 
greater in KET compared to CTR group at 28 DFC (Hs*t = 0.03 and 0.02 respectively). The 
prevalence of monocytes and basophils resulted higher in KET than CTR group during the 
whole experimental period (Hs = 0.04 and = 0.02 respectively). Hemoglobin concentration 
was higher in KET than CTR group at -48 DFC (Hs*t = 0.01). Mean cell volume and mean 
cell hemoglobin were greater in KET than CTR group (Hs < 0.01 for both). The prevalence of 
platelets resulted greater in KET than CTR group at -21 and -3 DFC (Hs*t < 0.01). 
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Whole blood stimulation assay 
Amount of cytokines produced in vitro by WBC increased after WBA (Table 6). 
Production of IL-1B was overall lower in KET than CTR group between -21 and 7 DFC (Hs 
and Hs*t < 0.01). Production of IL-6 by WBC was higher in KET than CTR group at 7 and 28 
DFC (Hs = 0.04; Hs*t = 0.01). 
Glucose uptake by WBC increased after WBA while production of DLA and LLA 
increased (Table 7). Glucose uptake by WBC was not different between groups, while lactate 
production resulted greater in KET than CTR group (Hs = 0.01 for LLA; Hs*t < 0.01 for both 
DLA and LLA). Production of NOx, NO2, and NO3 by WBC was not affected by the 
grouping (Supplementary file 3). 
Interferon gamma release assay and carrageenan skin test 
The production of IFNG (Figure 6.a) in whole blood in response to PPD was greater in 
KET than CTR group (Hs < 0.01). Total response to CST (Figure 6.b) was numerically lower 
in KET than CTR group for the whole experimental period, particularly at - 3 DFC. 
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DISCUSSION 
Alterations of blood parameters in prepartum in post-partum ketotic cows resemble 
preeclampsia conditions 
The higher level of PICs (IL-1B and IL-6) detected in blood of KET vs. CTR cows before 
calving is indicative of an activation of the immune system during the dry period. This is 
supported by the parallel increase of the main markers of neutrophils and monocytes 
activation (myeloperoxidase and AOPP), and the higher concentrations of oxidant species 
related to their antimicrobial activity (ROMt and NO3) in the blood of ketotic vs. control 
cows. Myeloperoxydase converts NO3 to a nitrating agent (Dedon and Tannenbaum, 2004) 
and generates hypoclorous acid that could generate ROM within the respiratory burst (Faith et 
al., 2008) while AOPP are markers of protein oxidation triggered by these metabolites (Celi 
and Gabai, 2015). The main cause of such activation of immune systems before ketosis is not 
clear, but trends of immune parameters during dry period are very similar to those observed in 
women affected by preeclampsia.  
According to Acauan Filho et al. (2016), “…preeclampsia is associated with the sequence 
of inadequate trophoblast invasion resulting in restricted spiral artery remodelling, low 
placental perfusion, placental ischemia, oxidative stress, and the consequent imbalance in the 
factors derived from placenta.” Although very little is known about the pathophysiology of 
this disease in women, and none reported such a condition to affect dairy cows, the 
generalized dysfunction of the maternal endothelium during preeclampsia appears to be part 
of an exaggerated systemic inflammatory response that involves maternal leukocytes and 
PICs (Raghupathy, 2013). Raise of PICs and parameters related to leukocytes activation 
(myeloperoxidase and ROM) has been widely reported in pre-eclamptic women (Mori et al., 
2014; Rocha-Penha et al., 2017; Cornelius, 2018) and suggests the development of a pre-
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eclamptic-like status during dry period of ketotic cows in our study, as also supported by 
trends of other plasma parameters. Increased platelet concentration found in our KET cows 
are consistent with the increased platelet aggregation reported during pre-eclampsia, as a 
consequence of vascular damages caused by active neutrophils during disease (Raghupathy, 
2013).  
Higher GGT levels found in our KET animals during dry period have previosly been 
reported in dairy cows prior to ketosis (Rodriguez-Jimenez et al., 2018) and suggest a liver 
damage . In fact GGT, as well as AST-GOT, are enzymes involved in hepatic AA 
metabolism, that increase in blood when a liver damage occurs, and such a condition has been 
widely reported in pre-eclamptic women (Cornelius, 2018). Such an impaired hepatic 
metabolism likely accounts for the greater amounts of thiol groups founded in blood of KET 
cows throughout our study, as higher thiol groups concentrations could be related to the 
reduced capacity of liver to pick up free glutathione (the most abundant free thiol group in 
blood stream) and sulphured amino acids from blood (Guzman Barron, 2006).  
Higher levels of NOx in blood of KET cows are also consistent with pre-eclampsia, as 
NOx is a potent endogenous vasodilator that is produced by nitric oxide synthase enzyme in 
endothelium. Its release relaxes the blood vessels muscle layer, affecting haemodynamic 
adaptation to pregnancy and play a pivotal role in pre-eclampsia pathogenesis (Acauan Filho 
et al., 2016).  
Preeclampsia-like conditions in KET cows is further reflected by trends of plasma 
minerals. In fact, lower levels of Na, K and P observed in our KET cows has been reported in 
woman affected by pre-eclampsia (Ikaraoha et al., 2012; Ebenezer et al., 2017) and could be 
driven by renal dysfunctions related to disease. Such an explaination is confirmed from the 
higher creatinine found in blood of KET cows during the entire experimental period, and 
reported in preeclamptic women (Leeman et al., 2016). Creatinine is related to 
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phosphocreatine utilization during normal muscular activity, and an increased hematic 
concentration of this metabolite indicates an impaired capacity of the kidney to remove it 
(Zoccali et al., 2006).  
Lower plasma zinc found in our cows has also been reported in pre-eclamptic women 
(Jihye et al., 2012). This mineral is known to serve as a secondary antioxidant aiding 
superoxide dysmutase enzymatic complex functioning, and its lower level reflect a greater 
consumption to face the oxidative stress status related to pre-eclampsia (Jihye et al., 2012).  
Finally, the greater IFNG response of peripheral blood leukocytes of KET cows to the ex-
vivo stimulation with M. avium further supports the development of a preeclampsia-like 
status. Increased production of IFNG has been reported in decidual lymphocytes and 
choriodecidual cells of placental trophoblast from pre-eclamptic pregnancies consequently to 
the reduced expression of IFNG receptor R2 (Raghupathy, 2013). The production of IFNG by 
T-helper cells type 1 has also been proposed as one of the primary causes of the disease 
(Banerjee et al., 2005) and could provide a linkage between preeclampsia and ketosis. 
Although a direct measurement of plasma IFNG is required to confirm such a hypothesis, we 
can speculate that higher prepartal IFNG production measured in vitro in leukocytes from 
cows having a preeclamptic-like status could probably reflect their greater activity in vivo.  
Higher IFNG concentrations could play a direct role in ketosis induction after calving. 
IFNG is known to inhibit the expression of peroxisome proliferation activated receptor 
(PPAR)-gamma (Floyd and Stephens, 2002). PPAR-gamma plays important roles in 
adipocytes biology. PPAR-gamma is a main player in maintaining insulin sensitivity of 
tissues, including adipose tissue (Waite et al., 2001; Choi et al., 2018). A link between insulin 
resistance and risk of ketosis in dairy cows has already been suggested (Youssef and El-
Ashker, 2017), consistently with the higher prepartal glucose concentrations detected in KET 
vs. CTR, although previous studies failed to reveal any alteration of such a parameter prior to 
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ketosis (Abuajamieh et al., 2016). Our study could also suggest a linkage of insulin resistance 
with the preeclamptic-like status affecting our KET cows before calving, consistently with the 
reported hyperglycaemia that affects preeclamptic women (Kaaja, 2011; Sacks et al., 2015). 
On the other hand, the prepartal increase of NEFA and BHB at non-pathologic levels found in 
our cows are well known prior to ketosis (Zhang et al., 2016). NEFA concentration at -14 
DFC has also been suggested as a predictive biomarker of disease (Chapinal et al., 2011). 
Increase plasma concentration of NEFA reflects mobilization of lipid sources while BHB is 
released in blood when liver oxidation is impaired by a fatty acids overload (Herdt, 2000). In 
this scenario, IFNG-driven PPAR-gamma inhibition could be pivotal to boosting ketosis onset 
after calving. Decreased lipogenesis and increased lipolysis arise when PPAR-gamma is 
inhibited (Waite et al., 2001), which may be conductive to a greater mobilization of NEFA for 
energy metabolism. However, greater mobilization of NEFA in KET vs. CTR did not reflect 
on any BCS difference in our study, in agreement with previous results (Rodriguez-Jimenez et 
al., 2018).  
Despite many parameters appears to be in line with a preeclampsia model none of the cows 
enrolled in this study had any diagnosed preeclampsia. Typical symptoms of preeclampia, 
including rapid weight gain, proteinuria, edema, increased abortion rates, and/or reduced 
newborn calf weight, were not detected. Thus, we certainly cannot conclude that our cows 
experience preeclampsia; however, due to the central role of placenta in preeclampsia 
(Roberts and Escudero, 2012), we can speculate that a subclinical dysfunction of the placenta 
might have been a co-cause of the observed changes in measured parameters in plasma 
prepartum with ensuing ketosis postpartum.  
Preeclampsia in women is associated also with obesity (Roberts et al., 2011) and several of 
the changes of measured parameters appears to be also associated with fat cow syndrome 
(Morrow, 1976). None of the cows in the study would have been considered obese and no 
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differences in BCS between KET and CTR were detected. In human, a higher production of 
adipokines have been associated with preeclampsia (Haugen et al., 2005). Disruptive 
production of adipokines in preeclampsia cases are associated with visceral adipose tissue 
(Huda et al., 2017). In non-obese dairy cows large variation in visceral adipose tissue is not 
visible by using BCS (Drackley et al., 2014). Thus, it is possible that ketotic cows in our 
study had higher production of adipokines by visceral adipose tissue compared to control 
animals. 
Cows with ketosis have impaired feed behavior 
Ketosis onset is related to the impairment of feeding behavior, as suggested by the reduced 
DMI and rumination time found in our study after calving. Low feed intake (Zhang et al., 
2016) and an average reduction of rumination time up to 25 min d-1 were consistently 
reported in dairy cows during the week of ketosis diagnosis (Abuajamieh et al., 2016). Recent 
studies highlighted alteration of these parameters also before calving (Kaufman et al., 2016; 
Rodriguez-Jimenez et al., 2018). Such an impairment in feeding behaviours in ketotic cows 
could arise from the strong anorexic effect resulting from combined raise of PICs, NEFA and 
BHB (Bertoni et al., 2008; Allen et al., 2009) as well as from the insulin resistance-like status 
occurred before calving (Youssef and El-Ashker, 2017), that could be involved in the 
reduction of feed intake. Furthermore, it could also be related to the impairment of rumen 
fermentations occurring with ketosis. Wang et al. (2012) reported a reduction of propionate-
forming bacteria (Megasphaera elsdenii and Selenomonas ruminantium) and an increase in 
lactate-producing bacteria (Streptococcus bovis), reflected in an increased lactate 
concentration and reduced VFA production in rumen of cows affected by acute ketosis (blood 
BHB concentration > 3 mMol/L). Unfortunately, rumen samples were collected during the 
fourth week of lactation in our study, while most animals had BHB peaks during the first and 
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second week from calving, which makes it difficult to correlate any rumen alteration with 
ketosis. Furthermore, the light ketosis status that affected our animals (blood BHB 
concentration > 1.2 mMol/L) could account for the lack of any effect on VFA and lactate.  
Reduced DMI and rumination time in KET cows, together with the increased energy 
demand related to the activation of their immune system during dry period, could had 
worsened the physiological NEB condition after calving (Soriani et al., 2012; Osorio et al., 
2014). This could account for the depression of milk yield, milk fat and protein outputs 
detected in our study with ketosis, consistent with milk losses up to 353.5 kg cow-1 in the 
whole lactation reported previously (Zhang et al., 2016). Lower glucose in KET vs. CTR 
cows post-partum can be due to several factors, including a higher utilization of glucose by 
immune cells but also an impaired glucogenic capacity of the liver (Loor et al., 2007). Lower 
glucose in blood had triggered a marked shift to other energy sources. This is consistent with 
the stepwise increase of both NEFA and BHB, that suggests a major role of lipid sources as 
energy supplier, as widely reported in ketotic cows during early lactation (Duffield, 2000). On 
the other hand, lower postpartal urea concentration detected in blood of KET cows is in 
contrast with Rodriguez-Jimenez et al. (2018), and reflects a less marked contribution of 
muscle tissues in supplying the energy deficit in KET vs. CTR cows, as blood urea partially 
arise from deamination of AA. Nevertheless, the detection of similar depression on milk urea 
level suggests the decreased feed intake of KET cows as the main cause in the alteration of 
this parameter (Bertoni et al., 2008).  
Ketosis is associated with inflammatory-like conditions post-partum 
A status of inflammatory-like condition appears physiological during TP in dairy cows 
(Bionaz et al., 2007; Bertoni et al., 2008). During inflammation, the liver shifts its anabolic 
priorities, and plasmatic trends of APP reflects the severity of the phenomenon (Castell et al., 
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1989). Plasma concentration of positive APP such as haptoglobin, ceruloplasmin, and SAA 
increases (Ceciliani et al., 2012), while concentration of other typical proteins known as 
negative APP, such as albumin, PON, lipoproteins, and retinol binding protein typically 
decrease (Bionaz et al., 2007; Trevisi et al., 2012).  
The lack of any prepartal difference in positive APP, together with the greater PON 
concentration of KET vs. CTR cows, suggests a lack of acute phase reaction despites the 
larger PIC during this phase. Conversely, the higher levels of positive APPs and the lower 
level of retinol reflect a more marked inflammatory status in KET animals after calving, 
although no difference were detected for other negative APP. Lower level of plasma zinc 
could further support the greater inflammatory conditions occurred in KET cows after 
calving, as this mineral is sequestred by the liver from the blood during an acute phase 
response (Bertoni and Trevisi, 2013). Furthermore, augmented postpartal concentration of 
GGT and AST-GOT found in our KET cows reflects results by Rodriguez-Jimenez et al. 
(2018), indicating liver damages to be aggravated with delivery. This is further confirmed by 
the greater bilirubin concentration observed in the same period. Bilirubin results from 
degradation of red blood cells, and its clearance is related to the activity of liver enzymes 
(Rodriguez-Jimenez et al., 2018).  
Attenuated response of white blood cells to LPS and possible immunosuppression in post-
partum ketotic cows 
WBC had a lower IL-1B production in response to LPS in KET vs. CTR already 21 days 
before calving that persisted for the first week post-partum, while the production of IL-6 in 
response to LPS was not different between KET and CTR during the same time frame, but 
WBC production of IL-6 after LPS was larger in KET vs CTR after ketosis, along with 
production of lactate. IL-1B is a well-known PIC, while IL-6 is known to have both pro and 
131 
 
anti-inflammatory activities, and the production of lactate has been reported to suppress the 
inflammasome and the production of PICs (Zhang et al., 2016). Such altered responses in 
WBC are consistent with their shift on anti-inflammatory response driven by altered gene 
expression at liver level with ketosis, although the effect found on IL-1B production prior to 
ketosis suggests another mechanism to contribute to such alteration. As indicated above, 
ketotic animals in our study had preeclampsia-like conditions; interestingly, preeclampsia 
status is known to weakened body defences (Cornelius, 2018). Such effects, occurred in early 
dry period (or even before), could have admit bacterial cells components to enter the 
organism (Trevisi et al., 2018), challenging immune cells and inducing an endotoxin tolerance 
condition in them. This is a protective mechanism against over exuberant inflammations 
developed from WBC after an endotoxin challenge. It consists in a decreased production of 
PICs and an up-regulation of anti-inflammatory genes, that triggers a transient unresponsive 
state against further challenges with endotoxins (Biswas and Lopez-Collazo, 2009).  
Metabolic asset related to the more severe NEB occurred with ketosis at the beginning of 
lactation could have further contribute in affecting WBC functions. In fact, a higher 
concentration of circulating WBC was expected in KET cows in comparison to CTR during 
the whole experimental period considering the activation of their immune system that 
occurred during dry period (higher levels of PICs, myeloperoxidase, ROMt, AOPP and NO3 
and greater IFNG production in vitro) and the more marked inflammatory condition they had 
after calving (reflected in positive APPs and liver function biomarkers trends). Nevertheless, 
increased numbers of circulating neutrophils and monocytes in KET cows were detected in 
the late post calving period only, when the metabolic status related to ketosis was overcome, 
suggesting WBC viability to be reduced during disease. Alternative energy sources are less 
efficiently utilized in WBC compared with glucose (Sordillo, 2016), and decreased 
proliferation, differentiation and viability has been reported for macrophages and 
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polymorphonuclear cells (PMN) with low glucose availability (Barghouthi, Everett, & Speert, 
1995; Gamelli, Liu, He, & Hofmann, 1996). Furthermore, impaired chemotaxis and 
phagocytosis were also reported in those cells (Pithon-Curi et al., 2004). Although differences 
were only numerical in our study, this seems to be consistent with the lower sensitivity to 
CST found in KET cows 3 days prior to parturition, suggesting WBC ability to reach 
peripheral tissues to be impaired in cows that developed ketosis after calving (Jahan et al., 
2015). Furthermore, high concentrations of NEFA and BHB, as those shown by KET cows 
throughout our study, are directly involved in the impairment of WBC functions. BHB cannot 
be utilized as energy source in WBC (Targowski and Klucinski, 1983; Hoeben et al., 1997; 
Sartorelli et al., 1999; Suriyasathaporn et al., 1999), while NEFA increases apoptosis and 
necrosis in macrophages and PMN through the stimulation of their respiratory burst activity 
(Scalia et al., 2006) and this could account for the higher ROMt and AOPP councentration 
found in KET cows in our experiment. Furthermore, NEFA increase the production of PICs 
and IFNs in lymphocytes (Hughes and Pinder, 2000); thus, higher NEFA concentrations 
detected in KET cows before calving could partially account for the higher PICs and for a 
greater response to IFNG by WBC. Finally, the higher level of lactate in blood of ketotic vs. 
control cows in early lactation could have impaired the immune system. Lactate is known to 
impair motility, killing capacity and effector functions of monocytes, macrophages, T and B 
cells (Zhang et al., 2016). Such an impairment could account for the numerically higher 
incidence of udder diseases found in ketotic cows, that has also been widely reported in 
previous works (Duffield, 2000). Mastitis was the only peripartum disease that showed a 
tendency for a Hs effect in our experiment, and both cases were clearly associated to ketosis, 
as they appeared three weeks after the BHB peak.  
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CONCLUSION 
In our study, occurrence of ketosis was preceded by preeclampsia-like status during the dry 
period including high oxidative stress, high PICs, high nitrate, possible lower renal function, 
liver damage, reduced blood minerals concentrations, and activated immune system. An 
increased production of IFNG by leukocytes in vitro was also detected, which may have 
affected PPAR-gamma expression and, thus insulin sensitivity. The latter might explain the 
larger plasma concentration of NEFA and BHB observed in KET cows pre-partum. The 
anorexic power exerted by PICs, NEFA and BHB and the high circulating glucose levels 
reduces DMI around calving. Furthermore, increased energy requirement related to activation 
of immune system in dry period could have contributed to worsen the NEB condition in early 
lactation. Such a condition induced severe milk yield losses and boosted the mobilization of 
lipid sources. The above conditions appeared to have accrued the larger acute phase response 
after calving, partly compromising liver function. Our data is indicative of a possible 
endotoxin tolerance of WBC in KET cows that could account for the reduced production of 
PICs and increased production of anti-inflammatory mediators, such as lactate, by WBC 
under LPS stimulation. Thus, our data is indicative of a role of the immune system, maybe 
associated with a still unclear placental role (or adipose tissue role), during the dry period in 
promoting ketosis early post-partum. Nevertheless, an in-depth study on alterations in 
pathways regulating energy metabolism prior to ketosis onset and on the role of the immune 
system in such alterations is required to fully elucidate the real contribution of IFNG and 
other cytokines to disease onset, and the linkage between preeclampsia-like status and ketosis. 
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TABLES AND FIGURES 
Table 1. Composition and characteristics of the experimental diets fed during the 5 
experimental phases. Between -55 and -40 DFC cows received grass hay, only 
1Supplements were composited to provide 150000 UI of vitamin A, 10000 IU of vitamin D, 
200 mg of vitamin E, 100 mg of vitamin K, 100 mg of vitamin H1 50 mg of vitamin B1, 0.5 
mg of vitamin B12, 500 mg of vitamin PP, 4000 mg of coline, 350 mg of Mn, 800 mg of Zn, 
40 mg of Cu, 20 mg of I, 1 mg of Co, 1 mg Se. 
2Estimate using NRC 2001. 
Diet, %DM  Phase 1  Phase 2 Phase 3 Phase 4 
 DFC -48; -7 -7; 0 1; 30 31; 60 
Item      
Corn silage  18.6 23.6 24.0 23.3 
Alfalfa hay  - - 13.7 11.1 
Grass hay  71.4 58.0 18.1 11.9 
Concentrate (Dry period)  10.0 10.1 5.00 - 
Concentrate (Lactation 
period) 
 - 8.30 44.2 53.7 
Concentrate composition, %DM Dry period Lactation period 
Corn flour  - 40.0 
Barley flour  - 1.4 
Sorghum grain expanded  - - 
Soybean meal  90.5 13.1 
Soybean dry rolled  - - 
Sunflower meal  - 4.9 
Corn gluten feed  - - 
Beet pulp  - 16.6 
Wheat bran  - 9.8 
Beet molasse slops  - 2.6 
Potato protein  - 2.2 
Hydrogenat palm oil  - 3.3 
Limestone  - 1.39 
Dicalcium phosphate  - 1.80 
Sodium bicarbonate  - 0.98 
Magnesium oxide  2.2 0.64 
Sodium Chloride  1.4 0.32 
Supplement1  5.9 1.07 
Chemical composition     
NEL, Mcal kg of DM
-1  1.45 1.53 1.60 1.63 
Crude protein, % DM  13.6 14.5 16.2 17.2 
Starch + sugar, %DM  16.8 19.3 26.0 18.3 
Ether extract, %DM  1.80 2.40 4.48 5.08 
NDF, %DM  49.3 45.5 35.7 32.6 
MP2, %CP  9.10 9.70 10.5 11.1 
RUP2, %CP  4.48 4.77 5.23 5.96 
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Table 2. Incidence of diseases (besides ketosis) observed between -48 and 35 days from 
calving (DFC) in control dairy cows or cows that showed beta-hydroxybutyrate levels higher 
than 1.4 mmol/L in the first month of lactation 
1Health status (CTR is control; KET is ketosis). 
2Cows that did not have any clinical diseases (besides ketosis) between -48 and 35 DFC. 
3Retained placenta. 
4Endometritis or metritis. 
5Milk fever. 
6Displacement of abomasum. 
7Mastitis. 
8Pneumonia. 
9Diarrhea. 
10Days before BHB peak appearance or after its conclusion (0 indicate that disease occurred 
during the BHB peak). 
Hs1 
Healthy 
cows2 
Problems occurrence, n 
RP3 ME/ED4 MF5 DA6 MA7 PN8 DH9 Total 
CTR 
(7 cows) 
5 0 0 0 0 0 0 2 2 
Period of 
manifestation 
DFC 
- - - - - - 14 18 - 
KET 
(6 cows) 
2 1 1 1 1 2 1 2 9 
Period of 
manifestation 
DFC 1 9 1 3 34  26 7 31 15 
- 
DFK10 -2 0 -2 0 20 23 0 17 8 
P 0.43 0.26 0.26 0.26 0.26 0.09 0.26 0.85 0.06 
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Table 3. Milk composition, rheological parameters and somatic cell count in control dairy 
cows or cows that showed beta-hydroxybutyrate levels higher than 1.4 mmol/L in the first 
month of lactation 
Item,  
Unit 
Hs1 
 DFC  
SE 
P-Value 
7 14 28 Hs1 t2 Hs*t3 
Butterfat,  
mg 100 mL-1 
CTR 4.47 4.27 4.54 0.349 0.67 0.10 0.18 
KET 5.18 4.60 3.96 0.377    
Fat output, 
g 
CTR 0.28 0.39 0.61 0.090 0.54 0.34 0.02 
KET 0.40 0.40 0.27* 0.097    
Total protein,  
mg 100 mL-1 
CTR 3.81 3.34 3.20 0.100 0.29 <0.01 0.89 
KET 3.73 3.21 3.04 0.108    
Protein output, 
g 
CTR 1.14 1.17 1.35 0.086 0.30 0.09 0.05 
KET 1.11 1.08 1.09* 0.093    
Fat/protein ratio, 
- 
CTR 0.15 0.25 0.32 0.076 0.41 0.64 0.32 
KET 0.33 0.34 0.26 0.082    
Lactose, 
mg 100 mL-1 
CTR 4.90 5.14 5.11 0.074 0.13 <0.01 0.64 
KET 4.71 5.09 5.00 0.080    
Caseins, 
mg 100 mL-1 
CTR 2.85 2.54 2.40 0.079 0.19 <0.01 0.84 
KET 2.76 2.39 2.26 0.085    
Titratable acidity, 
°SH 50 mL-1 
CTR 3.79 3.09 3.15 0.131 0.12 <0.01 0.40 
KET 4.11 3.47+ 3.31 0.142    
Urea nitrogen, 
mg dL-1 
CTR 35.0 34.4 28.1 2.80 0.11 0.10 0.10 
KET 23.4* 29.4 27.6 3.02    
Coagulation time 
(r), min 
CTR 13.9 18.4 15.0 2.54 0.22 <0.01 0.15 
KET 9.9* 17.8 14.2 2.74    
Curd firmness 
(a30), mm 
CTR 37.8 28.0 35.7 35.7 0.27 0.25 0.43 
KET 39.1 27.8 28.3 28.3    
SCC4, 
n mL-1 
CTR 194.6 - 42.3 88.0 0.36 0.04 0.87 
KET 121.2 - 56.9 88.0    
1Health status (CTR is control; KET is ketosis). 
2Time. 
3Health status x time interaction (* is P < 0.05; + is P < 0.1). 
4Somatic cells count. 
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Table 4. Ruminal pH, ammonia concentrations and volatile fatty acids molar proportion, 
determined at 28 days after calving, in control dairy cows or cows that showed beta-
hydroxybutyrate levels higher than 1.4 mmol/L in the first month of lactation 
Item Unit Hs1 
Standard error P-value 
CTR KET 
pH - 6.64 6.67 0.10 0.83 
Ammonia mg L-1 4.53 4.32 0.49 0.71 
VFA total2 mmol L-1 110.1 100.6 5.04 0.19 
Acetic acid  mol 100 mol-1 61.7 63.0 1.63 0.57 
Propionic acid  mol 100 mol-1 23.3 21.4 1.52 0.38 
Butyric acid  mol 100 mol-1 10.7 11.9 0.48 0.08 
Isobutyric acid mol 100 mol-1 0.78 0.78 0.08 1.0 
Valeric acid mol 100 mol-1 1.34 1.14 0.07 0.07 
Isovaleric acid mol 100 mol-1 1.55 1.31 0.08 0.05 
Caproic acid mol 100 mol-1 0.49 0.38 0.08 0.39 
Enanthic acid mol 100 mol-1 0.04 0.02 0.01 0.18 
Levitical lactic acid mmol L-1 32.2 36.7 5.39 0.55 
Dextroric lactic acid mmol L-1 31.6 37.4 5.34 0.44 
Total lactic acid mmol L-1 63.8 74.2 10.7 0.49 
1Health status (CTR is control; KET is ketosis). 
2Total volatile fatty acids. 
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Table 5. White blood cells profile in control dairy cows or cows that showed beta-
hydroxybutyrate levels higher than 1.4 mmol/L in the first month of lactation 
Item, 
Unit 
Hs1 
Days from calving 
SE2 
P-value 
-48 -21 -3 7 28 Hs1 t3 Hs*t4 
WBC5, 
K µL-1 
CTR 5.9 6.3 7.7 6.2 5.2 1.11 0.25 0.02 0.03 
KET 6.9 7.2 8.1 7.3 9.8** 1.20    
Neutrophils, 
K µL-1 
CTR 3.0 3.4 5.0 3.8 2.9 0.28 0.25 <0.01 0.02 
KET 3.1 3.4 4.7 4.2 6.4+ 0.31    
Monocytes, 
K µL-1 
CTR 0.41 0.51 0.77 0.57 0.49 0.15 0.04 <0.01 0.39 
KET 0.43 0.58 0.80 0.75 0.90 0.16    
Basophils, 
K µL-1 
CTR 0.06 0.05 0.04 0.07 0.06 0.21 0.02 0.18 0.41 
KET 0.07 0.06 0.10 0.10 0.11 0.23    
Hemoglobin, 
g dL-1 
CTR 10.4 10.3 10.5 10.3 9.5 0.32 0.18 <0.01 0.01 
KET 11.8** 10.6 10.9 11.0 9.8 0.35    
MCV6, 
fL 
CTR 46.1 46.5 48.2 48.1 47.3 1.14 <0.01 <0.01 0.24 
KET 51.2 50.8 51.8 50.9 49.8 1.24    
MCH7, 
pg 
CTR 16.0 16.1 16.5 16.6 16.5 0.26 <0.01 0.03 0.57 
KET 17.4 17.5 17.8 17.6 17.5 0.28    
Platelets, 
K µL-1 
CTR 317 251 390 314 435 30.9 0.67 <0.01 <0.01 
KET 288 381** 294* 347 460 33.3    
1Health status effect (CTR is control and KET is ketosis). 
2Standard error. 
3Time effect. 
4Health status x time interaction effect (+ is P < 0.1; * is P < 0.05; ** is P < 0.01). 
5White blood cells. 
6Mean cells volume. 
7Mean cells hemoglobin. 
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Table 6. Fold changes of cytokines in a whole blood stimulation assay with a low (L) or high 
dose (H) of bacterial lipopolysaccharides (LPS) in control dairy cows or cows that showed 
beta-hydroxybutyrate levels higher than 1.4 mmol/L in the first month of lactation. Values are 
expressed as fold change with respect to baseline 
Item D2 Hs1 
Days from calving SE3 Effect P-Value 
-48 -21 -3 7 28 
Interleukin-1, 
beta 
L 
CTR 11.8 14.5 17.3 18.1 9.0 0.28 Hs1 <0.01 
KET 4.5 3.9 7.0 5.6 11.9 0.30 t4 0.02 
H 
CTR 38.7 46.7 64.8 75.3 31.6 0.28 D2 <0.01 
KET 10.1 10.8 17.5 15.8 50.8 0.30 Hs*t5 <0.01 
Tot 
CTR 25.3 30.6 41.0 46.7 20.3 0.24 Hs*t*D6 0.71 
KET 7.3 7.3 
** 
12.3 
** 
10.7 
** 
31.3 0.26   
Interleukin-6 
L 
CTR 1.55 
 
1.46 1.53 1.63 1.55 0.12 Hs1 0.04 
KET 1.76 1.31 1.89 1.96 2.72 0.13 t4 <0.01 
H 
CTR 2.14 1.74 1.84 2.52 2.18 0.12 D2 <0.01 
KET 2.23 2.04 2.30 2.98 4.74 0.13 Hs*t5 0.01 
Tot 
CTR 1.8 1.6 1.7 2.1 1.9 0.10 Hs*t*D6 0.83 
KET 2.0 1.7 2.1 2.5 
+ 
3.7 
** 
0.11   
1Health status (CTR is control and KET is ketosis). 
2Dose (L is low, and H is high). 
3Standard error. 
4Time. 
5Health status x time interaction (** is P < 0.01; + is P < 0.1). 
6Health status x time x dose interaction. 
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Table 7. Fold changes of glucose and metabolites thereof in a whole blood stimulation assay 
with a low (L) or high dose (H) of bacterial lipopolysaccharides (LPS) in control dairy cows 
or cows that showed beta-hydroxybutyrate levels higher than 1.4 mmol/L in the first month of 
lactation. Values are expressed as fold change with respect to baseline 
Item D2 Hs1 
Days from calving SE3 Effect P-Value 
-48 -21 -3 7 28 
Glucose 
L 
CTR 0.97 0.98 0.93 0.97 0.98 0.05 Hs1 0.17 
KET 0.95 0.96 0.95 0.92 0.88 0.05 t4 0.18 
H 
CTR 0.93 0.95 0.90 0.89 0.95 0.05 D2 0.02 
KET 0.95 0.94 0.81 0.83 0.79 0.05 Hs*t5 0.34 
Tot 
CTR 0.95 0.96 0.91 0.93 0.96 0.04 Hs*t*D6 0.94 
KET 0.95 0.95 0.88 0.87 0.83 0.04   
D-lactic acid 
L 
CTR 1.03 1.05 1.10 1.00 0.96 0.03 Hs2 0.16 
KET 1.02 1.04 1.05 1.07 1.14 0.03 t4 0.10 
H 
CTR 1.05 1.06 1.14 1.06 1.06 0.03 D1 0.01 
KET 1.04 1.11 1.11 1.10 1.19 0.03 Hs*t5 <0.01 
Tot 
CTR 1.04 1.05 1.12 1.03 1.01 0.02 Hs*t*D6 0.90 
KET 1.03 1.08 1.08 1.09 1.17 
** 
0.03   
L-lactic acid 
L 
CTR 1.02 1.04 1.04 1.02 1.00 0.02 Hs2 0.01 
KET 1.03 1.04 1.03 1.09 1.11 0.02 t4 <0.01 
H 
CTR 1.03 1.05 1.06 1.06 1.08 0.02 D1 <0.01 
KET 1.04 1.08 1.07 1.11 1.17 0.02 Hs*t5 <0.01 
Tot 
CTR 1.02 1.05 1.05 1.04 1.04 0.01 Hs*t*D6 0.50 
KET 1.03 1.06 1.05 1.10 
** 
1.14 
** 
0.01   
1Health status (CTR is control and KET is ketosis). 
2Dose (L is low, and H is high). 
3Standard error. 
4Time. 
5Health status x time interaction (** is P < 0.01; * is P < 0.05). 
6Health status x time x dose interaction.  
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Figure 1. Scheduled time points, expressed as day from calving (DFC), for rumen sample 
collection ( ), carrageenan skin test performance ( ), milk sample collection ( ), blood 
sample collection for the interferon gamma release assay ( ), blood sample collection for 
white blood cells profile and whole blood stimulation assay ( ), blood sample collection for 
metabolic profile ( ; time points surrounded with dotted lines were used in the retrospective 
analysis of beta-hydroxybutyrate), milk yield measurement ( ), body weight and body 
condition score determination ( ), dry matter intake and rumination time determination ( ). 
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Figure 2. Average week values of dry matter intake (a), rumination time (b) and milk yield 
(c) in control dairy cows (CTR; solid bars) or cows that showed beta-hydroxybutyrate (BHB) 
levels higher than 1.4 mmol/L in the first month of lactation (KET; striped bars). ** is P < 
0.01; * is P < 0.05; + is P < 0.1; WFC is weeks from calving; Hs is health status effect; t is 
time effect; Hs*t is health status x time interaction effect.  
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Figure 3. Time course of plasma concentrations of glucose (a), not-esterified fatty acids 
(NEFA; b), beta-hydroxybutyrate (c), L-lactic acid (d), D-lactic acid (e), urea (f), creatinine 
(g), phosphorus (h), sodium (i), potassium (j), chlorine (k) and zinc (l) in control dairy cows 
(CTR; solid line) or cows that showed beta-hydroxybutyrate (BHB) levels higher than 1.4 
mmol/L in the first month of lactation (KET; dotted line). ** is P < 0.01; * is P < 0.05; + is P 
< 0.1; DFC is days from calving; Hs is health status effect; t is time effect; Hs*t is health 
status x time interaction effect. 
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Figure 4. Time course of plasma concentrations of aspartate amino transferase (AST-GOT; 
a), gamma glutamyl transferase (b), bilirubin (c), alkaline phosphatase (d), myeloperoxidase 
(e), haptoglobin (f), ceruloplasmin (g), serum amyloid alpha (h) and retinol (i) in control dairy 
cows (CTR; solid line) or cows showed beta-hydroxybutyrate (BHB) levels higher than 1.4 
mmol/L in the first month of lactation (KET; dotted line).  ** is P < 0.01; * is P < 0.05; + is P 
< 0.1; DFC is days from calving; Hs is health status effect; t is time effect; Hs*t is health 
status x time interaction effect. 
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Figure 5. Time course of plasma concentrations of paraoxonase (a), interleukin-1 (b), 
interleukin-6 (c), total reactive oxygen metabolites (d), thiol groups (e), advanced oxidation 
protein products (AOPP; f), nitric oxide (g) and nitrate (h) in control dairy cows (CTR; solid 
line) or cows that showed beta-hydroxybutyrate (BHB) levels higher than 1.4 mmol/L in the 
first month of lactation (KET; dotted line). ** is P < 0.01; * is P < 0.05; + is P < 0.1; DFC is 
days from calving; Hs is health status effect; t is time effect; Hs*t is health status x time 
interaction effect. 
147 
 
 
Figure 6. Optical density difference (∆OD) between avian purified protein derivative-
stimulated and control wells in the interferon gamma (IFNG) release assay (a) and total 
peripheral response after the carrageenan skin test (CST; b) in control dairy cows (CTR; solid 
bars) or cows that showed beta-hydroxybutyrate (BHB) levels higher than 1.4 mmol/L in the 
first month of lactation (KET; striped bars). ** is P < 0.01; * is P < 0.05; DFC is days from 
calving; Hs is health status effect; t is time effect; Hs*t is health status x time interaction 
effect. 
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SUPPLEMENTARY FILE 
Supplementary file 1. Trends of body weight (BW) and body condition score (BCS) in 
control dairy cows (CTR) or cows that showed beta hydroxybutyrate levels higher than 1.4 
mmol/L during the transition period (KET) 
1Health status (CTR is control; KET is ketosis). 
2Difference between BCS value at 28 and 1 DFC. 
3Time. 
4Heath status x time interaction effect. 
Item, 
Unit 
Hs1 
Days from calving P-Value 
-45 -21 1 14 21 28 ∆2 
Hs1 t3 Hs*t4 
BW,  
Kg 
CTR 628 667 623 577 570 570 - 0.22 <0.0
1 
0.67 
KET 683 711 652 608 593 597 - 
BCS 
CTR 2.40 2.43 2.3
9 
2.1
9 
2.0
9 
2.0
9 
0.30
8 
0.31 <0.0
1 
0.99 
KET 2.54 2.57 2.5
3 
2.3
0 
2.2
0 
2.1
6 
0.32
9 
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Supplementary file 3. Fold changes of nitrogen species in a whole blood stimulation assay 
with a low (L) or high dose (H) of bacterial lipopolysaccharides (LPS) in control dairy cows 
or cows that showed beta-hydroxybutyrate levels higher than 1.4 mmol/L in the first month of 
lactation. Values are expressed as fold change with respect to baseline 
Item D2 Hs1 
Days from calving 
SE3 Effect 
P-
Value 
-48 -21 -3 7 28 
Nitric oxide 
L 
CTR 1.03 1.03 1.05 1.00 0.97 0.06 Hs1 0.30 
KET 0.99 0.98 1.05 1.07 1.00 0.06 t4 0.76 
H 
CTR 1.21 1.09 1.06 1.07 1.09 0.06 D2 0.11 
KET 0.96 1.03 1.09 1.09 1.03 0.06 Hs*t5 0.35 
Tot 
CTR 1.12 1.06 1.06 1.03 1.03 0.04 Hs*t*D6 0.96 
KET 0.98 1.00 1.07 1.08 1.02 0.04   
Nitrite 
L 
CTR 0.97 1.02 1.18 0.99 0.99 0.07 Hs1 0.13 
KET 0.90 1.20 1.16 0.98 1.10 0.07 t4 <0.01 
H 
CTR 0.98 1.03 1.14 1.01 0.93 0.07 D2 0.79 
KET 0.94 1.12 1.26 0.98 1.16 0.07 Hs*t5 0.11 
Tot 
CTR 0.98 1.03 1.16 1.00 0.96 0.05 Hs*t*D6 0.96 
KET 0.92 1.16 1.21 0.98 1.13 0.05   
Nitrate 
L 
CTR 1.04 1.04 1.03 1.00 0.96 0.08 Hs1 0.13 
KET 1.02 0.91 1.03 1.10 0.97 0.09 t4 0.74 
H 
CTR 1.40 1.12 1.05 1.09 1.16 0.08 D2 0.11 
KET 0.93 1.06 1.05 1.14 0.99 0.09 Hs*t5 0.27 
Tot 
CTR 1.22 1.08 1.04 1.04 1.06 0.06 Hs*t*D6 0.74 
KET 0.98 0.99 1.04 1.12 0.98 0.06   
1Health status (CTR is control and KET is ketosis). 
2Dose (L is low, and H is high). 
3Standard error.  
4Time. 
5Health status x time interaction.  
6Health status x time x dose interaction. 
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Supplementary file 2. Pattern of plasmatic concentration of packed cell volume (PCV; a), 
calcium (b), magnesium (c), protein (d), globulin (e), albumin (f), cholesterol (g), ferric 
reducing antioxidant power (h), oxygen reactive antioxidant capacity (i), tocopherol (j), beta-
carotene (k) and nitrite (l) in control dairy cows (CTR, solid line) or cows that showed beta 
hydroxybutyrate levels higher than 1.4 mmol/L during the transition period (KET; dotted 
line). ** is P < 0.01; * is P < 0.05; + is P < 0.1; DFC is days from calving; Hs is health status 
effect; t is time effect; Hs*t is health status x time interaction effect.  
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CHAPTER IV - METABOLIC EFFECTS OF AN IMMUNE STIMULANT IN 
TRANSITION COWS 
Administration of an immune stimulant during the transition period improved energy 
metabolism and rumination without affecting inflammatory conditions  
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ABSTRACT 
Omnigen-AF (OAF) is effective in increasing leukocytes functions in immunosuppressed 
animals and reduces incidence of infectious diseases in early lactating dairy cows. Its mode of 
action has never been elucidated, and a wider perspective of its metabolic effect could 
highlight its effectiveness in facing metabolic disorders of transition period also. Thus, a 
group of 10 Holstein dairy cows were housed in tied stalls and divided into 2 groups: treated 
group (TRT; 5 cows) received 32.5 g of Omnigen-AF® (Phibro Animal Health Corporation) 
twice a day (65 g d-1) as top-dress on the morning and afternoon feeds, while control group 
(CTR; 5 cows) did not receive any supplementation. From -62 to 42 days from calving BCS, 
BW, DMI, rumination time and milk yield were measured, and blood samples were collected 
regularly to assess a wide hematochemical profile and to test white blood cell functions by ex-
vivo challenge assays. Data were submitted to ANOVA using a mixed model for repeated 
measures including treatment, time and their interaction as fixed effects. 
Administration of OAF at dry-off did not affect BW, BCS, milk yield, milk and rumen 
fluid composition, and neither affected blood neutrophils concentrations. Nevertheless, it 
increased rumination time and improved the energy metabolism after calving (lower NEFA 
and BHB concentrations). TRT cows had an increased lymphocytes abundance at blood level, 
and their leukocytes had greater efficiency in facing biological stressors during the peripartum 
(lower lactate production and lower glucose consumption after an LPS challenge). Despite 
these positive effects on immune cells, OAF did not affect the positive acute phase proteins 
concentrations after calving. A reduced abundance of albumin, PON and antioxidants also 
occurred with OAF after calving, suggesting some impairment of hepatic functions to occur. 
Nevertheless, the lack of any effect on main biomarkers related to liver function (bilirubin) 
and liver damage (GGT, AST-GOT, ALP) dismisses a real impairment of liver activities to 
occur with OAF. Positive effects in favoring the recovery of rumen functions, reducing 
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mobilization of body fats after calving suggest OAF to be an effective strategy in preventing 
metabolic disorders of transition period. 
Key Words. Immune stimulant, metabolic disorders, transition period, immune 
dysfunctions. 
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INTRODUCTION 
The immune system eliminates sources of tissue injury, restores immune homeostasis and 
returns tissues to their normal function (Sordillo, 2016). Inflammatory process is the main 
defense until lymphocytes develop antibodies against antigens (Janeway et al., 2005). During 
inflammation, bacterial invasions in peripheral tissues stimulates the production of pro-
inflammatory cytokines (PICs) and chemokines. Interleukin-8 (IL-8) enters the blood flow 
interacting with a surface protein of neutrophilic polymorphonuclear cells (PMN) named L-
selectin, that allows their slow rolling along the interior vessel walls (Paape et al., 2002). 
Thus,  adhesion molecules and reactive oxygen metabolites (ROM) are produced by PMN, 
promoting their migration to peripheral tissues and enhancing their respiratory burst activity 
against bacteria (Paape et al., 2003; Forsberg, 2004).  
In PMNs of dairy cows, functions related to ROM production, myeloperoxidase activity, 
chemotaxis and phagocytosis (Cai et al., 1994; Kimura et al., 1999; Mehrzad et al., 2001) are 
impaired  from 2-4 weeks prior through approximately 2 weeks after parturition (Sordillo and 
Streicher, 2002; Nace et al., 2014; Jahan et al., 2015). Consequently, cows become 
hyposensitive to antigens, and the incidence of infectious diseases increases (Shuster et al., 
1996; Mallard et al., 1998). On the other hand, immune system became unable in solving 
inflammations (Trevisi et al., 2015; Putman et al., 2018) triggering chronic phenomena 
(Bionaz et al., 2007; Trevisi et al., 2012; Jahan et al., 2015), while oxidant species produced 
by active leukocytes deplete antioxidant defenses, triggering an oxidative stress (Celi, 2011; 
Sordillo, 2016). Those conditions concur in boosting the development of metabolic disorders 
in transition period (Curtis et al., 1985; Suriyasathaporn et al., 1999). 
The immune stimulant Omnigen-AF (OAF) improves PMNs functions in 
immunosuppressed animals (Wang et al., 2007) altering mRNA transcripts and protein 
expression related to innate immune system (Wang et al., 2009; Ryman et al., 2013). Its mode 
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of action has not been fully elucidated, but an interaction of yeasts and fungal cells walls (as 
Saccharomyces cerevisiae and Trichoderma longibrachiatum) composing OAF with intestinal 
M-cells mediating the response of lymphoid tissue (Ohno, 2016) could be hypothesized. After 
its administration in transition dairy cows, OAF down-regulated the expression of genes 
responsible for leukocytes death (e.g., glucocorticoids modulatory element binding protein-1), 
inhibiting apoptosis and increasing the circulating leukocytes. mRNA encoding for cytokines 
(such as receptor alpha for interleukin-4 and myeloid differentiation primary response gene 
88) were up-regulated, improving sensitivity of PMN to extracellular signaling and cell-to-
cell communication. OAF also enhanced PMN diapedesis through the up-regulation of 
mRNA encoding for L-selectin (Wang et al., 2004), and augmented phagocytosis and 
respiratory burst through the improvement of oxidative phosphorylation pathway involved in 
ROM production (Revelo et al., 2013; Ryman et al., 2013; Nace et al., 2014). Improved PMN 
functions account for the reduced incidence of mastitis found with OAF (Nace et al., 2014), 
suggesting its use as a potential strategy to reduce infectious diseases in transition period. 
However, none of previous studies investigated the effect of OAF on the adverse metabolic 
conditions of transition period, although elucidate such an effect is crucial to assess its 
effectiveness in preventing metabolic disorders. Thus, the objective of our study was to assess 
the effect of supplementing OAF from dry-off to early lactation on metabolism, 
inflammatory-like conditions, oxidative and immune status in dairy cows. Our hypothesis was 
that metabolic asset around calving could be improved by the additive, mitigating 
inflammatory-like status and oxidative stress of treated animals. 
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MATERIALS AND METHODS 
Experimental design and animal management 
The trial was carried out at Università Cattolica del Sacro Cuore research dairy barn 
(Experiment Station, San Bonico, Piacenza, Italy) in accordance with Italian laws on animal 
experimentation (DL n. 26, 04/03/2014) and ethics (Authorization of Italian Health Ministry 
N 1047/2015-PR). A group of 10 Italian Holsteins dairy cows were housed in individual tied 
stalls under controlled environmental conditions (room temperature of 20 °C, relative 
humidity of 65%, 14 hours of light) from -62 to 42 days from calving (DFC). At -55 DFC 
cows were dried off with a deep milking and a treatment with a mammary antibiotic 
(Mamyzin A; Haupt Pharma Latina S.r.l., Borgo San Michele – Latina, Italy). Before dry-off 
and after calving, cows were milked twice a day at the stand, at 4:00 am and pm. All the cows 
were individually fed a component diet offered with two equal meals of forages at 12 h 
intervals and 2-8 meals of concentrates supplied by computer feeder. Before dry-off, animals 
received a lactating ration with soybean meal, alfalfa dehydrated hay and corn silage (Phase 
1). After dry-off, animals received only hay till -48 DFC. From -47 DFC till -7 DFC animals 
received a hay-based ration with soybean meal and corn silage (Phase 2). Seven days before 
the expected day of calving, 1 kg of lactation concentrate was gradually added to the diet 
(Phase 3). After calving, 3 kg of alfalfa-dehydrated hay and 2 kg week-1 of corn silage (till a 
maximum of 20 kg d-1) were added to the diet. Grass hay was gradually reduced to 2-2.5 kg d-
1 and concentrate was increased by 0.5 kg d-1 to satisfy the requirement of 1 kg per 3 kg of 
produced milk (Phases 4 and 5). The same batches of hay and corn silage were used during 
the trial. Feeds were collected fortnightly and, after dry matter determination, samples were 
pooled for subsequent analyses. Feeds and diet composition are shown in Table 1. 
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At dry-off, cows were enrolled in 2 homogeneous group. Treated group (TRT; 5 cows) 
received 32.5 g of Omnigen-AF® (Phibro Animal Health Corporation) twice a day (65 g d-1) 
as top-dress on the morning and afternoon feeds, while control group (CTR; 5 cows) did not 
received any supplementation. The amount of immune stimulant was determined on the 
average body weight (BW) of the animals at dry-off, to ensure the daily assumption of 9 g of 
product each 100 kg of BW. Between -62 and 42 DFC periodical checks were performed and 
blood samples were collected regularly, according to the time schedule shown in Figure 1 and 
described in the following sections.   
Body weight, body condition score, dry matter intake, rumination time and milk yield 
The body weight (BW) was measured with a single walking-in scale. The body condition 
score (BCS) was determined from the same operator with a 1 to 4 scale (Agricultural 
Development and Advisory Service, 1986) and his variation (∆BCS) was calculated as the 
difference between data at calving day and 28 DFC. The individual DMI was measured by 
weighing the amounts of feed administered and residuals for each distribution. Rumination 
time was registered using the Ruminact system (SCR Europe, Podenzano, PC, Italy). Milk 
yield was weighed after each milking. Daily values of DMI, rumination time and milk yield 
were expressed as average weekly value. 
Health status 
Health conditions of cows were monitored daily and all veterinary interventions that 
occurred from -62 to 42 DFC were recorded. The body temperature was measured daily with 
a rumen bolus (DVM System TempTrackTM, HerdStrong, LLC, Greeley, CO). Mastitis was 
diagnosed by visual evaluation of abnormal milk from each quarter and SCC analysis on 
suspicious cases, retained placenta when the fetal membranes were not expelled within 24 h 
after calving, endometritis and metritis according to Sheldon et al. (2006), and milk fever, 
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displacement of abomasum and pneumonia by inspection of a veterinary practitioner. 
Diarrhea was diagnosed by visual evaluation of feces consistency and color according to the 
fecal score method (Ireland-Perry and Stallings, 1993), assuming diarrheic feces those have a 
fecal score ≤ 2. 
Blood samples collection  
Blood samples were harvested trough jugular venipuncture in evacuated collection tubes 
(BD Vacutainer; BD and Co., Franklin Lakes, NJ) before the morning feeding. Samples were 
used to perform different assays (Figure 1). 
Metabolic profile assessment. Samples were collected into heparinized tubes and 
processed as described by Calamari et al. (2016). A clinical auto-analyzer (ILAB-650, 
Instrumentation Laboratory, Lexington MA, USA) was used to determine the concentration of 
glucose, NEFA, BHB, urea, creatinine, Ca, P, Mg, Na, K, Cl, Zn, aspartate amino transferase-
glutamate oxaloacetate transaminase (AST-GOT), gamma glutamyl transferase (GGT), 
alkaline phosphatase (ALP), total protein, haptoglobin, ceruloplasmin, albumin, total 
bilirubin, cholesterol and globulin in accordance with Calamari et al. (2016). Furthermore, 
ROM, ferric reducing antioxidant power (FRAP), nitrate (NO3), nitrite (NO2) and nitric 
oxides (NOx) were determined according to Jacometo et al. (2015), PON according to Bionaz 
et al. (2007), thiol groups (SHp) according to Minuti et al., (2014), myeloperoxidase 
according to Bradley et al. (1982) and advanced oxidation protein products (AOPP) 
according to Hanasand et al. (2012). Finally, L-lactic acid (LLA) and D-lactic acid (DLA) 
were determined with a commercial kit (K-DLATE, Megazyme Co., Wicklow, Ireland). A 
multi-detection microplate reader (BioTek Synergy 2, Winooski, VT, USA) and commercial 
kits for ELISA method were used to determine the concentration of interleukin-1, beta (IL-
1B; ESS0029; Thermo Scientific, Frederick, MD, USA) and interleukin-6 (IL-6; ESS0027; 
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Thermo Scientific, Frederick, MD, USA) according to Jahan et al. (2015) and those of serum 
amyloid alpha (SAA; TP-802, Tridelta D.L., Ireland). Furthermore oxygen reactive 
antioxidant capacity (ORAC) was determined with a fluorimetric method according to 
Jacometo et al. (2015). Retinol, tocopherol and beta-carotene were analyzed by reverse-phase 
HPLC (LC-4000, Jasco Europe, Carpi MO, Italy), as described by Jahan et al. (2015).  
White blood cells profile. Samples were collected in K-EDTA tubes and analyzed with 
Cell-DYN 3700 (Abbott Diagnostic Division, Santa Clara, CA). A laser optic assay was used 
to determine the amounts of total leukocytes, neutrophils, lymphocytes, monocytes, 
eosinophils and basophils. The neutrophils to lymphocytes ratio was calculated. The amount 
of red blood cells, hematocrit, mean cell volume, red cell distribution width, number of 
platelets and mean platelet volume were determined via electrical impedance assay. The 
amount of hemoglobin, mean cell hemoglobin and mean cell hemoglobin concentration where 
determined using spectrophotometry assay. 
Whole blood stimulation assay. Samples were collected in heparinized serum tubes and 
stimulated with 0 (baseline), 0.01 (low dose; L) and 5 µg/mL (high dose; H) of bacterial 
lipopolysaccharides (LPS, Escherichia coli O111:B4; Sigma–Aldrich Company Ltd., UK, 
Cat. No. L3012), according to Jahan et al. (2015).  After whole blood stimulation assay 
(WBA), plasma samples were stored at −80 ºC for the measurement of glucose, DLA, LLA, 
IL-1B, IL-6, NOx, NO2 and NO3. Variation of plasma parameters after WBA with L and H 
doses of LPS were expressed as fold change relative to the baseline. 
Interferon gamma release assay. For the interferon gamma (IFNG) release assay, whole 
blood samples were also collected into heparinized tubes (Figure 1). After collection, the 
tubes were stored in vertical position in a warm bath at a temperature of 38 ºC and transported 
to the laboratory within 20 min for the stimulation procedure. Whole blood was used in an 
IFNG release assay for Mycobacterium avium (internal method IZSLER, MP 13/011). 
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Briefly, two 1-ml aliquots of each blood sample were distributed in a 24-well tissue culture 
microtiter plate. One well was supplemented with 100 µl of a 1:10 dilution of Mycobacterium 
avium purified protein derivative (PPD, IZS Umbria e Marche, Perugia, Italy, 0.5 mg/mL) to 
PBS, and 1 well with 100 µl of sterile PBS as control. The plate was positioned in a heated 
incubator (Grant Boekel, HIR10 M) set to a temperature of 38 ºC and with a relative humidity 
of 95% for 24 h.  After incubation, the blood was centrifuged at 8500 × g for 16 min at 4 ºC 
and plasma was stored at -20 °C until use. Plasma was later thawed and analyzed in a 
sandwich ELISA assay for bovine IFNG with a couple of monoclonal antibodies, as 
previously described (Trevisi et al., 2014). Results were evaluated in terms of optical density 
difference (∆OD) between avian PPD-stimulated and control wells. 
Milk samples collection and analysis 
Milk samples were collected during the morning milking (Figure 1) into 100-ml 
polypropylene bottles. Butterfat, protein, lactose, casein contents, titratable acidity and 
coagulation properties [rennet clotting time (r) and curd firmness at 30 min (a30)] were 
measured by using infrared instrumentation (MilkoScan FT 120, Foss Electric, Hillerød, 
Denmark) according to Calamari et al. (2010) and Chessa et al. (2014). Furthermore, the 
outputs of fat and protein, and the fat to protein ratio were also calculated. Urea nitrogen was 
determined on skimmed milk by a spectrophotometric assay, using a urea nitrogen kit (cat# 
0018255440, Instrumentation laboratory, Milano, Italy) in association with a clinical auto-
analyzer (ILAB-650, Instrumentation Laboratory, Lexington MA, USA). Somatic cell count 
(SCC) were determined using an optical fluorimetric method with an automated cell counter 
(Fossomatic 180, Foss Electric). 
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Carrageenan skin test 
The carrageenan skin test (CST) was performed as specified by Jahan et al. (2015) to 
evaluate  peripheral immune responses (Figure 1). The skin thickness was measured using a 
skinfold caliper (cat# 470119-588, VWR, USA) immediately before carrageenan injection 
(day 0), then at 2 and 9 days after the injection. The total response of each challenge was 
calculated as the area under the curve of the thickness, measured at day 2 and day 9, 
subtracting the thickness measured at day 0. 
Rumen fluid parameters 
Rumen samples were collected with an orogastric probe (Ruminator, Proofs Products, 
Guelph, Canada) prior to the morning feed administration (Figure 1). The pH was 
immediately measured (GLP 21, Crison Instrument SA, Alella, Barcellona, ESP). A 2-mL 
aliquot of the supernatant was transferred into tubes with 1 mL of 0.12 M oxalic acid and 
immediately frozen at –20°C for later analysis. Total volatile fatty acids (VFA) concentration, 
molar proportion of acetic, propionic, butyric, iso-butyric, valeric, iso-valeric, caproic, iso-
caproic and enanthic acids were analyzed as previously described (Minuti et al. 2014). VFA 
were expressed as relative amounts on total VFA concentration. A spectrophotometric clinical 
auto-analyzer (ILAB-650, Instrumentation Laboratory, Lexington MA, USA) and commercial 
kits for urea nitrogen (cat# 0018255440, Instrumentation laboratory, Milano, Italy) and lactate 
(K-DLATE, Megazyme Co., Wicklow, Ireland) were used to assess the concentration of 
ammonia and those of LLA, DLA and total lactic acid respectively. 
Statistical analysis  
Data in the tables are presented as means and standard errors. Before analysis, the 
normality of distributions was verified for each parameter by reckoning skewness and kurtosis 
according to the Shapiro test of SAS. Non-normally distributed parameters were normalized 
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through natural logarithms (among plasma parameters IL-1B, IL-6, LLA, GGT, bilirubin, 
beta-carotene, NOx, NO2 and NO3; among white blood cells profile eosinophils; among 
WBA the fold change of IL-1B, IL-6, glucose, DLA, LLA, NO2, NO3 and NOx; the total 
response to CST; among milk quality parameters fat, fat output, fat/protein ratio, r and SCC) 
or square root transformation (among plasma parameters the BHB) and back transformed to 
plot them in the graphs and tables. 
Prevalence of health problems recorded during the study was evaluated by χ2 analysis 
(Freq procedure, SAS Inst. Inc., Cary, NC). Data of DMI, BW, BCS, rumination time, milk 
yield, plasma parameters, white blood cells profile, WBA, milk quality parameters, response 
to IFNG release assay and CST were submitted to ANOVA using a mixed model for repeated 
measures (Mixed procedure, SAS Inst. Inc., Cary, NC) in accordance with Littell et al. 
(1998). The statistical model included the fixed effect of treatment (T; CTR and TRT), time 
(t), and their interaction (T*t). For those parameters that were measured daily (DMI, 
rumination time and milk yield) time effect considered the average weekly value, while for 
other parameters (BW, BCS, plasma parameters, white blood cells profile, WBA, milk quality 
parameters, IFNG release assay and CST) it considered single DFC. The time was considered 
as a repeated measure within cow. For WBA, also the dose (D; L and H) and the full 
interaction effect (T*t*D) were considered. The analysis was carried out using three 
covariance structures: autoregressive order, compound symmetry, and spatial power. These 
were ranked according to their Akaike information criterion, with the one having the lowest 
Akaike information criterion being eventually chosen (Littell et al., 1998). The pair-wise 
comparison was done using the least significant difference test. Parameters that showed a 
significant T*t interaction effect before treatment administration were covariate using data 
collected at -62 DFC (among plasma parameters glucose, IL-1B, IL-6, cholesterol, retinol and 
tocopherol) as baseline. 
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Data of rumen fluid parameters were analyzed by a one-way ANOVA (GLM procedure, 
SAS Inst. Inc., Cary, NC), considering only the fixed effect of T.  
Post-hoc comparisons between treatments are discussed when the P-value for main effect 
was ≤ 0.05. Main effects at P ≤ 0.10 are discussed in the context of tendencies. Differences 
between treatments at single time points are discussed at P ≤ 0.10 for the main interaction 
effect. Relevant trends not supported from statistical differences are discussed as numerical.  
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RESULTS 
Body weight, body condition score, dry matter intake, rumination time and milk yield 
The DMI (Figure 2.a) tended to be lower in TRT than CTR group at 5 weeks from calving 
(P < 0.1). Rumination time (Figure 2.b) resulted higher in TRT than CTR group at 3 and 6 
weeks from calving (P < 0.05) and tended to be higher at 7 weeks from calving (P < 0.1). 
Body weight, BCS, (Supplementary file 1), and milk yield (Figure 2.c) were not affected by 
the treatment.  
Health status 
The χ2 analysis on the occurrence of clinical diseases (Supplementary file 2) did not found 
any treatment effect, but the total incidence of diseases resulted lower and the number of cows 
without any clinical disease resulted greater in TRT than CTR group (P < 0.01). 
Milk quality and rumen fluid parameters 
Among milk quality and rheological parameters (Table 2), lactose tended to be higher in 
TRT than CTR group at 7 DFC (P < 0.1). Other milk parameters were not affected by the 
treatment, and neither rumen fluid parameters (Table 3). 
Metabolic profile 
Packed cell volume, energy, protein and mineral metabolism biomarkers. Packed cell 
volume (Figure 3.a) tended to be lower in TRT than CTR group (T = 0.07). Among energy 
metabolism biomarkers, TRT cows had tended to have lower concentration of NEFA (T = 
0.06; Figure 3.b) and lower concentration of BHB (Figure 3.c) at 14 DFC (P < 0.01 for BHB) 
in comparison to CTR. Furthermore, LLA (Figure 3.d) tended to be lower in TRT than CTR 
group at -21 and 42 DFC (P < 0.1). Glucose (Supplementary file 3.a) and DLA concentrations 
166 
 
(Supplementary file 3.b) were not affected by the treatment. Among protein metabolism 
biomarkers, creatinine concentration (Figure 3.e) was lower in TRT than CTR group (T < 
0.01) with differences between -28 and -3 DFC and from 7 DFC up to the end of the 
experimental period (P < 0.05). No effect was detected on urea concentration (Supplementary 
file 3.c). Among mineral metabolism biomarkers, Zn concentration (Figure 3.f) was higher in 
TRT than CTR group at -53 DFC (P < 0.01) and tended to be higher at -21 and 42 DFC (P < 
0.1). No effect was detected on the concentration of other minerals (Supplementary files 3.d-
i). 
Liver function and inflammation biomarkers. No effect was detected on liver enzyme 
biomarkers (Supplementary files 4.a-d). Among inflammation biomarkers, cows treated with 
OAF had lower myeloperoxidase concentration (Figure 3.g) at -21 and -14 DFC (P < 0.05) 
while globulin (Supplementary file 5.a) and total proteins (Supplementary file 5.b) were not 
affected. None of the positive APP were affected by OAF (Supplementary files 5.e-f). Among 
negative APP, albumin concentration (Figure 3.h) was lower in TRT than CTR group at -3 
and 3 DFC (P < 0.05) and tended to be lower at 14 and 28 DFC (P < 0.1). Cholesterol 
concentration (Figure 4.a) tended to be higher in TRT than CTR group at -53 DFC (P < 0.1). 
PON concentration (Figure 4.b) was numerically lower in TRT than CTR group during the 
entire experimental period. Retinol (Supplementary file 4.h) as well as IL-1B (Figure 4.c) and 
IL-6 (Figure 4.d) were not affected by OAF.  
Oxidative stress biomarkers. Among antioxidant capacity indicators, compared to CTR, 
TRT had lower concentration of SHp (Figure 4.e) from -3 to 28 DFC (P < 0.05) and lower 
concentration of FRAP (Figure 4.f) at 3 DFC (P < 0.01). No effect was detected for 
tocopherol, beta-carotene, and ORAC concentration (Supplementary files 5.c-e). Among 
oxidant species, ROM (Figure 4.g) tended to be lower in TRT than CTR group at -28 DFC (P 
< 0.1), while nitric oxygen species were not affected (Supplementary files 5.f-h). AOPP 
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(Figure 4.h) resulted lower in TRT than CTR group (T = 0.02) at -48, -3, 1 and 3 DFC (P < 
0.05).  
White blood cells profile 
Among white blood cells profile (Table 4), the number of lymphocytes resulted 
numerically higher in TRT than CTR group during the whole experimental period. Mean cell 
volume and mean cell hemoglobin tended to be lower in TRT than CTR group (T = 0.08). 
The number of platelet tended to be higher, and the mean platelet volume was lower in TRT 
than CTR group (T = 0.07 and = 0.01 respectively). In TRT cows, mean platelet volume was 
lower at -48 and -1 (P < 0.05) and tended to be lower at 7 DFC (P < 0.1) in comparison to 
CTR. No differences appeared on total leukocytes, neutrophils, neutrophil to lymphocytes 
ratio, eosinophils, red blood cells, hemoglobin, mean cell hemoglobin concentration and red 
blood cell distribution width (data not shown). 
Whole blood stimulation assay, interferon gamma release assay and carrageenan skin test 
OAF treatment did not affect the cytokines response in WBA (Table 5). Fold change of 
glucose tended to be higher in TRT than CTR group at -21 DFC (P < 0.1) and was higher at 7 
DFC (P < 0.01).  Fold change of DLA tended to be lower (P < 0.1) and those of LLA was 
lower (P < 0.05) in TRT than CTR group at 28 DFC (Table 6). The response to LPS 
stimulation of nitric oxygen metabolites (Table 7), the response to IFNG release assay (Figure 
5.a) and the total response to CST (Figure 5.b) were not affected by OAF treatment. 
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DISCUSSION 
Administration of OAF did not affect BW, BCS and milk yield in our experiment, 
confirming previous results (Wang et al., 2007; Ryman et al., 2013). Furthermore, the lack of 
any differences on milk composition suggests OAF to have no direct effects on metabolic 
parameters under homeostasis condition. The use of OAF has been suggested as a strategy to 
reduce the susceptibility to infectious diseases at the beginning of lactation in dairy cows 
(Wang et al., 2007), as decreased incidences of new cases of mastitis has been reported after 
its administration (Nace et al., 2014). The investigation of such an effect was beyond the aim 
of our study, as the small size of our experimental groups did not allow us to speculate on the 
lower number of total diseases and higher number of healthy cows founded in TRT group. 
Nevertheless, the occurrence of ketosis in three out five of our CTR cows, together with the 
lower NEFA and BHB concentration and with the higher rumination time founded in TRT 
animals after calving, suggest OAF to have improved the capacity of the animals to overcome 
the severe digestive and metabolic challenges that are widely reported during TP (Trevisi et 
al., 2011a; Van Knegsel et al., 2014). Two possible mode of action of OAF could account for 
such effects: 1) OAF could exert a direct effect on energy metabolism, reducing 
lipomobilization and hepatic ketogenesis, and the higher rumination time founded in TRT 
animals could thus arise from the reduced incidence of ketosis in comparison to CTR, or 2) 
yeasts and fungal cells walls composing OAF could have a modulatory effect on rumen 
fermentations, improving the recovery of rumen motility after parturition and reducing the 
negative energy balance degree in early lactation, and thus ameliorated energy metabolism 
founded in TRT cows could be consequential to their more efficient utilization of feedstuffs 
(Soriani et al., 2012; Calamari et al., 2014). A clear statement on which is the driving 
mechanism is not possible, as none reported a direct effect of OAF on lipolysis and energy 
metabolism, while the collection time of our rumen samples makes it difficult to elucidate the 
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effect of the additive on rumen fermentations after sudden alterations related to calving. In 
fact, our samples were collected before morning feeding at 28 DFC, way after the occurrence 
of alterations related to calving and when fermentation patterns where at their nadir. Thus, the 
lack of any increase in VFA production with OAF does not dismiss its role in modulating 
rumen fermentations, as such higher production could have been balanced by a higher 
absorption. Whatever the driving mechanism could be, the improved feeding behavior and 
energy metabolism in early lactation could account for the effectiveness of OAF in favoring 
the recovery of normal body functions after stressing events (Nace et al., 2014), suggesting it 
to be effective in the prevention of metabolic disorders of TP, and could also account for an 
improvement of leukocytes functions with OAF. In fact, ameliorated rumen functions and 
decreased incidence of metabolic disorders could account for the effectiveness of OAF in 
reducing blood cortisol concentrations after calving reported by Hall et al. (2014), and this 
could explain the effect reported by Rowson et al. (2011) in augmenting the expression of L-
selectin and improving diapedesis of PMN. In fact, cortisol level is dependent on the 
occurrence of stressing events, and its raise is known to shade the L-selectin from the surface 
of PMN, impairing their diapedesis (Burton et al., 1995). Furthermore, a positive effect on 
leukocytes functions could also arise from the reduced mobilization of body fats occurring 
with OAF. In fact, both NEFA and BHB are known to impair the viability of white blood 
cells (Stevens et al., 2011; Calder, 2013; Sordillo, 2016) and their reduction could explain the 
lower lactate production and the higher glucose concentration found in blood of TRT cows 
after the stimulation of leukocytes with LPS. In fact, production of lactate by neutrophils and 
monocytes is known to impair motility, killing capacity and effector functions of leukocytes, 
to suppress the inflammasome and the production of PICs (Sordillo, 2016; Zhang et al., 
2016). Thus, a lower production of this metabolite in activated leukocytes could reflect their 
greater immune competence. On the other hand, the lower glucose consumption after the 
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stimulation with LPS could be driven from a more efficient metabolism of leukocytes while 
they cope with a biological stressor, reflecting an improved killing capacity of those cells. 
This is also consistent with the previously reported effectiveness of OAF in improving 
phagocytosis, ROM production and respiratory burst activity of PMN (Wang et al., 2009). 
Furthermore, the numerically higher lymphocytes number founded in blood of TRT animals 
during the entire experimental period is consistent with previous results (Wang et al., 2007), 
and also suggests an effect of the product on the migration of lymphocytes from lymphoid 
tissue to blood . 
State these positive effects on lipomobilization and white blood cells functions, an 
improvement of liver function and a faster resolution of inflammatory phenomena, reflected 
from typical trends of plasma parameters (Castell et al., 1989), were expected with OAF at 
metabolic level. Nevertheless, the concentration of IL-1B and IL-6 were not affected by the 
treatment, even though the augmented expression of genes triggered from toll like receptors in 
PMNs has been widely reported as main effect of OAF (Nace et al., 2014). Furthermore, OAF 
did not affect the concentrations of α-globulins (haptoglobin, ceruloplasmin and SAA), named 
positive acute phase proteins (APP) as their hepatic synthesis increase during inflammation 
(Ceciliani et al., 2012). Less clear is the effect of OAF on albumin, PON and lipoproteins 
concentrations. These parameters are named negative APP, as they decrease during 
inflammation due to the shift of liver synthesis on positive APP (Bertoni et al., 2008). TRT 
animals had higher concentration of cholesterol during dry period, reflecting a greater hepatic 
synthesis of lipoproteins (Gruys et al., 2005) and a better liver shape prior to calving. The 
lower myeloperoxidase, ROMt and AOPP concentration reflects also a less marked leukocyte 
activation in the peripheral blood to occur in TRT animals during dry period. In fact, 
myeloperoxydase generates hypoclorous acid that is converted into ROM within the 
respiratory burst (Faith et al., 2008; Celi, 2011) while AOPP are markers of protein oxidation 
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triggered by this metabolite (Celi and Gabai, 2015). Furthermore, the lower LLA found in 
TRT animals during the same phase could reflect a less marked body effort to suppress the 
inflammasome restoring normal tissue functions (Sordillo, 2016; Zhang et al., 2016). These 
results suggest that greater cholesterol concentrations found in TRT animals before calving 
could depend on a lower activation of defense systems. Such an anti-oxinflammatory effect 
exerted by OAF before calving could arise from a better stabilization of PMN and monocytes, 
that need a stronger stimulus for mounting an inflammatory reaction in TRT animals. On the 
other hand, TRT animals had lower levels of PON and albumin in early lactation in 
comparison to CTR, indicating a greater impairment of liver function to occur with calving, 
and thus a reduction of positive effect of OAF in stabilize leukocytes ameliorating 
inflammatory status. Nevertheless, trends of cytokines and positive APP dismiss 
inflammation as the main cause of post-partal reduction of negative APP in TRT animals, and 
the higher zinc concentration they had during the whole experimental period suggest no acute 
manifestation to occur neither before calving. In fact this mineral is sequestered by the liver 
during inflammatory processes (Bertoni and Trevisi, 2013), and a reduction of its blood 
concentration should be evident whenever an inflammation occurs. Despite that, the above 
trends of positive APP clearly suggest an impairment of some liver activities to occur in TRT 
animals after calving, and this is further reflected from their lower post partal availability of 
antioxidant systems (SHp and FRAP), as antioxidant capacity directly depends on liver 
activity (Sordillo and Aitken, 2009; Celi, 2011). In fact, blood SHp mainly reflects albumin, 
lipoic acid, glutathione and cysteine concentration, while FRAP provides a measurement of 
antioxidant power provided by blood concentration of bilirubin, uric-acid, proteins and 
vitamins C and E (Benzie and Strain, 1996). A dysregulation of liver functions involved in 
controlling blood concentrations of such compounds could account for post partal trends of 
negative APP and antioxidant systems with OAF, despite the lack of any effect on the 
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concentration of bilirubin or enzymes related to amino acids metabolism in liver (AST-GOT, 
GGT, ALP) dismiss any impairment of liver function to occur (Rodriguez-Jimenez et al., 
2018). Thus, we may hypothesize that the depletion of antioxidant systems observed with 
OAF could arise from a weak antioxidant activity of the product. In fact, antioxidant 
biosynthesis and release are regulated processes, as the administration of weak oxidants is 
known to up-regulate endogenous antioxidant mechanisms (Gesslbauer and Bochkov, 2017). 
Conversely, it could be hypothesized that weak antioxidant activity exerted by OAF could 
have reduced body requirements of endogenous antioxidant compounds, down-regulating 
their synthesis de-novo.  
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CONCLUSIONS 
Administration of OAF at dry-off did not affect BW, BCS, milk yield, milk and rumen 
fluid composition, and neither affected neutrophils diapedesis. Nevertheless, it seemed to 
ameliorate the recovery of rumen functions after calving, improving the rumination time, the 
energy metabolism and reducing ketogenesis. Such an improvement could justify the greater 
efficiency of leukocytes to face biological stressors during the peripartum, as suggested from 
their lower lactate production and lower glucose consumption after an LPS challenge. 
Furthermore, an increased lymphocytes abundance at blood level also occurred with OAF. 
Despite these positive effects on immune cells, OAF seem to be ineffective in reducing the 
degree of inflammation over calving. A reduced abundance of albumin, PON and antioxidants 
also occurred with OAF after calving, suggesting some impairment of hepatic functions to 
occur. Nevertheless, the lack of any effect on main biomarkers related to liver function 
(bilirubin) and liver damage (GGT, AST-GOT, ALP) dismisses a real impairment of liver 
activities to occur with OAF. This could suggest OAF to act as a weak antioxidant reducing 
body requirements for endogenous antioxidants synthesis. Despite no effect of OAF has been 
detected on liver function and inflammation, positive effects in favoring the recovery of 
rumen functions, reducing lipomobilization after calving suggest OAF to be an effective 
strategy in preventing metabolic disorders of transition period. A deeper investigation on 
rumen fluid composition, collecting rumen samples immediately after calving and when 
rumen fermentations reach their peak, is required to elucidate its effect at rumen level, 
understanding its real mode of action in ameliorating energy metabolism and antioxidants 
biosynthesis in early lactation. 
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TABLES AND FIGURES 
Table 1. Composition and characteristics of the experimental diets fed to cow during the 5 
experimental phases. Between -55 and -48 days from calving (DFC) cows received only grass 
hay 
1Supplements were composited to provide 150000 UI of vitamin A, 10000 IU of vitamin D, 
200 mg of vitamin E, 100 mg of vitamin K, 100 mg of vitamin H1 50 mg of vitamin B1, 0.5 
mg of vitamin B12, 500 mg of vitamin PP, 4000 mg of coline, 350 mg of Mn, 800 mg of Zn, 
40 mg of Cu, 20 mg of I, 1 mg of Co, 1 mg Se. 
2Estimated using NRC 2001. 
Diet, % DM Phase 1 Phase 2  Phase 3 Phase 4 Phase 5 
DFC -62; -55 -47; -7 -6; 0 0; 30 31; 42 
Item      
Corn silage 28.5 18.6 23.6 24.0 23.3 
Alfalfa hay 16.4 - - 13.7 11.1 
Grass hay 23.4 71.4 58.0 18.1 11.9 
Concentrate (Dry period) - 10.0 10.1 5 - 
Concentrate (Lactation period) 31.7 - 8.3 44.2 53.7 
Concentrate composition, % DM Dry period  Lactation period 
Corn flour -  40.0 
Barley flour -  1.4 
Sorghum grain expanded -  - 
Soybean meal 90.5  13.1 
Soybean dry rolled -  - 
Sunflower meal -  4.9 
Corn gluten feed -  - 
Beet pulp -  16.6 
Wheat bran -  9.8 
Beet molasse slops -  2.6 
Potato protein -  2.2 
Hydrogenated palm oil -  3.3 
Limestone -  1.39 
Dicalcium phosphate -  1.80 
Sodium bicarbonate -  0.98 
Magnesium oxide 2.2  0.64 
Sodium Chloride 1.4  0.32 
Supplement1 5.9  1.07 
Chemical composition      
NEL, Mcal*kg of DM
-1 1.59 1.45 1.53 1.60 1.63 
Crude protein, % DM 14.9 13.6 14.5 16.2 17.2 
Starch + sugar, % DM 23.7 16.8 19.3 26.0 18.3 
Ether extract, % DM 3.80 1.80 2.40 4.48 5.08 
NDF, % DM 39.4 49.3 45.5 35.7 32.6 
MP2, % CP 9.80 9.10 9.70 10.5 11.1 
RUP2, % DM 4.64 4.48 4.77 5.23 5.96 
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Table 2. Milk composition, rheological parameters and somatic cell count in control dairy 
cows or cows receiving 65 g*d-1 of Omnigen-AF® as top-dress between -55 and 42 days from 
calving 
Item,  
Unit 
T1 
Days from calving 
SE5 
P-Value 
7 14 28 42 T1 t2 T*t3 
Butterfat,  
mg 100 mL-1 
CTR 4.69 4.24 4.68 3.67 0.35 0.21 0.01 0.78 
TRT 4.33 4.14 3.82 3.36     
Fat output, 
kg 
CTR 0.38 0.41 0.65 0.48 0.07 0.17 0.02 0.65 
TRT 0.27 0.37 0.48 0.44     
Total protein,  
mg 100 mL-1 
CTR 3.84 3.30 3.07 3.09 0.10 0.49 <0.01 0.66 
TRT 3.81 3.34 3.25 3.19     
Protein output, 
kg 
CTR 1.21 1.18 1.33 1.36 0.06 0.61 <0.01 0.15 
TRT 1.15 1.18 1.38 1.50     
Fat/protein ratio, 
- 
CTR 1.22 1.28 1.54 1.19 0.12 0.11 0.11 0.64 
TRT 1.14 1.24 1.19 1.05     
Lactose, 
mg 100 mL-1 
CTR 4.79 5.25 5.06 5.17 0.07 0.73 <0.01 0.03 
TRT 4.96 
+ 
5.09 5.16 5.14  
  
 
Caseins, 
mg 100 mL-1 
CTR 2.84 2.50 2.28 2.33 0.08 0.42 <0.01 0.59 
TRT 2.85 2.51 2.45 2.40     
Titratable acidity, 
°SH 50 mL-1 
CTR 3.96 3.33 3.23 3.12 0.17 0.77 <0.01 0.93 
TRT 3.86 3.19 3.20 3.12     
Urea-N, 
mg dL-1 
CTR 31.2 34.7 26.8 31.2 3.11 0.64 0.08 0.66 
TRT 33.7 33.3 30.2 33.0     
Coagulation time 
(r), min 
CTR 12.3 20.0 14.0 14.5 2.03 0.77 <0.01 0.68 
TRT 11.5 16.2 14.8 16.1     
Curd firmness 
(a30), mm 
CTR 37.7 23.2 35.3 32.8 4.59 0.27 0.31 0.40 
TRT 43.4 33.6 35.6 34.7     
SCC4, 
n mL-1 
CTR 293.4 - 37.7 - 91.4 0.47 0.18 0.31 
TRT 72.4 - 54.9 -     
1Treatment (CTR is control; TRT is treated). 
2Time. 
3Treatment x time interaction (* is P < 0.05; + is P < 0.1). 
4Somatic cells count. 
5Standard error. 
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Table 3. Ruminal pH, ammonia concentrations and volatile fatty acids molar proportion, 
determined at 28 days after calving in control dairy cows or cows receiving 65 g*d-1 of 
Omnigen-AF® as top-dress between -55 and 42 days from calving 
Item Unit T1 
SE3 P-value 
CTR TRT 
pH - 6.78 6.54 0.10 0.14 
Ammonia mg L-1 4.65 4.47 0.10 0.96 
VFA total2 mmol L-1 103.8 109.0 0.59 0.61 
Acetic acid  mol 100 mol-1 66.2 67.0 6.83 0.89 
Propionic acid  mol 100 mol-1 21.8 25.4 4.24 0.38 
Butyric acid  mol 100 mol-1 11.4 12.3 2.69 0.50 
Isobutyric acid mol 100 mol-1 0.89 0.80 0.86 0.44 
Valeric acid mol 100 mol-1 1.26 1.42 0.08 0.47 
Isovaleric acid mol 100 mol-1 1.55 1.57 0.15 0.95 
Caproic acid mol 100 mol-1 0.55 0.46 0.14 0.59 
Enanthic acid mol 100 mol-1 0.04 0.03 0.11 0.36 
L-lactic acid mmol L-1 35.3 33.7 0.01 0.88 
D-lactic acid mmol L-1 34.8 33.7 6.81 0.91 
Total lactic acid mmol L-1 70.1 67.4 6.78 0.89 
1Treatment effect (CTR is control; TRT is treated). 
2Total volatile fatty acids. 
3Standard error.  
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Table 4. White blood cells profile in control dairy cows or cows receiving 65 g*d-1 of 
Omnigen-AF® as top-dress between -55 and 42 days from calving 
Item, 
Unit 
T1 
Days from calving SE2 P-value 
-62 -48 -21 -3 7 28 T1 t3 T*t4 
WBC5, 
K µL-1 
CTR 6.4 5.8 6.3 7.7 6.0 5.9 0.77 0.54 <0.01 0.59 
TRT 7.5 6.6 6.8 8.4 6.8 5.7 0.77    
Neu6, 
K µL-1 
CTR 3.3 3.0 3.2 4.7 3.6 3.2 0.61 0.52 <0.01 0.69 
TRT 4.0 3.3 3.5 5.1 3.9 3.0 0.61    
Lym7, 
K µL-1 
CTR 2.2 2.0 2.2 2.2 1.7 1.9 5.09 0.56 <0.01 0.04 
TRT 2.7 2.6 2.6 2.3 2.2 2.0 6.15    
HGB8, 
g dL-1 
CTR 10.8 11.4 10.6 11.0 10.7 9.8 0.40 0.20 <0.01 0.42 
TRT 10.0 10.5 10.0 10.2 10.4 9.4 0.40    
MCV9, 
fL  
CTR 48.3 48.6 48.6 51.0 49.6 48.7 1.4 0.08 <0.01 0.78 
TRT 45.8 45.5 45.9 47.5 47.6 46.8 1.4    
MCH10, 
pg 
CTR 16.5 16.9 16.9 17.2 17.1 16.9 0.47 0.08 0.06 0.69 
TRT 15.7 15.7 16.0 16.5 16.4 16.4 0.47    
PLT11, 
K µL-1 
CTR 323.8 273.6 280.0 305.8 313.8 420.4 38.2 0.07 0.02 0.84 
TRT 354.6 348.8 345.8 412.8 357.2 437.6 38.2    
MPV12, 
fL 
CTR 6.9 8.3 7.6 6.9 6.8 5.8 0.36 0.01 0.01 0.01 
TRT 6.1 5.7 
** 
6.3 
* 
6.5 5.9 
+ 
5.5 0.45 
  
 
1Treatment effect (CTR is control and TRT is treated). 
2Standard error. 
3Time effect. 
4Treatment x time interaction effect (+ is P < 0.1; * is P < 0.05; ** is P < 0.01). 
5White blood cells. 
6Neutrophils. 
7Lymphocytes. 
8Hemoglobin. 
9Mean cell volume. 
10Mean cell hemoglobin. 
11Platelets. 
12Mean platelet volume. 
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Table 5. Fold change values (expressed with respect to baseline) of interleukin-1, beta (IL-1) 
and interleukin-6 (IL-6) in a whole blood stimulation assay with a low or high dose of 
bacterial lipopolysaccharides in control dairy cows or cows receiving 65 g*d-1 of Omnigen-
AF® as top-dress between -55 and 42 days from calving 
Item D2 T1 
Days from calving 
SE3 Effect P-Value 
-62 -45 -21 -3 7 28 
IL-1 
L 
CT
R 
3.5 9.9 10.0 20.2 18.7 6.9 11.3 T1 0.66 
TRT 5.2 9.9 13.1 10.2 9.8 9.7 11.3 t4 <0.01 
H 
CT
R 
13.1 21.2 33.6 52.1 55.3 23.7 11.3 
D2 
<0.01 
TRT 20.0 40.9 39.9 51.8 59.6 32.3 11.3 T*t5 0.13 
To
t 
CT
R 
8.3 15.5 21.8 36.1 37.0 15.3 9.3 T*t*D6 0.87 
TRT 12.6 25.4 26.5 31.0 34.7 21.0 9.3   
IL-6 
L 
CT
R 
1.34 1.61 1.27 1.92 1.57 1.91 0.39 T1 0.97 
TRT 1.69 1.65 1.56 1.33 1.78 1.60 0.39 t4 0.06 
H 
CT
R 
1.90 2.19 1.99 2.10 2.40 3.07 0.39 
D2 
<0.01 
TRT 2.20 2.38 1.77 1.71 2.87 2.38 0.39 T*t5 0.10 
To
t 
CT
R 
1.62 1.90 1.63 2.01 1.98 2.49 0.31 T*t*D6 0.95 
TRT 1.95 2.01 1.67 1.52 2.32 1.99 0.31   
1Treatment effect (CTR is control and TRT is treated). 
2Dose (L is low, and H is high). 
3Standard error. 
4Time. 
5Treatment x time interaction effect (+ is P < 0.1; * is P < 0.05; ** is P < 0.01). 
6Treatment x time x dose interaction effect.  
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Table 6. Fold change values (expressed with respect to baseline) of glucose (Glu), L-lactic 
acid (LLA) and D-lactic acid (DLA) after a whole blood stimulation assay with a low or high 
dose of bacterial lipopolysaccharides in control dairy cows or cows receiving 65 g*d-1 of 
Omnigen-AF® as top-dress between -55 and 42 days from calving 
Item D2 T1 
Days from calving 
SE3 Effect P-Value 
-62 -45 -21 -3 7 28 
Glu 
L 
CTR 0.96 0.96 0.94 0.96 0.93 0.97 0.04 T1 0.13 
TRT 0.98 0.98 0.99 0.91 1.08 0.97 0.04 t4 0.41 
H 
CTR 0.95 0.94 0.89 0.91 0.88 0.93 0.04 D2 0.02 
TRT 0.92 0.93 0.96 0.85 1.00 0.91 0.04 T*t5 0.06 
Tot CTR 0.95 0.95 0.91 0.93 0.91 0.95 0.03 T*t*D6 1.00 
TRT 0.95 0.95 0.98 
+ 
0.88 1.04 
** 
0.94 0.03   
DLA 
L 
CTR 0.97 1.00 1.05 1.12 1.08 1.09 0.04 T1 0.62 
TRT 1.02 1.03 0.99 1.07 1.01 0.99 0.04 t4 0.01 
H 
CTR 0.98 1.00 1.09 1.13 1.11 1.15 0.04 D2 0.04 
TRT 1.06 1.06 1.05 1.12 1.09 1.07 0.04 T*t5 0.08 
Tot CTR 0.98 1.00 1.07 1.12 1.10 1.12 0.03 T*t*D6 0.99 
TRT 1.04 1.05 1.02 1.10 1.05 1.03 
+ 
0.03   
LLA 
L 
CTR 1.02 1.02 1.02 1.04 1.06 1.06 0.02 T1 0.35 
TRT 1.04 1.02 1.03 1.04 1.02 1.00 0.02 t4 0.10 
H 
CTR 1.03 1.03 1.08 1.07 1.10 1.14 0.02 D2 <0.01 
TRT 1.07 1.03 1.04 1.06 1.05 1.08 0.02 T*t5 0.10 
Tot CTR 1.02 1.02 1.05 1.06 1.08 1.10 0.02 T*t*D6 0.84 
TRT 1.05 1.02 1.04 1.05 1.04 1.04 
* 
0.02   
1Treatment effect (CTR is control and TRT is treated). 
2Dose (L is low, and H is high). 
3Standard error. 
4Time. 
5Treatment x time interaction effect (+ is P < 0.1; * is P < 0.05; ** is P < 0.01). 
6Treatment x time x dose interaction effect.  
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Table 7. Fold change values (expressed with respect to baseline) of nitrite (NO2), nitrate 
(NO3) and nitric oxides (NOx) after a whole blood stimulation assay with a low (L) or high 
dose (H) of bacterial lipopolysaccharides in control dairy cows or cows receiving 65 g*d-1 of 
Omnigen-AF® as top-dress between -55 and 42 days from calving 
Item D2 T1 
Days from calving 
SE3 Effect P-Value 
-62 -45 -21 -3 7 28 
NO2 
L 
CTR 1.02 0.99 1.03 1.11 0.96 1.13 0.07 T1 0.96 
TRT 0.97 0.97 1.23 1.23 1.03 0.97 0.07 t4 0.00 
H 
CTR 1.04 1.00 1.03 1.18 0.99 1.06 0.07 D2 0.74 
TRT 1.05 1.01 1.01 1.14 1.02 0.95 0.07 T*t5 0.16 
Tot 
CTR 1.03 1.00 1.03 1.15 0.97 1.10 0.05 T*t*D6 0.70 
TRT 1.01 0.99 1.12 1.18 1.03 0.96 0.05   
NO3 
L 
CTR 0.95 1.07 1.05 1.06 1.04 1.01 0.12 T1 0.96 
TRT 0.99 1.01 0.98 1.02 1.02 0.96 0.12 t4 0.99 
H 
CTR 1.20 1.05 1.20 1.05 1.04 1.05 0.12 D2 0.03 
TRT 1.14 1.40 1.13 1.02 1.11 1.23 0.12 T*t5 0.94 
Tot 
CTR 1.07 1.06 1.12 1.05 1.04 1.03 0.08 T*t*D6 0.78 
TRT 1.06 1.20 1.05 1.02 1.07 1.09 0.08   
NOx 
L 
CTR 0.98 1.05 1.05 1.07 1.02 1.05 0.07 T1 0.73 
TRT 0.98 1.01 1.03 1.05 1.03 0.97 0.07 t4 0.97 
H 
CTR 1.14 1.08 1.15 1.08 1.02 1.05 0.07 D2 0.03 
TRT 1.11 1.17 1.07 1.04 1.09 1.14 0.07 T*t5 0.94 
Tot 
CTR 1.06 1.06 1.10 1.08 1.02 1.05 0.05 T*t*D6 0.79 
TRT 1.05 1.09 1.05 1.04 1.06 1.06 0.05   
1Treatment effect (CTR is control and TRT is treated). 
2Dose (L is low, and H is high). 
3Standard error. 
4Time. 
5Treatment x time interaction effect (+ is P < 0.1; * is P < 0.05; ** is P < 0.01). 
6Treatment x time x dose interaction effect. 
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Figure 4. Scheduled time points, expressed as day from calving (DFC), for dry-off (DRY), 
treatment administration (-), rumen sample collection ( ), milk sample collection ( ), blood 
sample collection for the interferon gamma release assay ( ), carrageenan skin test 
performance and blood sample collection for white blood cells profile and whole blood 
stimulation assay ( ), blood sample collection for metabolic profile ( ), milk yield 
measurement ( ), body weight and body condition score determination ( ), dry matter 
intake and rumination time determination ( ). Empty ticks indicate -55; -53; -3; 1 and 3 DFC 
respectively.  
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Figure 5. Average week values of dry matter intake (a), rumination time (b) and milk yield 
(c) in control dairy cows (CTR; solid line) or cows receiving 65 g*d-1 of Omnigen-AF® as 
top-dress (TRT; dotted line) between -55 and 42 days from calving. Upper solid line indicates 
timing of treatment administration; T is treatment effect; t is time effect; T*t is the treatment x 
time interaction effect (* is P < 0.05; † is P < 0.1); WFC is weeks from calving; DRY is dry-
off day (-55 days from expected calving). 
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Figure 6.Time course of packed cell volume (a) and plasma concentrations of not esterified 
fatty acids (NEFA; b), β-hydroxybutyrate (c), L-Lactic acid (d), creatinine (e), zinc (f), 
myeloperoxidase (g) and albumin (h) in control dairy cows (CTR; solid line) or cows 
receiving 65 g*d-1 of Omnigen-AF® as top-dress (TRT; dotted line) between -55 and 42 days 
from calving. Upper solid line indicates timing of treatment administration; T is treatment 
effect; t is time effect; T*t is the treatment x time interaction effect (** is P < 0.01; * is P < 
0.05; † is P < 0.1); DFC is days from calving; DRY is dry-off day (-55 days from expected 
calving). 
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Figure 4.Time course of plasma concentrations of cholesterol (a), paraoxonase (b), 
interleukin 1-β (c), interleukin-6 (d), thiol groups (e), ferric reducing antioxidant power 
(FRAP; f), total reactive oxygen metabolites (ROMt; g) and advanced oxidation of proteins 
product (AOPP; h) in control dairy cows (CTR; solid line) or cows receiving 65 g*d-1 of 
Omnigen-AF® as top-dress (TRT; dotted line) between -55 and 42 days from calving. Upper 
solid line indicates timing of treatment administration; T is treatment effect; t is time effect; 
T*t is the treatment x time interaction effect (** is P < 0.01; * is P < 0.05; † is P < 0.1); DFC 
is days from calving; DRY is dry-off day (-55 days from expected calving); cindicate that 
parameter has been covariate on -62 value. 
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Figure 5. Optical density difference (∆OD) between avian PPD-stimulated and control wells 
in the interferon gamma (IFNG) release assay (a) and total peripheral response (Rt) after the 
carrageenan skin test (b) in control dairy cows (CTR; solid line) or cows receiving 65 g*d-1 of 
Omnigen-AF® as top-dress (TRT; dotted line) between -55 and 42 days from calving. Upper 
solid line indicates timing of treatment administration; T is treatment effect; t is time effect; 
T*t is the treatment x time interaction effect; DFC is days from calving; DRY is dry-off day (-
55 days from expected calving). 
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SUPPLEMENTARY FILE 
Supplementary file 1. Trends of body weight (BW) and body condition score (BCS) in 
control dairy cows or cows receiving 65 g*d-1 of Omnigen-AF® as top-dress between -55 and 
42 days from calving 
1Treatment effect (CTR is control and TRT is treated). 
2Difference between BCS value at calving and 28 DFC. 
3Time. 
4Treatment x time interaction effect. 
Item, 
Unit 
T1 
Days from calving P-Value 
-65 -45 -21 1 14 21 28 45 T1 t3 T*t4 
BW,  
Kg 
CTR 644.6 649.8 683.6 630.6 587.6 582.2 582.9 585.9 0.96 <0.01 0.99 
TRT 638.2 643.2 679.0 631.4 593.5 585.4 583.8 578.5 
BCS, 
- 
CTR 2.55 2.54 2.56 2.51 2.28 2.20 2.19 2.15 0.54 <0.01 0.88 
TRT 2.41 2.43 2.45 2.44 2.26 2.13 2.13 2.04 
∆BCS2, 
- 
CTR    0.32     0.94 - - 
TRT    0.31        
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Supplementary file 2. Incidence of diseases observed between -62 and 42 days from calving 
(DFC) in control dairy cows or cows receiving 65 g*d-1 of Omnigen-AF® as top-dress 
between -55 and 42 DFC 
1Treatment (CTR is control and TRT is treated). 
2Cows that did not have any clinical disease between -62 and 42 DFC. 
3Retained placenta. 
4Endometritis or metritis. 
5Milk fever. 
6Displacement of abomasum. 
7Mastitis. 
8Pneumonia. 
9Diarrhea. 
10Ketosis (blood BHB higher than 1.4 mmol*L-1). 
T1 Healthy2 
Problems occurrence, n 
RP3 ME/ED4  MF5 DA6 MA7  PN8  DH9  KET10 Total 
CTR 
(5 cows) 
0 0 0 0 0 0 0 2 3 5 
TRT 
(5 cows) 
4 0 0 0 0 0 0 0 1 1 
P <0.01 - - - - - - 0.11 0.2 <0.01 
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Supplementary file 3.Time course of plasma concentrations of glucose (a), D-lactic acid (b), 
urea (c), calcium (d), phosphorus (e), magnesium (f), sodium (g), potassium (h) and chlorine 
(i) in control dairy cows (CTR; solid line) or cows receiving 65 g*d-1 of Omnigen-AF as top-
dress (TRT; dotted line) between -55 and 42 days from calving. Upper solid line indicates 
timing of treatment administration; T is treatment effect; t is time effect; T*t is the treatment x 
time interaction effect; DFC is days from calving; DRY is dry-off day (-55 days from 
expected calving); cindicates that parameter has been covariate on -62 values. 
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Supplementary file 4.Time course of plasma concentrations of aspartate aminotransferase – 
glutamate oxaloacetate transaminase (AST-GOT; a), γ-glutamyl transferase (b), alkaline 
phosphatase (c), bilirubin (d), haptoglobin (e), ceruloplasmin (f), serum amyloid-α (g) and 
retinol (h) in control dairy cows (CTR; solid line) or cows receiving 65 g*d-1 of Omnigen-AF 
as top-dress (TRT; dotted line) between -55 and 42 days from calving. Upper solid line 
indicates timing of treatment administration; T is treatment effect; t is time effect; T*t is the 
treatment x time interaction effect; DFC is days from calving; DRY is dry-off day (-55 days 
from expected calving); cindicates that parameter has been covariate on -62 values. 
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Supplementary file 5.Time course of plasma concentrations of globulin (a); total protein (b), 
tocopherol (c), β-carotene (d), oxygen reactive antioxidant capacity (ORAC; e), nitric oxide 
(f), nitrite (g) and nitrate (h) in control dairy cows (CTR; solid line) or cows receiving 65 g*d-
1 of Omnigen-AF as top-dress (TRT; dotted line) between -55 and 42 days from calving. 
Upper solid line indicates timing of treatment administration; T is treatment effect; t is time 
effect; T*t is the treatment x time interaction effect; DFC is days from calving; DRY is dry-
off day (-55 days from expected calving); cindicates that parameter has been covariate on -62 
values. 
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CHAPTER V - FINAL REMARKS 
General considerations on altered immune functions during peripartum of dairy cows   
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INTRODUCTION 
In the last decades, immune dysfunctions have been reported in dairy cows during the 
phase named transition period (TP), which includes the three weeks prior to calving and the 
first three weeks of lactation (Kehrli et al., 1989; Drackley, 1999). Such alterations consist in 
two distinct phenomena: 1) a reduced competence of the innate immune system, triggering a 
hypo-responsive state in leukocytes, and 2) the occurrence of systemic inflammations, that 
activates leukocytes triggering the acute phase response. Despite opposite effects they have 
on leukocyte functions, those two phenomena suddenly appears together during TP of dairy 
cows (Bertoni and Trevisi, 2013). The risk ratio of both metabolic and infectious diseases in 
early lactation is strictly related to the degree of immune dysfunction. In turn, the occurrence 
of a disease could further impair leukocytes functions, increasing the likelihood of other 
diseases (Ingvartsen, 2006). This vicious circle increases drugs costs and could impair fertility 
of the animals, frequently resulting in their culling. A wide literature background has been 
developed trying to elucidate the causes of immune dysfunction, but the driving cause remain 
unclear. This work was aimed to investigate the changes that occurs on dairy cow’s immunity 
during peripartum and their effect on metabolism, productive performances, and health status. 
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THE ROLE OF DRY-OFF ON IMMUNE DYSFUNCTIONS 
Our data suggests that roots of immune dysfunctions could sink way before TP, and that 
dry-off could have a fundamental role in their development. In fact, dry-off has been revealed 
as a challenging phase in high-yielding cow’s career, related to deep changes in feeding 
behavior, metabolism and immune parameters. A systemic inflammation occurred at dry-off 
in all the animals, impairing liver function and triggering oxidative stress conditions during 
the early dry period. Such an inflammation could probably arise from leukocytes contribution 
in the involution phase of mammary gland, as indicated from the decreased neutrophils and 
monocytes amounts in blood after dry-off, which reflects their migration in peripheral tissues, 
probably also in mammary gland (Putman et al., 2018). Animals with an average milk yield 
higher than 15 L d-1 in the last week prior to dry-off had the worst condition, and this could 
probably be related to the deeper metabolic changes they faced at dry-off time consequently 
to milking interruption, to the udder pain due to milk accumulation and to the greater amount 
of parenchymatic tissue to be reabsorbed. Metabolic stress at dry-off has already been related 
to the production of cortisol, that is known to impair immune competence when released in 
massive quantity (Bertulat et al., 2013).  Sudden changes in feeds composition and rumen 
functions, as those occurring during the dry period, could affect the integrity of rumen 
epithelia, allowing the migration of bacterial components to internal tissues, as Minuti et al. 
(2014) had well demonstrated in the transition from dry to lactation phase.  
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IMMUNE FUNCTIONS AND KETOSIS 
Our results on cows affected from sub-clinical ketosis (blood beta-hydroxybutyrate -BHB- 
higher that 1.2 mmol/L) in early lactation, revealed higher prepartal plasma concentrations of 
pro inflammatory cytokines (PICs – Interleukin-1, beta and Interleukin-6) and 
myeloperoxidase, an enzyme that is related to the respiratory burst activity of neutrophils 
(Faith et al., 2008), and higher concentrations of reactive oxygen metabolites. Furthermore, 
they had lower level of plasma minerals and higher creatinine, suggesting an impaired kidney 
functionality, and higher concentration of gamma-glutamyl transferase (GGT), suggesting a 
liver damage to occur. Leukocytes from the same cows had greater production of interferon 
gamma (IFNG) after stimulation with Mycobacterium avium in the same period, suggesting 
ketosis to be preceded from a metabolic preeclamptic-like status. Greater IFNG production 
may account for insulin resistance and increased plasma concentration of NEFA and BHB 
observed in KET cows. The anorexic power exerted by NEFA and BHB and the high 
circulating glucose levels reduced DMI around calving and, together with the energy 
requirement related to activation of immune system in dry period, worsen the negative energy 
balance (NEB) in early lactation. Such a condition induces severe milk yield losses and 
boosts the mobilization of lipid sources. The impaired liver function and the activation of the 
immune system during the dry period consequential to preeclampsia accrues the physiologic 
acute phase response after calving, further impairing oxidizing capacity in liver. Anti-
inflammatory regulatory mechanisms, both at liver and leukocytes level (Biswas and Lopez-
Collazo, 2009; Akbar et al., 2015), could account for the reduced production of PICs and 
increased production of anti-inflammatory mediators (such as lactate) in leukocytes of KET 
cows after a stimulation with lipopolysaccharides (LPS). Lower PICs detected before ketosis 
onset suggested the development of an endotoxin tolerance status during dry period. It 
consists in a transient unresponsive state against further challenges with endotoxins, leading 
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to the upregulation of anti-inflammatory genes in leukocytes (Biswas and Lopez-Collazo, 
2009). During ketosis, leukocytes function can be further impaired by the combination of 
higher lipomobilization (Sordillo, 2016) and of a greater expression of anti-inflammatory 
genes at liver level to cope with inflammation and prevent fatty liver condition (Akbar et al., 
2015). 
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OMNIGEN-AF AS A STRATEGY TO COPE WITH IMMUNE DYSFUNCTIONS 
The administration of immune-stimulant products could be an effective strategy to 
minimize negative effects of immune dysfunctions in TP. Omnigen-AF (OAF) has been 
widely investigated in this respect (Nickerson et al.; Wang et al., 2004; Ortiz-Marty et al., 
2013). A positive effect on leukocyte function and a consequent reduction of the incidence of 
infectious diseases in TP has been widely reported with OAF (Wang et al., 2007; Nace et al., 
2014). Although a direct effect of OAF on neutrophils gene expression has been reported, our 
data suggests an indirect effect of the additive on immune function. In our experiment, the 
administration of 65 g/d of OAF from dry-off (55 days prior to calving) to 45 days after 
parturition did not affect neutrophils diapedesis at the carrageenan skin test and neither had 
any effect on the amelioration of liver metabolism and inflammation of dairy cows over 
calving. Nevertheless, it seemed to ameliorate the recovery of rumen functions after calving, 
improving the rumination time, the energy metabolism and reducing ketogenesis. Such an 
improvement could justify the greater efficiency of leukocytes to face biological stressors 
during the peripartum, as suggested from their lower lactate production and lower glucose 
consumption after an LPS challenge. Furthermore, an increased lymphocytes abundance at 
blood level also occurred with OAF. Despite these positive effects on immune cells, OAF 
seem to be ineffective in reducing the degree of inflammation over calving. A reduced 
abundance of negative acute phase proteins and antioxidants also occurred with OAF after 
calving, suggesting some impairment of hepatic functions to occur. Nevertheless, the lack of 
any effect on main biomarkers related to liver function (bilirubin) and liver damage (GGT, 
aspartate-amino transferase, alkaline phosphatase) dismisses a real impairment of liver 
activities to occur with OAF. This could suggest OAF to act as a weak antioxidant reducing 
body requirements for endogenous antioxidants synthesis.  
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GENERAL CONCLUSION 
In conclusion, our data allow us to state that: 1) dry-off could affect metabolism and trigger 
an acute phase response, especially when milk yield was higher than 15 L/d in the week prior 
to milking interruption 2) an activation of immune system during dry period could trigger an 
endotoxin tolerance status, that could contribute in decreasing immune cells functions around 
calving 3) altered immune functions before calving, and IFNG production in particular, could 
boost the development of sub clinical ketosis in early lactation 4) administration of OAF 
could be effective in reducing rumen alteration after stressing events, as dry-off and calving, 
and could act as a weak antioxidant.  
Nevertheless, our data does not allow us to 1) clearly identify the role of acute phase 
response occurred at dry-off in triggering endotoxin tolerance prior to ketosis onset 2) fully 
elucidate the driving mechanism of the preeclamptic-like status occurred in our cows prior to 
ketosis, 3) fully understand the real mode of action of OAF on rumen fermentations. 
A wider study considering the whole peripartal period should be performed to clearly 
elucidate the effect of milk yield and other stressing events occurring at dry-off on the onset 
of diseases in early lactation. Furthermore, a wider experimental group should be enrolled to 
clearly identify the role of preeclamptic-like status in the onset of such diseases (immune 
dysregulation and ketosis in particular). Finally, an experimental design involving multiple 
rumen samples during the administration of OAF should be adopted to test its effects on 
rumen fermentation and metabolism. The adoption of specific tools aimed to elucidate the 
interactions of the product with microbiota and immune cells at the mucosal level, and their 
relationship with the acute phase response at metabolic level, should be essential to elucidate 
the exact mode of action of the molecule on immune cells during the whole peripartum 
period. 
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APPENDIX 
Appendix 1. Abbreviations used throughout this thesis and their definitions 
ABBREVIATION DEFINITION ABBREVIATION DEFINITION 
∆BCS Body condition score 
difference 
MD*t*D Milk yield at dry-off x 
time x dose interaction 
effect 
∆OD Optical density difference MDA5 Melanoma 
Differentiation-
Associated protein 5 
a30 Curd firmness at 30 min  MHC Major 
histocompatibility 
complex 
AIC Anti-inflammatory 
cytokines 
MPO Myeloperoxidase 
ALP Alkaline phosphatase mRNA Messengers-RNA 
AOPP Advanced oxidation 
protein products 
NADPH Nicotinamide adenine 
dinucleotide-phosphate 
APP Acute phase proteins NEB Negative energy 
balance 
AST-GOT Aspartate amino 
transferase-glutamate 
oxaloacetate 
transaminase 
NEFA Non-esterified fatty 
acids 
BCS Body condition score NEL Net energy for lactation 
BHB Beta-hydroxybutyrate  NFC Not fiber carbohydrates 
BIRC1 Inhibitor of apoptosis 
domain-containing 
protein 1 
NF-κB Nuclear factor-κB 
cAMP-BP Cyclic adenosine 
monophosphate response 
element binding protein  
NLR Nucleotide binding 
oligomerization 
domain-like receptors  
CD Cluster of differentiation NO2 Nitrite 
CIITA Class II major 
histocompatibility 
complex transactivator 
NO3 Nitrate 
CLA Conjugated linoleic acid NOx Nitric oxides 
CLR C-type lectin receptors OAF Omnigen-AF 
COX Cyclooxygenases ORAC Oxygen reactive 
antioxidant capacity 
CST Carrageenan skin test PAMPs Pathogen associated 
molecular patterns 
D Dose effect PCV Packed cell volume 
DAMPs Damage associated 
molecular patterns 
PEB Positive energy balance 
DCs Dendritic cells peNDF Physical effective-
neutral detergent fiber 
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DFC Days from calving PG Prostaglandin 
DFD Days from dry-off PI Physiological 
imbalance 
DHA Docosahexaenoic acid PIC Pro-inflammatory 
cytokines 
DLA D-lactic acid PMN Polymorphonuclear 
cells 
DM Dry matter PON Paraoxonase 
DMI  Dry matter intake PPARA Peroxisome 
proliferation activated 
factor, alpha 
EPA Eicosapentaenoic acid  PPARD Peroxisome 
proliferation activated 
factor, delta 
FGF21 Fibroblast growth factor 
21 
PPARG Peroxisome 
proliferation activated 
factor, gamma 
GGT Gamma-glutamyl 
transferase 
PPD Purified protein 
derivative 
GH Growth hormone PRR Pattern of recognition 
receptor 
H High dose PUFA Poly-unsaturated fatty 
acids 
HLA Human leukocytes 
antigen 
r Rennet clotting time 
HM High milk yield at dry-off RIG Retinoic acid-inducible 
gene 
Hs Health status effect RLR RIG-like receptors  
Hs*t Health status x time 
interaction effect 
ROM Reactive oxygen 
metabolites 
Hs*t*D Health status x time x 
dose interaction effect 
RP Retained placenta 
IFNA Interferon, alpha SAA Serum amyloid, alpha 
IFNG Interferon, gamma SCC Somatic cells count 
IGF-1 Insulin-like growth 
factor-1 
SELL Selectin, L 
Igs Immunoglobulins SFA Saturated fatty acids 
IL-10 Interleukin-10 SHp Thiol groups 
IL-12 Interleukin-12 t Time effect 
IL-17 Interleukin-17 T Treatment effect 
IL-1B Interleukin-1, beta T*t Treatment x time 
interaction effect 
IL-2 Interleukin-2 T*t*D Treatment x time x 
dose interaction effect 
IL-4 Interleukin-4 Tc T-cytotoxic cells 
IL-8 Interleukin-8 Th T-helper cells 
L Low dose TLR Toll-like receptor 
LDA Left displacement of 
abomasum 
TNFA Tumor necrosis factor, 
alpha 
LLA L-lactic acid TP Transition period 
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LM Low milk yield at dry-off Treg T-regulatory cells 
LOX Lipoxygenases TX Thromboxane 
LPS Lipopolysaccharides UFA Unsaturated fatty acids 
LT Leukotrienes VFA Volatile fatty acids 
LX Lipoxins VLDL Very low-density 
lipoproteins 
MD Milk yield at dry-off 
effect 
WBA Whole blood 
stimulation assay 
MD*t Milk yield at dry-off x 
time interaction effect 
WBC White blood cells 
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Appendix 2. Publications edited by the thesis author 
DATE JOURNAL/CONFERENCE, publication 
January 3rd, 2019  Gene X 
- Busato S., Mezzetti M., Logan P., Aguilera N. and 
Bionaz M. 2018. “What’s the norm in normalization? A 
frightening note on the use of RT-qPCR in the livestock 
science”. Gene X. 1:100003. 
doi:10.1016/j.gene.2018.100003  
June 24th, 2018 – June 
27th, 2018 
 
 
 
Annual Meeting of the American Dairy Science Association 
Knoxville, Tennessee, USA.  
- Mezzetti M., Jaaf S., Busato S., Premi M., Trevisi E., 
Bobe G., and Bionaz M. 2018. “Calves born from cows 
fed with alfalfa enriched with selenium have higher Se in 
blood and higher phagocytosis”. 2018 ADSA Annual 
Meeting Abstract#154 
- Jaaf S., Mezzetti M., Krueger A., Batty B., Belveal J., 
Premi M., Foster J., Trevisi E., Bobe G., Estill C. and 
Bionaz M. 2018. “Effect of selenium-enriched hay on Se 
concentration in blood and milk, immune function, and 
performance in dairy cows during the transition period”. 
2018 ADSA Annual Meeting Abstract#268 
- Busato S., Aguilera N., Mezzetti M., and Bionaz M. 
2018. “What’s the norm in normalization? A note on the 
use of RTqPCR in livestock-related studies”. 2018 
ADSA Annual Meeting Abstract#429 
June 22nd, 2018 – June 
24th, 2018 
 
Annual meeting of the Italian Association of Veterinary 
Sciences (SISVet). Torino, Italy 
- Minuti A., Amadori M., Mezzetti M., Lovotti G., 
Piccioli-Cappelli F. and Trevisi E. 2018. “The interferon 
gamma response to Mycobacterium avium in vitro can 
be correlated with a higher risk of clinical ketosis in 
dairy cows”. 2018 SISVet Annual Meeting Abstract 
June 28th, 2017 – July 1st, 
2017 
Annual meeting of the Italian Association of Veterinary 
Sciences (SISVet). Naples, Italy 
- Trevisi E., Minuti A., Mezzetti M., Soares J.F.F., Riva 
F., Bani P. and Amadori M. 2017. “Monensin affects the 
innate immune response in the rumen”. 2017 SISVet 
Annual Meeting Abstract 
June 13th, 2017 
 
Annual meeting of the Association for Science and Animal 
Productions (ASPA). Perugia, Italy 
- Trevisi E., Minuti A., Mezzetti M., Ferrari A., and 
Piccioli-Cappelli F. 2017. “Supplements of Aloe 
arborescens improve health and inflammo-metabolic 
status of transition dairy cows”. 2017 ASPA Annual 
Meeting Abstract 
- Piccioli-Cappelli F., Maiocchi M., Minuti A., Mezzetti 
M., and Trevisi E. 2017. “Effect of rumen-protected 
methionine and choline supplementation during dry 
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